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Clinical guidelines are recommendations targeted at medical professionals which aim to 
optimise patient care. When successfully implemented, clinical guidelines have been shown to 
improve processes of care and clinical outcomes. However, clinical guidelines are often not 
successfully implemented and there exists a significant variation in rates of compliance 
between different doctors. Factors which affect compliance fall in to four categories: patient, 
doctor, environment and guideline.  
In 2015 the Canterbury District Health Board changed to a new platform of online clinical 
guidance called Hospital HealthPathways. This platform differed significantly from its 
predecessor The Blue Book in both the development process and design of the clinical 
guidance. This study compared the use of and compliance with guideline recommendations 
between these two different platforms of clinical guidance.  By doing so, this study was able to 
examine how guideline use and compliance is affected by the development process and design 
of a clinical guideline.  Sub-group analysis examined how compliance varied between different 
clinicians, different patients, and different environments and also the interaction between these 
factors and guideline design.  
A sub-analysis examined barriers to guideline compliance reported by clinicians to understand 
the perceived obstacles clinicians had to following guideline recommendations. 
Finally, this study developed the concept of “appropriate non-compliance” by quantifying and 
describing cases where it was appropriate for clinicians not to follow local clinical guideline 
recommendations whilst managing patients.  
Methods 
This study adopted a mixed-methods methodology. Three conditions were selected for study: 
community acquired pneumonia (CAP), acute pancreatitis and intracranial haemorrhage (ICH) 
on warfarin. For each condition two distinct equivalent time periods were selected for 
comparison: the first when patients were managed by guidance in The Blue Book and the 
second when patients were managed by guidance in Hospital HealthPathways.  
The use of the clinical guideline website was assessed by analysing unique page views of the 
guidance pages using Google Analytics. Compliance with guideline recommendations was 
assessed by a retrospective audit of the clinical notes. A survey was developed and sent to all 
hospital doctors to understand barriers to compliance. The concept of appropriate non-
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compliance was explored by documenting, quantifying and categorising reasons for non-
compliance with clinical guideline recommendations documented in the clinical notes.  
 
Results 
This study found that a change in the guideline development process and design not only 
improved use and compliance but also reduced the variation in practice between doctors. 
Presence of co-morbidity and severity of illness, were significant factors contributing towards 
non-compliance. 
Clinicians agreed that clinical guideline recommendations do not apply to all patients. This 
study documented and quantified cases where following a guideline recommendation was not 
appropriate.  
Conclusion  
Patient factors, including co-morbidities and severity of illness, were significant factors 
contributing to non-compliance. However, a change in the guideline development and 
presentation not only improved use and compliance but also reduced the variation in practice 
between doctors. Previous research has suggested that usability can improve compliance but 
this study is the first to show how a modified platform can improve compliance and reduce 
clinician-related variation.   
Non-compliance with guidelines is, at times, appropriate. The rate of appropriate non-
compliance can be quantified. 
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1 Chapter One - Introduction 
 
1.1 Chapter Overview  
 
Clinical guidelines are recommendations that guide decision making in health care. The 
successful implementation of clinical guidelines has been shown to improve processes of care 
and clinical outcomes (1, 2). However, guidelines are often not effectively implemented and 
their recommendations not consistently followed by clinicians. The rates of compliance with 
guideline recommendations by doctors have repeatedly been shown to be low (3-5). 
Additionally, compliance significantly varies not only between different clinicians but also 
guidelines (2, 6).  
Variables which affect compliance fall in to four categories: patient, doctor, environment and 
guideline(7, 8). The aim of this study was to understand which variables within each of the four 
categories positively and negatively affect guideline use and compliance.  
In 2015 the Canterbury District Health Board changed from a well-established clinical 
guidance publication called the Blue Book (1983-2015) to a new platform called Hospital 
HealthPathways (2015-present), which differed significantly in both the development and the 
presentation of the clinical guidance. The study described in this thesis compared the use of and 
compliance with the two clinical guidance websites. By doing so, this study examined the 
effects of modifiable variables within the guideline category: the development process and 
design of a clinical guideline. Sub-group analysis examined how compliance varied between 
different clinicians, different patients, and different environments. 
By comparing practice between patients managed in 2015 and 2016 the study was able to 
examine how a change in the development and design of a clinical guidance website affected 
compliance with guideline recommendations. Sub-group analysis was not only able to show the 
effects that patient, clinician and environmental factors had on rates of compliance, but also the 
interplay between these factors and guideline design. A sub-analysis examined barriers to 
guideline compliance reported by clinicians to understand the perceived obstacles clinicians 
had to following guideline recommendations. Finally, this study developed the concept of 
“appropriate non-compliance” by quantifying and describing cases where it was appropriate for 
clinicians not to follow local clinical guideline recommendations whilst managing patients.  
This introduction provides an overview of this study. The initial discussion focuses on the 
definition, roles and effects of clinical guidelines. Data on rates of compliance with clinical 
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guidelines and factors which may influence compliance in the existing literature will be 
described in detail.  
The chapter then introduces the setting in which the study was carried out, namely Canterbury, 
New Zealand. The local history of clinical guidelines in Canterbury is described, including the 
origins of The Blue Book and Hospital HealthPathways, with a comparison of the respective 
contents, development processes, and styles.  
Finally, the development of the aim and objectives of this study are summarised.  
 
1.2 Clinical Guidelines 
 
1.2.1 Definition  
 
Clinical guidelines are recommendations that guide decision making in healthcare, and their 
use has become increasingly commonplace in modern medical practice across all clinical 
specialties. Guidelines have been developed by a variety of groups ranging from hospital 
departments to international governing bodies, and can influence choices ranging from those 
made by the junior doctor at the bedside, to national governmental spending decisions.  
Clinical guidelines have been defined by the Institute of Medicine (IOM) as “statements that 
include recommendations intended to optimize patient care that are informed by a systematic 
review of evidence and an assessment of the benefits and harms of alternative care options.”(9) 
This definition recognises systematic review of the available evidence as an essential part of 
the guideline development process. The importance of evidence is reflected in the methods of 
many leading guideline creating institutions, such as The National Institute for Health and Care 
Excellence (NICE), a guideline producing non-departmental public body of the United 
Kingdom Department of Health. Each NICE guideline is developed through a systematic 
review of the available evidence (10). This evidence is collated, critically appraised, and then 
summarised for the user.  
However, not all clinical guidelines are developed in this way. Some guidelines are developed 
using a consensus or committee approach (11), for example when creating a localised version 
of a national guideline to decide how best to manage patients in accordance with that guidance 
in a specific setting and within available resources. This pragmatic approach may then involve 
the inclusion of recommendations which do not come from the results of systematic reviews. 
Consensus guidelines may also be adopted in areas of health care in which there are few 
3 
 
randomised control trials upon which to base a systematic review, for example palliative care. 
Finally, the development of an evidence-based guideline requires significant investment both 
financially, and in terms of time and expertise. There may not be sufficient resources in a given 
setting to develop an evidence-based guideline, thus the need for a consensus approach in this 
context.  
There are a large number of terms used when referring to clinical guidelines, and words under 
the umbrella term of guideline are often used inconsistently or synonymously in the literature. 
Examples of these words include: pathway, protocol, care map, and care bundle (12). 
Furthermore, there are no agreed definitions for a number of commonly used terms. A term 
other than guideline is generally used to describe documents which detail not only the evidence 
but also a step-wise approach to applying recommendations in clinical practice. The most 




Within the primary goal of optimising patient care, clinical guidelines have a number of roles 
in both medical research and clinical practice. 
Firstly, clinical guidelines serve as a means of translating evidence in to practice. Recent 
decades have seen an exponential proliferation of biomedical research (13). To date there are 
over a million randomised controlled trials registered with Cochrane CENTRAL database (14) 
It is way beyond the ability of any one clinician to read, and appraise this mass of information.  
The development of an evidence-based clinical guideline involves a systematic review of the 
available evidence, the results of which are distilled in to a series of recommendations on how 
clinicians can apply this evidence in everyday practice.  Guidelines therefore act as a conduit 
between the researcher and clinician. 
Secondly, clinical guidelines aim to standardise healthcare provision, both between individual 
clinicians and institutions. The standardisation of clinical management between different 
clinicians, institutions and countries has been identified by the World Health Organisation 
(WHO) as key to improving patient safety (15). Getting all clinicians to follow guideline 
recommendations can ensure that interventions are delivered in a uniform way. The origins and 
continuance of this role can also be attributed in part to the aforementioned proliferation in 
biomedical research. The validity of trials is dependent on the standardisation of categories, 
instruments, procedures, and protocols used, and collective evaluation of an intervention often 
requires collaboration between distant research and healthcare institutions. Guidelines provide a 
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communication tool between clinical researchers by setting out consistent terminology, 
practices, and standards. For example, in the field of oncology a number of chemotherapy 
treatment guidelines have their origins in research protocols developed for clinical trials (16).  
Clinical guidelines also provide a means of monitoring and regulating the quality of healthcare 
Individual guideline recommendations are often used as standards for auditing clinical practice 
(17). For instance, when producing a guideline, NICE also release a series of ‘quality 
standards’ based upon that guideline (18). Clinical practice can be audited against these 
standards by both health professionals and external regulatory bodies. This measures-based 
approach to quality is controversial as it is sometimes seen as undermining a clinician’s 
autonomy (7, 19, 20). Advocates of evidence-based care have argued, however, that institutions 
and clinicians should be aiming to reach these targets if patient outcomes are to be improved.  
Lastly, clinical guidelines have a role in healthcare rationing, and the allocation of finite 
healthcare resources. This involves deliberation on maximising the value and ‘health gain’ of 
clinical practice. Many guideline developers take steps to ensure that their recommendations 
maximise value, with interventions that lead to an improvement in care at an acceptable cost 
(21). Defining ‘improvement in care’ and ‘acceptable cost’ is the subject of much debate. For 
example, NICE assess both the clinical effectiveness and cost effectiveness of their 
recommendations using Quality Adjusted Life Years (QALYs)(22). QALYs represent both the 
quality and quantity of years of life, with one QALY equalling one year in perfect health. The 
current ‘acceptable cost’ of an intervention is £20,000-30,000 per QALY gained (22, 23). 
Interventions which exceed this financial limit are not included in NICE guidelines and are not 
funded by the UK’s National Health Service (NHS). This example shows how, by measuring 
the cost-effectiveness of an intervention alongside clinical effectiveness, a guideline developer 
has a role in rationing healthcare resources. 
 
1.2.3 Effects of Clinical Guidelines 
 
The intended goal of clinical guidelines is to optimise patient outcomes. Their widespread 
publication, and the significant investment required to produce them, has led to the critical 
evaluation of guidelines themselves as an intervention.  
Two key systematic reviews address the effects of clinical guidelines on processes of care and  
clinical outcomes (1, 2). Processes of care are the actions health professionals take, and clinical 
outcomes are the effects those actions have on patients. Rotter et al. specifically examined 
clinical pathways(1).These are defined as a guideline that presents a structured multi-
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disciplinary plan of care and a step-wise guide to applying guideline recommendations in a 
local context (12). The review examined the effects that clinical pathways had on processes of 
care, clinical outcomes and hospital costs. Meta-analysis found that compliance with clinical 
pathways led to falls in in-hospital complications, hospital costs, and length of stay. 
Furthermore, they found an improvement in documentation by clinicians. The review showed 
that the introduction of clinical pathways had no effect on readmission rates, or on in-hospital 
mortality. The review undertaken by Grimshaw et al. assessed the effect of clinical guidelines 
on processes of care and on clinical outcomes (2). The authors concluded that for the most part 
the implementation of clinical guidelines led to an improvement in both areas. Fifty-five of the 
fifty-nine included studies demonstrated an improvement in the processes of care, and nine out 
of the eleven studies showed an improvement in clinical outcomes. 
 
1.2.4 Compliance Rates and Variation in Practice  
 
Despite the evidence supporting guidelines as an intervention, there is a wide variation, both 
within and between studies, in the size of the effect guidelines have on processes of care, and 
on clinical outcomes. This variation has been identified as being due to varying levels of 
compliance with guideline recommendations (2).  
Compliance with clinical guidelines often falls short of desired standards. The expected levels 
of compliance with guideline recommendation is often given as 100 %(18). However, guideline 
recommendations are only followed on average in 61% of clinicians’ decisions (6), and only 
54.9% of all care provided to patients is in keeping with guideline recommendations (24). 
Furthermore, in spite of the intended goal of standardising care, variation in compliance with 
guideline recommendations exists between different clinicians, between different 
recommendations within the same guideline, and between guidelines for different conditions(6, 
24).  
In the past researchers have argued that low compliance, and variation in compliance is due to 
a failure in the process of developing strategies to promote the acceptance and adoption of 
guidelines(2, 6). This argument may account for the variation in compliance between different 
guidelines and the same guideline in different settings. However it does not explain the 
variation in compliance between different clinicians in the same setting, and between different 
recommendations within the same guideline (6). This suggests that understanding why a 
clinician complies with an individual guideline recommendation in clinical practice is complex 




1.2.5 Factors Affecting Guideline Compliance 
 
In the existing literature, a framework has been suggested for understanding guideline 
compliance which is based upon a psychological model of behavioural change: the knowledge, 
attitude and behaviour (KAB) model (25). This model states that for a clinician to follow a 
guideline recommendation, a change in behaviour must be preceded by changes in their 
knowledge and attitudes.  
This theoretical model has been used by qualitative researchers to identify factors which 
influence a clinician’s knowledge, attitude and behaviour in relation to guideline 
recommendations. These factors, which can be considered barriers to or predictors of guideline 
compliance, can be grouped in to four categories: patient, clinician, environment and guideline 
(7, 8).   
The first category to exert an influence on guideline compliance are factors related to the 
patient. Patient characteristics can place limits on guideline implementation. They act as a 
barrier at the behaviour change stage of the KAB model. These factors include the clinical 
features of the presentation, the patient’s past medical history and, demographic characteristics. 
The second category are those factors related to the clinician. A clinician must have knowledge 
of a guideline and a positive attitude towards it to comply with the recommendations, but 
knowledge, attitude and behaviour can be affected by implicit biases associated with their own 
demographics, such as age or gender. A third category for consideration is the environment in 
which the guideline is being used. This broad category includes the geographical location, the 
type of healthcare institution, resources available within a given setting, the team environment, 
and whether there has been an implementation program for that guideline. Environmental 
factors act as external influences on behavioural change. Finally, the characteristics of the 
guideline itself have been shown to influence use. This includes both the topic of the guideline, 
which can affect the knowledge and attitude of a clinician, and the usability of the guideline, 
which can be a facilitator of or a barrier to use(7).   
Understanding clinician compliance with guideline recommendations requires not only 
examination of each of these four categories in isolation, but also the interplay between these 




1.2.6 Non-Compliance with Clinical Guideline Recommendations 
 
Non-compliance is generally explored by examining barriers or obstacles to following 
guideline recommendations (7). This approach aims to change clinical practice by adapting 
guidelines to address clinicians’ perceived barriers to change (26).  
Non-compliance may not be a limitation of the clinician or a barrier in the environment in 
which they are working but rather an example of rational clinical decision making. Guideline 
recommendations are not applicable to all clinical scenarios(27), and there may be times when 
it is appropriate for clinicians not to follow a clinical guideline. This is important to consider 
when examining patient factors associated with non-compliance. For example, managing a 
patient with co-morbidities may require deviation from guideline recommendations for a 
number of clinically sound reasons. 
 The concept of appropriate non-compliance was explored in a systematic review carried out 
by Arts et al (28). Arts et al defined appropriate or intentional non-compliance as ‘a conscious 
decision of the patient or physician not to follow a guideline’. This study reviewed sixteen 
cohort studies which listed and adjudicated on documented reasons for ‘intentional’ non-
compliance with clinical guidelines. The review was limited somewhat by significant 
heterogeneity between the included studies. However, the results noted that non-adherence with 
clinical guideline recommendations ranged from 8.2-65.3%. The proportion of reasons for non-
adherence which were deemed valid in adjudication ranged from 6.6-93.6%. There emerged 
five categories of reasons for non-compliance with clinical guideline recommendations: 
“patient decision”, contra-indications”, “patient demographics”, “physician decision”, and 
“other”. The most commonly noted category of non-adherence was “patient decision” or 
“contra-indication”.  
NICE recognises that there are scenarios where non-compliance is appropriate, however does 
not identify possible reasons for appropriate non-compliance, nor does it factor in intentional 
non-compliance when calculating quality standard rates. NICE recommends a target of 100% 







1.3 Clinical Guidelines in the CDHB  
 
1.3.1 History of The Blue Book 
 
This study examined utilisation and compliance with local clinical guidelines used by 
clinicians working in the Canterbury District Health Board. 
Local clinical guidelines within the CDHB date back to 1979 when a formal continuing 
medical education programme was launched.  As part of this programme physicians were 
required to carry out audits to assess the quality of care being provided. The audits were 
presented at weekly lunchtime meetings organised by the Canterbury Association of Physicians 
and attended by general and specialist physicians. These audits showed that patients with 
common medical conditions were receiving sub-standard and inconsistent care. It was felt that 
quality of care could be improved through development of local clinical guidelines detailing the 
assessment and management of a series of common medical presentations and conditions, 
prepared by clinicians within the relevant specialty. These guidelines would be targeted at 
hospital-based junior doctors, resident medical officers (RMOs), working within the CDHB. 
(29)  
Under the supervision of Dr Mike Beard, the first set of guidelines was published in 1983, 
under the title ‘Management Guidelines for Common Medical Conditions’ but quickly 
becoming universally known as ‘The Blue Book’ due to the colour of the cover. The Blue Book 
proved popular with RMOs, and its use was so much a part of everyday practice that 
subsequent editions were published in A5 size to better fit in the pocket of a white coat. 
A new and updated version of The Blue Book was published every two years to ensure 
guidance remained valid. In the early 2000s Streamliners Ltd, a technical writing company in 
Christchurch, was contracted to create an online searchable PDF version of the Blue Book, with 
the first online version appearing in 2001. The fifteenth and final edition of The Blue Book was 
published in December 2013.  
The Blue Book was a hugely popular resource and it helped develop a culture within the 





1.3.2 Content of The Blue Book 
 
The Blue Book was structured around chapters for each medical specialty, with each chapter 
consisting of a series of guidelines for symptoms, diseases or procedures under the remit of that 
specialty. The guidelines in The Blue Book all roughly followed a similar structure starting 
with general information about the topic, followed by specific guidance on how to assess and 
manage the patient. This structure was not strictly applied throughout the book and there was a 
degree of inconsistency in the content and format of different guidelines.  
There was no formal policy addressing the style of writing for guidelines and chapters of The 
Blue Book.  
In the online version of The Blue Book each guideline was presented as a PDF file.  
 
1.3.3 The Blue Book Team and the Development Process 
 
The production of each edition of The Blue Book was overseen by The Blue Book Editorial 
Committee. The committee was made up of senior medical officers and registrars who would 
review each guideline prior to publication. In the early days of The Blue Book the Editorial 
Committee consisted entirely of doctors from medical specialities. However, over the years as 
the content of the book expanded anaesthetists and emergency medics also joined. All members 
of the committee volunteered their time, and there were no members of staff involved in the 
development of each edition full time.  
Each chapter in The Blue Book was developed as a collaboration between the Clinical Director 
of the department and The Blue Book editorial committee. With each new edition the Clinical 
Director (or a delegated senior medical officer) would be approached and asked to review and 
update the relevant content, which would then be reviewed by The Blue Book Editorial 
Committee prior to publication.  
Technical writers from Streamliners converted paper versions of guidelines into PDF 
webpages, which were uploaded to a searchable website. However, there was no technical 





1.3.4 History of Hospital HealthPathways 
 
Hospital HealthPathways is the current model of local clinical guidance delivery for doctors 
working in the CDHB. It is a web-based collection of guidelines consisting of 
recommendations on local best practice for the assessment and management of common 
medical conditions. 
The HealthPathways model of clinical guidance initially started in the community. The 
HealthPathways project began in 2008, at a time when the CDHB was undergoing a series of 
reforms intended to create a better integrated health care system. The goal was to ensure that 
the CDHB delivered “the right care, right place, right time by the right person” (30). One of the 
key elements identified for re-design was the interaction between primary and secondary care 
physicians. General practitioners felt that the referral criteria for secondary care services were 
opaque, and that their referrals were being rejected unpredictably. For their part, hospital 
clinicians felt inundated with inappropriate referrals, and did not have a clear understanding of 
services available in the community. To address these problems, meetings began to be held 
between general practitioners and hospital clinicians to discuss and negotiate the management 
of common medical conditions in the community, and the referral criteria for secondary care 
involvement. As a result of these meetings, in 2008 a clinical pathway was developed detailing 
the assessment, management and referral criteria for patients with chronic obstructive 
pulmonary disease (COPD). (30, 31).  
Streamliners Ltd were employed to present this pathway online. Following the development of 
10 further pathways for different conditions, the website HealthPathways was launched. The 
number of pathways grew rapidly, and today there are over 500 clinical pathways on the 
website.  
In 2015, the guidance within the current edition of The Blue Book was due to be updated. Due 
to limited staffing resources, there was no plan for a new edition of the book to be produced.  
Ceasing development of The Blue Book would lead to a vacuum in up-to-date local clinical 
guidance for doctors working in the hospitals in Canterbury. This impending vacuum coupled 
with the success of the HealthPathways project in the community led to calls for the 
HealthPathways model to be adopted in the hospital setting(32).  
The HealthPathways in the Hospital project, soon to be known as Hospital HealthPathways, 






This study examined use of and compliance with local clinical guidance by clinicians working 
for the Canterbury District Health Board in Canterbury, New Zealand.  
Canterbury is a region on the South Island of New Zealand. It has a population of just over half 
a million people, which equates to 11.5% of the New Zealand population. The largest city in 
Canterbury is Christchurch, which is home to 65% of the region’s population (33).  
The population of Canterbury is predominantly of European ethnicity (86.9%). The largest 
ethnic minority group is Māori followed closely by Asian, making up 8.1 and 6.9% of the 
population respectively (34). These groups make up a smaller proportion of the population than 
the national average.  
The age of the population is above the national average, and the proportion of older residents 
in the population is growing. The average age of a Canterbury resident is 39.9 years - two years 
older than the New Zealand average (35). The most recent population predictions show that 
15.8% of Canterbury’s population is over 65 and this is predicted to rise to 25% by 2026(36).  
The Canterbury District Health Board (CDHB) is the public body responsible for providing 
health care to the Canterbury region. It owns and is responsible for managing six major 
hospitals and thirty smaller rural facilities. The major hospitals include: Christchurch Public, 
Christchurch Women’s, Burwood, Princess Margaret, Hillmorton and Ashburton. Christchurch 
Public Hospital is the largest hospital with 650+ inpatient beds. It provides secondary care for 
the Canterbury population, and tertiary care for the South Island. Christchurch Public Hospital 
is the location of the city’s emergency department which has approximately 91,000 
presentations per annum (36). The CDHB has over 1,000 contracts with organisations that 
provide health care to the population including primary health care, mental health, ambulance 
service, pharmacies, and laboratories.  
 
1.4.1 Content of Hospital HealthPathways  
 
Hospital HealthPathways (HHP) is an online collection of clinical pathways. Like the Blue 
Book, these pathways are targeted at hospital resident medical officers (RMOs) working in 
Canterbury. Each pathway consists of a series of recommendations on the management of 
common medical conditions. Again, like its predecessor, each page is based around a single 
common symptom, disease, or procedure.  
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There is a uniform structure across all pages on the website. Each page, or pathway, consists of 
content under five headings: About, Assessment, Management, Request and Information.  
The About section is a short sentence with information about the scope and purpose of the 
pathway followed by a drop down box with a summary of information about the topic.  
The Assessment section consists of recommendations on how to reach the initial diagnosis, 
how to assess severity, and how to re-assess a patient who has already been diagnosed.  
The Management section consists of advice on the initial management. This section also 
contains advice regarding ongoing management, both within the hospital and with regard to 
discharge planning and follow-up. This section has links to pathways for conditions which 
commonly co-exist with the acute presentation, e.g. links to Sepsis in Adults from within the 
Community Acquired Pneumonia pathway. 
The Requests section summarises all requests that may be made by a clinician following this 
pathway. This includes details on requests for further investigations and reviews within the 
hospital and community follow-up on discharge.   
The final part of each pathway is the Information section, made up of links to patient 
information sources, suggestions for further reading, references to evidence included in the 
pathway, and links to relevant national guidelines (37). 
The same style is applied across every pathway on the Hospital HealthPathways website. All 
pathways are made in accordance with an agreed ‘Style Guide’, a set of rules and regulations 
for ensuring consistency and clarity of content across the website(37). The Style Guide 
encompasses a number of different domains including a consistent use of acronyms, numbers, 
symbols and punctuations. The goal of adopting a uniform style is to make the pathways easy 
to use and follow 
There is also a consistency in regards to design of the website. Where a paper or PDF-based 
resource presents all information on the same level, the use of hyperlinks and drop-down boxes 
in HHP ensures that only key content is presented at the top-level, with more detailed 
information available within the page should the user wish to access it. 
Consistent grammar is used throughout the pathways. A key component of this is the use of 
‘active’ rather than ‘passive’ language. When using active language the subject of a sentence 
performs an action stated by a verb. In passive language the subject of the sentence is acted 
upon by the verb. For example, consider the following two sentences: ‘The referral to the 
respiratory team should be sent by fax’ and ‘Fax the referral to the respiratory team’. The 
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wording in the first example adopts passive use of the verb, whereas the latter adopts an active 
use.  
HHP pathways are written using simple words and phrases in preference to more complex 
alternatives. For example, the word ‘start’ would be used over the word ‘commence’. 
Additionally, the use of medical jargon in pathways is avoided if possible.  
A final element of every page on the HHP website is a link which allows pathway users to 
provide feedback on the pathway to the HHP team.   
On the top right and at the bottom of each pathway page is a link that allows users to email 
feedback directly to the HHP coordinator (fig.1-1, pg. 13). If there is an error in the wording, 
language, or format of the site the feedback will be sent to the technical writers. If there is 
feedback regarding the clinical content then this will be addressed by the clinical editor of that 
pathway. Once the issue has been discussed the user who provided the feedback will be 
informed of the outcome.  
 
Figure 1-1 Hospital HealthPathways Community Acquired Pneumonia Page 
 
1.4.2 The Hospital HealthPathways Team & Development Process  
 
The content for Hospital HealthPathways is produced by a team of people including a clinical 
editor, a subject matter expert, and a technical writer. A clinical editor (CE) is a health 
professional who is usually a member of the target audience of Hospital HealthPathways, such 
as an RMO or a senior nurse. Some senior medical officers also undertake the CE role, 
particularly if they have recently been RMOs and if they are from a general specialty. The role 
of the CE is to produce draft pathways in collaboration with subject matter experts. Subject 
matter experts (SME) are clinical directors (or delegated senior medical officers (SMO)) of the 
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relevant clinical specialty. The role of the subject matter expert is to help establish the goals of 
the pathways, and to provide feedback on the clinical content. The subject matter expert will 
also have responsibility for signing off a final draft of a pathway. The technical writer 
constructs the pathway webpage from the draft document created by the clinical editor, edits 
the language, structure and style of each pathway and ensures the pathway is accordance with 
the Style Guide.  
The process for developing each pathway begins with identification of the ‘lead team’: the 
clinical editor, subject matter expert and technical writer responsible for producing the 
pathway. The goals and outline of the pathway will be identified in an initial meeting between 
the subject matter expert and the clinical editor. The clinical editor will then produce a first 
draft document version of the pathway. The draft will be reviewed by the technical writer who 
will create the online pathway and make appropriate changes to the style and language. The 
clinical editor will then review this draft and feedback to the technical writer, particularly if the 
changes to the wording have altered the meaning of the clinical content. Once a consensus has 
been reached between the clinical editor and technical writer, the SME will review the draft. 
The feedback from the SME will be collated by the clinical editor and any appropriate changes 
will be made. The draft will then be put out for wider review by key stakeholders such as other 
CEs, and SMEs in other specialties. The feedback will once again be reviewed by the clinical 
editor, and the clinical editor and technical writer will collaborate on the final draft. Each 
pathway is ‘signed off’ for publication by the clinical lead for HHP and the clinical director of 
the department taking ownership of the pathway. Following sign off, the pathway ‘Goes Live’ 
on the Hospital HealthPathways website (38).  
 
1.4.3 Comparison between The Blue Book and Hospital HealthPathways 
 
At first glance The Blue Book and Hospital HealthPathways platforms appear similar in many 
ways. They are both websites consisting of collections of clinical guidance targeted at hospital 
RMOs. Each page consists of recommendations on locally agreed best practice for the 
management of common symptoms, diseases and procedures.  
However, there are key differences between the two platforms in regards to the authorship, 
development process, appearance, and content of each page. Each chapter in The Blue Book 
was authored by potentially just one doctor who, as a senior medical officer, was not the target 
audience of the guidance. HHP pathways are authored by clinical editors who are members of 
the target audience of the website. The involvement of technical writers in the development of 
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individual pages, and of the website as a whole, ensures consistency across the site. The style, 
language and format used is applied consistently across the HHP site. Whilst a technical writing 
company created the online version of The Blue Book, they did not edit the content or style of 
the pages.  
Table 1-1 (pg. 15-16) summarises the different constituents of each platform, highlighting their 
similarities and differences.  
 
Component Clinical Guidance Website 
 The Blue Book Hospital HealthPathways 
Primary Audience 
Resident medical officers working in 
hospitals in the Canterbury District 
Health Board 
Resident medical officers working 
in hospitals in the Canterbury 
District Health Board 
Author 
Clinical director (or designated SMO) 
of relevant medical specialty 
Clinical editor, technical writer, 
subject matter expert(s) 
Development 
process 
Clinical director approached every 
two years and asked to review their 
department’s chapter(s). Drafts were 
reviewed by the Blue Book editorial 
committee prior to publishing a new 
edition of Blue Book 
Clinical editor creates a draft in 
collaboration with technical writers. 
Subject matter expert provides 
feedback on the draft, and changes 
are made. A new draft is sent for 
wider review by key stakeholders, 
before the final draft is signed off 
by the clinical lead and responsible 
SME. 
Website content 
Pages based around a symptom, 
disease or procedure. 
Pages based around a symptom, 
disease or procedure. 
Structure No uniform structure for pages. 
Uniform structure across whole 
website. Content of each page 
follows the same structure of 
assessment, management, requests 
and information 
Language 
No compulsory language adopted 
throughout 
Active language, simple words, 
and simple sentences. 
Spelling and abbreviations used 
consistently throughout 
Evidence base 
Expert opinion of local clinical 
director. 
No references provided 
Local consensus guidelines. 
Clinical editors are advised to 




Relevant references in information 
section on each page 
Feedback 
Feedback emailed to chair of Blue 
Book editorial committee 
Feedback button on all pathways 
allowing users to provide feedback. 
All feedback reviewed by clinical 
coordinator and clinical editor. 
Table 1-1 Components of The Blue Book and Hospital HealthPathways Clinical Guidance Websites 
 
1.5 Aims of the Study  
 
The aim of this project was to understand what factors affect guideline use and compliance.  
The objectives of the project were to:  
1. To examine the effect of a change in the development process and design of a clinical 
guideline on use of that guideline  
2. To examine the effect of a change in the development process and design of a clinical 
guideline on compliance with guideline recommendations  
3. To determine how patient, clinician and environmental variables affect compliance 
with local clinical guidance 
4. To determine how a change in the development process and design of a clinical 
guideline interacts with the effects of patient, clinician and environmental variables on 
compliance.  
5. To describe doctors’ attitudes towards facilitators and barriers to the implementation of 
local clinical guidance in their practice.  
6. To describe and quantify reasons for ‘appropriate’ non-compliance with guideline 
recommendations. 
This comprehensive evaluation of the factors that influence guideline compliance will aid in 
the understanding of guideline implementation. This will contribute towards the successful 
implementation of guidelines and thus improve processes of care and clinical outcomes.  
 
1.6 Outline of Thesis 
 
This thesis will consist of five chapters. This introductory chapter has provided a background 
to clinical guidelines in general and local clinical guidelines in Canterbury. It has presented the 
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aim and objectives of the project. Chapter Two is a systematic review of the literature regarding 
patient, doctor, environmental, and guideline related predictors of guideline compliance. The 
results of this review guided the identification of dependent variables to be included in analysis 
as potential predictors of guideline compliance. The methodology of the study including the 
development of outcomes, identification of study sample, data collection and statistical analysis 
is presented in Chapter Three. Chapter Four presents the results of this study. Chapter Five will 
consist of a summary of key findings, a discussion of the strengths and limitations of the study 




As discussed in Section 1.2.1 there are a number of terms used for clinical guidelines. For 
simplicity, this thesis hereafter refers to The Blue Book and Hospital HealthPathways either by 
name or as clinical guidelines. The contents of the guidelines will be referred to as 










 The decision to apply guideline recommendations in clinical practice has been shown to be 
influenced by a number of factors. These factors have been grouped in to four categories 
including: factors relating to the patient, the doctor, the environment and to the guideline itself. 
This systematic review of the literature was undertaken to determine what variables within each 
of the four categories are associated with guideline compliance. The secondary outcome was to 
determine the effect of the interaction between different categories of factors on guideline 
compliance.  
The identification of these factors contributed to this project as a whole by being used to plan 
what independent variables are to be included in the compliance analysis of this study. 





This review aimed to answer the question: what factors are associated with guideline 
compliance?  
The outcome of interest was compliance with clinical guidelines by doctors. Therefore, the 
study population of interest in this review was either doctors or patients managed by doctors. 
This review included studies that focussed on doctor’s compliance with clinical guideline 
recommendations, as opposed to other health professionals. Studies that assessed guideline 
compliance of multi-disciplinary teams were included if a/ the team included doctors and b/ the 
compliance rate was described by different jobs within the team. Studies assessing guideline 




The independent variables associated with clinical guidance compliance were grouped in to the 
following categories:  
- Factors associated with patient 
- Factors associated with the doctor 
- Factors associated with the environment in which the doctor is working 
- Factors associated with the clinical guideline 
These categories were adapted from classifications developed in previous systematic reviews. 
(7, 8).  
For the most part, this review compared compliance across the different identified independent 
variables. However, when relevant this review included studies that compared practice and care 
provided between different guideline implementation strategies and different forms or versions 
of the same guideline.  
The primary outcome of interest was compliance with clinical guidelines: recommendations 
that guide decision making in health care.  
This review included studies concerning: 
• clinical guidelines in both online and paper format. 
• all sources of clinical guidance (national governing bodies, academic colleges, local 
specialty departments, etc.). 
• both newly implemented and existing clinical guidelines. 
•  all different formats of clinical guidelines, including more structured plans of care 
such as pathways (12).  
Compliance was defined as the patient receiving care that conformed to a recommendation in a 
clinical guideline. Compliance has also been described throughout the literature as “guideline 
implementation” and “guideline adherence”.   
This review only included studies that measured compliance by: a) quantifying the numbers, 
proportions or odds of patients receiving care that conformed to recommendations within a 
guideline or b) quantifying the number, proportions or odds of doctors observed to be providing 
care that conformed to guideline recommendations. 
In a large proportion of the literature guideline compliance was measured by self- reported 
compliance i.e. the doctor saying they followed a guideline in their clinical practice. Studies 
that measured guideline compliance in this way were not included. The rational for the 
exclusion of these studies was that doctors have been shown to over-estimate their own 
compliance with guidance recommendations. Comparisons between self-reported and observed 
21 
 
compliance rates have found that self-reported compliance rates were a median of 27% higher 
than observed compliance rates (39).  
Due to the nature of the subject matter it was deemed inappropriate to limit this review to 
include just randomised control trials. The following study types were included: randomised 
control trials, systematic reviews, observational studies, controlled before and after studies and 
time series analysis. Qualitative studies, surveys, case vignettes and editorials were not 
included.  
This review chose to only include articles published after 1990 after the evidence based 
medicine movement created an interest in the efficacy of clinical guideline implementation.  
The search was not limited to English language publications.  
 




The PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) checklist 




The definition of characteristics of eligible studies were defined using the PICOS process (41). 
PICOS is an acronym which stands for: Population, Intervention, Comparison, Outcome, and 
Study Design. The ‘Intervention’ domain was adapted to ‘Independent Variable’ to reflect the 
nature of the review question. Criteria for eligibility was defined in each domain within the 





Domain Inclusion Criteria 
Population Doctors (or patients being treated by doctors) 
Independent Variables Patient, doctor, environmental and guideline related factors  
Comparison 1 Guideline with standard practice 
2 Active vs passive guideline dissemination 
3 Two different versions of the same guideline 
Outcome Compliance with guideline recommendations 
Study Design The following study types were included: randomised control 
trials, systematic reviews, observational studies, controlled before 
and after studies and time series analysis 
Table 1-2-1 Literature Review Inclusion Criteria 
 
2.2.3 Information Sources 
 
A search of the literature was undertaken in the following databases: MEDLINE, Embase, 
CENTRAL and Google Scholar. The search was initially carried out in February 2017 and 
repeated in August 2017. Citation searching of key articles was undertaken to capture any 




The search process was developed with guidance from the Cochrane Handbook for Systematic 
Reviews. (42). The search strategy was also developed using the PICOS method with the 
advice of the specialist subject matter librarians at the University of Otago. The search strategy 
was developed on MEDLINE and then adapted for other databases. This search strategy 





#1   Search Physicians/ 
#2   Search  Medical staff, hospitals/ 
#3   Search  Practice guideline/ 
#4   Search  Guideline adherence/ 
#5   Search  Critical pathways/ 
#6   Search  Case control studies/ 
#7   Search  Retrospective studies 
#8   Search  Randomised control trials as topic/ 
#9   Search  Cross sectional studies/ 
#10 Search  Systematic review/ 
#11 Search  #1 OR #2  
#12 Search  #3 or #4 OR #5 
#13 Search  #6 OR #7 OR #8 OR #9 or #10 
#14 Search  #11 AND #12 AND #13 
Table 2-2 MEDLINE Search Strategy 
 
2.2.5 Data Collection 
 
A data collection form was devised in advance of the literature search based on a PICOS 
framework.  Data were collected from all included articles and entered on to data collection 
forms. The forms were then compiled by entering each item in to an Excel spreadsheet. The 
following data items were collected from each included study: year of publication, country of 
publication, study design, study population included, intervention (if appropriate), independent 
variables and outcome variables. The key results of the outcomes of individual studies were 
also noted. 
 
2.2.6 Quality Assessment  
 
The assessment of the quality of articles was completed using an adaption of the quality 
assessment tool in ‘Developing NICE Guidelines: The Manual’(43). This tool was used to 
assess bias by considering the appropriateness of study design and methodology. Following 
quality assessment the quality of included studies were classified as being “High”, “Moderate” 
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or “Low” using this tool. A quality assessment form was devised in advance of appraisal of the 




2.3.1 Study Selection 
 
There were fifty studies selected for inclusion. The process of the study selection is illustrated 
in Figure 2-1. 
Studies identified through database 
searching 
 Identified through citation 
searching 
 1668 studies  
  20 duplicates removed 
 Screening of titles and abstracts 
1648 studies 
 
  1438 studies excluded 
 Screening of full texts 
210 studies 
 



















 51 studies  
 
 
  1 study publication not 
available  
 50 included studies  




2.3.2 Study Characteristics 
 
The characteristics of the fifty included studies are summarised in Table A-1, Appendix A. The 
oldest included study was published in 1994(44) and the most recent studies were published in 
2017(45, 46). 
Twenty-six of the included studies were published in the United States of America, six in the 
Netherlands, three in Canada, two in the United Kingdom and Germany and single studies from 
Australia, Denmark, France, India, Italy, Japan, Norway, Sweden, Switzerland, Turkey and 
Paraguay.  
The search yielded a variety of study designs including: twenty-four retrospective audits, nine 
controlled before and after studies, four cross-sectional studies, five randomised control trials, 
two cluster randomised control trials, two prospective audits, two mixed-methods studies, one 
systematic review and one meta-analysis.  
There was a wide range of study size with number of participants ranging from thirty (47) to 
4,956,444 (48). The population studied to measure guideline adherence was patients being 
managed by the guideline, doctors using the guidelines or aggregates such as health practices or 
hospitals.  
 
2.3.3 Quality Assessment 
 
The quality assessment of individual studies is presented in Appendix B. Due to the nature of 
the subject matter, blinding would not be possible for participants in studies in which involved 
an intervention. As a result, there was a high risk of performance bias across these studies.   
 
2.3.4 Results of Individual Studies 
 
The collected data items and results of individual studies are included in Appendix C.  
There was significant heterogeneity between studies. Outcome statistics were described as 
proportion of patients receiving guideline adherent care, odds or likelihood of receiving 
guideline compliant care, assigned ‘quality scores’ based on following guideline 
recommendations and clinical processes as a surrogate marker of guideline adherence (e.g. 
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number of laboratory tests ordered as per elderly dementia screening guidelines). This 






There is a lack of agreement in the literature on whether the gender of the patient has an effect 
on guideline compliance. Ten of the studies included the gender of the patient as an 
independent variable. The results of these ten studies were inconsistent: four found that male 
patients were more likely to receive guideline compliant care, two found that female patients 
were more likely to receive guideline compliant care and four studies found that the gender of 
the patient was not significantly associated with guideline compliant care.  
An association between male gender and guideline-compliant care was found in four studies. 
Two studies found that male patients treated for sexually transmitted infections in the 
emergency department were more likely to receive care that was compliant with guideline 
recommendations (49, 50). Quality assessment of these two studies found them to be of 
“Moderate” quality due to several methodological errors. However, these results are consistent 
with the findings of Kelly et al. (51), a study which performed highly in quality assessment, 
which found a positive association between male gender and guideline adherent care with a 
stroke thrombolysis guideline.  
Conversely, two high quality studies found that male gender was instead associated with 
receiving care which was not compliant with guidelines. Halm et al. reported following a 
multiple regression analysis that male gender was a significant predictor of guideline non-
adherent care for patients with community acquired pneumonia (OR 2.3 (95% CI 1.0-5.2), 
p=0.04)(52). Solomon et al. also found that male patients were less likely to receive guideline 
adherent care for osteoporosis (OR 0.17 (95% CI 0.12-23))(53).  
Baumhakel et al. examined in detail the effect of the patient gender, physician gender and the 
interaction of the two in the management of heart failure(54). Female patients were found to be 
less likely to receive the correct medication and the correct dose of medication for heart failure. 
This effect appears to originate from differential treatment by male physicians. Male physicians 
were more likely to provide guideline adherent care to their male patients than their female 
patients. This difference was not noted in female physicians. In multivariate analysis, not only 
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were patient gender and physician gender independent predictors of guideline adherence but, 
indeed, so was the interaction between physician and patient gender.  
Four studies found that gender of the patient did not significantly affect the odds of receiving 
guideline adherent care (48, 55-57).  
 
2.3.5.2 Age  
 
In the majority of published studies the increasing age of the patient was significantly 
associated with reduced odds of the patient receiving guideline compliant care across a number 
of clinical scenarios. There is, however, a notable variation in definition, with older age groups 
ranging from over 50 to over 75 years.  
There were five studies which demonstrated that older age groups were less likely to receive 
guideline compliant care than younger patients (51-53, 58, 59). All of these studies received 
moderate or high quality assessment scores. However, of note, the quality of Haas et al. was 
assessed as being reduced due to a noted reporting bias (58). These results were consistent in 
both in-patient and outpatient care and acute and non-acute presentations. Additionally, two of 
the studies were large population based studies and therefore these findings are likely to be 
externally valid (51, 53).   
There was only one study of high quality with low levels of bias that found that increasing age 
was associated with increasing compliance with clinical guidelines. Imai-Kamata et al. in a 
large, multi-centre study found that older patients were significantly more likely to receive 
guideline compliant antibiotic prophylaxis than their younger counterparts (56).  
There were two studies which examined the effect of age in paediatric populations. These 
studies had contrasting results. Bekmezian et al. found that younger children (<2yrs) were more 
likely to have guideline non-adherent care (a delay in the administration of corticosteroids in 
acute exacerbation of asthma) than older children (60). Conversely, Bryan et al. in examining 
adherence with bronchiolitis guidelines found that children in the highest adherence groups 
were significantly younger (45). In comparing the two studies, Bekmezian et al. was of an 
overall higher quality. One key differential of note was in the rigour of statistical analysis, 
Bekmezian et al. adjusted for patient, physician and system related confounders when 
determining the effect of age. The analysis undertaken by Bryan et al. only adjusted for the 
environment in which the patient was managed, therefore the findings related to the age of the 
child may be confounded by patient and physician related variables.  
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Two publications examined how the effect of age on guideline adherence interacted with the 
gender of the patient. Both concluded that age had a stronger effect as a factor in female 
patients than male patients.  Ohlsson et al. found that women aged 70-79 had the lowest odds of 
receiving guideline compliant care when treated in private practice, a finding that was not 
evident in men. However, this finding was far from conclusive as it was only evident in one 
practice setting and was not evident in the oldest age group 80-89(57). Dronkers et al. found 
that older females had an increased likelihood of choosing to receive non-standard treatment 
but that both age and gender were not statistically significant factors in the decision to propose 
non-standard treatment by health professionals (61). Therefore, there is insufficient evidence to 
support the existence of an interaction between age and gender on guideline compliance.   
The remaining studies which addressed age had either inconsistent or inconclusive results (48, 
55, 62) or lacked rigour in the statistical analysis (63).  
 
2.3.5.3 Race and ethnicity  
 
Two studies in this review found, after multivariate analyses, that the race of the patient was 
associated with guideline compliance. Solomon et al. found that patients of black race had 
significantly reduced odds of receiving guideline adherent care when compared to white 
patients (OR  0.40; 95% CI: 0.34 to 0.47) (53). Beckman et al. noted that Hispanic patients had 
lower odds of receiving guideline compliant care (OR 0.3; 95% CI 0.1 to 0.9) (49). These 
studies were both assessed as being of high quality. Of note, these studies were both published 
in America and it may be that the same racial biases do not exist in other countries.  
There were two further studies included in the analysis which addressed race and ethnicity of 
the patient as factors in guideline compliance (48, 59). These studies did not find a significant 
association between race or ethnicity and guideline compliance.   
 
2.3.5.4 Co-morbidity  
 
There were seven studies that addressed the effect a patient’s co-morbidities had on receiving 
guideline adherent care.  
Five studies, including one meta-analysis, found that patients with co-morbidities were less 
likely to receive guideline adherent care. Four out of five of these studies were found to be of 
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high quality on assessment (8, 51, 53, 61, 64) and one was found to be of low quality on 
assessment (64). 
Only one of the seven studies found that the presence of a co-morbidity was associated with 
guideline adherent care. It should be noted that this was the only study addressing the effects of 
a co-morbidity on a paediatric population. The study noted that obesity led to increased 
likelihood of guideline adherent lipid screening (65). 
Sales et al. examined in detail the effects of different types of co-morbidities on guideline 
adherence(66). This study was found to be of high quality and low risk of bias on assessment. 
Co-morbidities were categorised in respect to their concordance with the acute condition. 
Concordance was defined as conditions in which there is an overlap with the treatment of the 
acute condition e.g. hypertension and acute myocardial infarction.  Patients with a co-morbidity 
which was highly concordant with the acute condition were more likely to receive guideline 
adherent care. The concordance of the co-morbidity meant that the co-morbidity did not present 
any conflicts for the clinician in following the guideline. This study also examined the effect of 
how ‘symptomatic’ a co-morbidity was on guideline adherence. Symptomatic co-morbidities 
are conditions which commonly manifests symptoms, such as asthma, whereas an 
asymptomatic co-morbidity is one that does not commonly manifest symptoms, such as 
hypertension. Patients with highly symptomatic co-morbidities were less likely to have 
guideline adherent care.  
 
2.3.5.5 Severity  
 
There were eight studies which analysed the effect that the severity of the illness had on 
guideline adherence.  
The effect of severity of illness appears to vary depending on the acuity of the illness. A more 
severe illness was found to be predictive of increased odds of guideline adherence in the acute 
setting whereas the effects are reversed in the non-acute setting.  
In the acute settings two studies found that a more severe asthma presentation was associated 
with increased adherence to guidelines for the management of asthma.(60, 67).  Kelly et al. 
found that patients presenting with higher levels of impairment caused by stroke (as quantified 
by an NIH score) were more likely to have guideline recommended imaging completed within 
25 mins than patients with lower levels of impairment (51).  
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In the non-acute setting, the results are reversed. Both Erickson and Dronkers et al. found that 
an advanced tumour stage was associated with guideline non-adherence (59, 61). However, 
Schiffman et al. presents contrary results which noted that patients with advanced prostate 
cancer (quantified as a high Gleason score) were more likely to have guideline adherence care 
in regards to pelvic lymph node dissection (62). The quality of the three articles which assessed 
tumour stage were all found to be moderate, so cannot explain the different findings between 
these published studies.  
These results are likely to reflect the realities of medical practice. Patients with more severe 
acute disease are more likely to have guideline compliant care because the management of 
medical emergencies is often protocol driven, for example, the Advanced Life Support 
treatment algorithm (68) (69).  In a non-acute setting, more severe disease may mean that a 






In the meta-analysis performed by Francke et al., three systematic reviews concluded that 
younger doctors with fewer years clinical experience were more likely to follow guidelines in 
their practice (8). There were no studies that found that older doctors were more likely to 
follow guidelines.  
 
2.3.6.2 Gender  
 
The literature search yielded two studies which examined the effect the gender of physician 
had on compliance with clinical guideline recommendations. Both of these studies concluded 
that male physicians were less likely to provide guideline adherent care to their patients.  
Solomon et al. found that there was an association between receiving care from a male 
physician and reduced odds of receiving guideline adherent care in the form of osteoporosis 
screening and receiving a medication for osteoporosis OR 0.70 (95% CI 0.55–0.89)(53). This 




Baumhakel et al. in a high quality study examined the effect of the gender of the patient and 
the gender of the physician on the choice and dose of medication for heart failure as indicated 
by guidelines(54). Furthermore, they examined the interaction between physician and patient 
gender. They noted that female patients treated by male physicians had the lowest proportion of 
guideline recommended heart failure medication prescribed. Multiple regression analysis noted 
that gender of the patient, gender of the physician and the interaction between the two had a 





The seniority of the clinician was a variable examined by three studies. This was described 
both in terms of number of years of training (70) and by assigned grade of clinician (71, 72).  
The results of these studies found that both the grade of the doctor and the number of years of 




Patients are more likely to receive guideline compliant care if they are assessed and managed 
by clinicians who are specialists in the area of medicine relevant to their acute presentation. 
Three studies found that higher proportions of patients treated by specialists in the acute 
condition had a higher likelihood of receiving guideline compliant care than those patients 
treated by generalists (63, 71, 73). However, two of these studies had significant concerns 
regarding internal validity due to not adjusting their statistical analysis for confounders (63, 
73), leading to the results potentially being subject to bias. Thomas et al. had a more rigorous 
approach to statistical analysis (71). Additionally, all three studies were small, single centre 
studies and as a result their findings may not be externally applicable.   
There were two studies which examined the effect that the involvement of a primary care 
physician in the admission of the patient to secondary care had on guideline compliance. Halm 
et al. noted that primary care physician involvement significantly increased the odds of 
guideline non-adherent care in patients with community acquired pneumonia (OR 3.0 (95% CI 
1.2 -7.1), p=0.01) in multivariate analysis(52). Delangle et al. examined the assessment and 
management of patients with acute bacterial meningitis in the emergency department (74). 
They found that a referral from a primary care physician to the emergency department did not 
32 
 
significantly affect guideline adherence. This study had a very small sample size (n=23). The 
difference in findings between these two studies is likely to be due to the different outcomes 
measured. The primary outcome for Halm et al. was admission of low risk pneumonia patients. 
If a GP had referred a patient to hospital this is generally viewed as a request for admission. On 
the other hand, Delangle et al. had the outcome measure of delay in antibiotic prescription on 
arrival to the emergency department. A GP referral is unlikely to affect the timing of the 
prescription of medication by another doctor once the patient is in the emergency department. 
 
2.3.7  Guideline 
 
There were no studies found in this review that included guideline characteristics in a 
multivariate analysis. As a result no included studies examined the interplay between guideline 
factors and both patient and doctor factors. 
 
2.3.7.1 Guideline Attributes  
 
There were five studies, including one meta-analysis, which examined the effect of guideline 
characteristics on guideline compliance (6, 8, 44, 75, 76). They all assessed guideline qualities 
by assigning attributes to individual guideline recommendations. Attributes were defined as 
features of guidelines which determine their use in clinical decision making. In each study, 
guideline recommendations were assigned different attributes by expert panels. None of the 
studies confirmed that users of the guideline agreed with the attributes assigned by the expert 
panels. These attributes were then related to decision making by assessing compliance with the 
recommendations. In considering the results of these studies, three out of the five studies were 
found to be of moderate to low methodological quality. The meta-analysis by Francke et al. was 
found to be of moderate quality(8). Foy et al. was also found to be of high quality, however, 
this study examined the effect of each of these attributes in conjunction with the intervention of 
audit and feedback (76).  
In examining the attributes of guidelines researchers have shown that a guideline which is easy 
to follow is more likely to be followed. Ease can manifest at each stage of the knowledge, 
attitude and behaviour model. Guidelines that are perceived to be easy to read are more likely 
to be followed (8, 75). Guidelines are more likely to be followed if they do not require complex 
decision making , both in regards to clinical complexity(44, 75) but also in regards to not 
adding complexity by opposing clinicians values (76)or being controversial(6). Finally, 
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guidelines that do not require any new knowledge or skills (75) have higher levels of 
compliance, as did guidelines which did not require a change to the clinician’s routines (76).  
Another emerging theme was the concept of trialability. The trialability of a recommendation 
is the ease at which a clinician can trial a recommendation and observe the effects of the use of 
this guideline on their patient.  Two studies concluded that guideline recommendations which 
were trial-able had higher levels of compliance (8, 44). This also links to the theme of ease of 
use. Guidelines which are trial-able allow the clinician to try out following the guideline 
recommendation.  
Guideline recommendations supported by a strong evidence base were associated with higher 
levels of compliance in one study (75).  
The final emerging concept was that guidelines developed by their target group had higher 
levels of compliance than guidelines developed by outside bodies (8).  There were no studies 
found which compared compliance with guideline recommendations produced by different 
bodies – for example an academic body compared to a governmental body.  
 
2.3.7.2 Guideline Topic 
 
Grilli et al. noted that the type of procedure detailed in the guideline (e.g. diagnostic vs 
therapeutic) did not significantly affect adherence (44). This review also studied the effect the 
topic of guidelines had on adherence. The review noted that guidelines in cardiology and 
oncology had the highest level of adherence. The results of this study may have limited validity 
due to a number of methodological faults in this review both in regards to search strategy and 
reporting of publications.  
 
2.3.7.3 Guideline Design 
 
There were no studies found which examined the effect of the design or presentation of a 
guideline. 
There were two studies which analysed the effects of guidelines in the format of checklists 
being amalgamated in to team briefings. Both of these studies took the form of a pre-operative 
team briefing undertaken by operating teams. These studies both showed that a check-list pre-
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operative team briefing significantly improved adherence to guideline recommendations (46, 
77).  
 
2.3.7.4 Guideline Development Process 
 
There were no studies found in the literature that examined the effect of the development 




2.3.8.1 Implementation strategies 
 
There are a number of studies which assessed the impact of different implementation strategies 
for guidelines. The effect of single strategies and multi-faceted strategies has been examined at 
length. No one single strategy or multi-faceted strategy has been consistently shown to be 
effective.  
There were eight studies which examined the effects of multi-faceted implementation 
strategies (47, 78-84). These strategies included combinations of the following: audit and 
feedback, barrier identification, localisation of the guideline, amalgamation of the guideline in 
to the electronic medical record, local learning groups, academic details, local opinion leaders, 
education sessions and implementation team. The combination in each study is presented in 




Components Included in Multi-faceted Implementation Strategy 
Studied 
Doherty SR  Audit and feedback, barrier identification, education sessions, 
localisation, implementation team 
Dykes P Amalgamation in to the electronic medical record, education tool, access 
to evidence, audit and feedback 
Mol P Localisation of guideline, academic detailing 
Mold J Localisation, academic detailing 
Holroyd B Education session, audit and feedback, local opinion leaders 
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Waldorff F Audit and feedback, academic detailing, education sessions 
Dyc N Audit and feedback, education sessions 
Van der Berg N Audit and feedback, education sessions 
Table 2-3 Components of Multi-Faceted Implementation Strategies  
 
Seven out of the eight studies were found to be of moderate to high quality on assessment. 
However, the study carried out by Dyc et al. had a number of methodological limitations (47).  
The results of multi-faceted implementation studies were mixed: five studies found no change 
in guideline compliance following their implementation, three studies found compliance 
improved following the implementation of the strategies. The common factor of the studies 
which noted an improvement in guideline adherence was an attempt at localisation of the 
guideline to fit with local resources and practices (78, 80, 81). This finding fits with results of 
the guideline section of this chapter that ease of use is an important factor in guideline 
compliance. The process of localisation of recommendations makes the guideline easier for 
doctors to apply.  
Yealy et al. examined the effects of differing levels of intensity of multi-faceted 
implementation strategies(85). It was noted that as level of intensity of the implementation 
programme increased so did the proportion of patients treated in accordance with the guideline.  
Two studies examined the effect of having a specific member of staff or team of staff 
responsible for the promotion and implementation of a guideline. Berg et al. compared 
management of septic patients by a “Sepsis Response Team” (SRT) compared to standard care 
(86). This study noted that the SRT was more compliant with guidelines than standard care. 
These results differ from Owen et al. who examined the effect of a trained nurse promoting 
guideline adherent pharmaceutical management of schizophrenia(87). They noted that the 
presence of this trained nurse had no effect on guideline concordant dosing of anti-psychotic 
medication. These findings show that having a specific team implementing guideline 
recommendations improves compliance whereas having a team member simply promote 
guideline recommendations does not.  
There were four studies which examined the effects of audit and feedback on guideline 
implementation.  Two studies examined generalised departmental feedback. Two moderate to 
high quality studies examined individualised feedback: one individualised by patient and one 
individualised by clinician. The study which examined the effects of individualised clinician 
feedback noted an improvement following this intervention (88).  However, the study which 
individualised feedback based on the patient did not find a sustained improvement in 
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compliance at follow up (89). Both studies which examined the effects of departmental audit 
and feedback found that this implementation improved guideline adherence (76, 90).  
One study examined the effect of an implementation strategy which focused on solely on 
‘barrier identification’. Researchers identified reported barriers to the implementation of a 
dementia screening guideline in primary care. The barriers were subsequently addressed 
through training and educational sessions and then guideline compliance was measured. This 
intervention improved compliance to certain guideline recommendations but not others. A 
significant limitation of this study was that individual barriers were identified but not team and 
organisational barriers (91).  
 
2.3.8.2 Health Care Provider Type 
 
There were three studies which included the type of health care provider, private or public, as a 
variable in analysis.  
There were two studies in developed countries which found that compliance with guidelines 
was higher in public health care practices than private health care practices (57, 92). One study 
carried out in India found significant deficiencies in the care provided by public health services 
when compared with private health care (93). This study did however note that private health 
care providers were more likely to carry out invasive diagnostic testing and management 
procedures likely reflecting a pay for services economy.   
 
2.3.8.3 Hospital Size 
  
Hospital size was found to be significantly associated with guideline compliance in two 
moderate to high quality studies. These studies found that patients treated in larger hospitals 
were less likely to receive guideline compliant care than patients treated in smaller hospitals 
(56, 94).  
 
2.3.8.4 Hospital Volume  
 
Two studies examined the effect of patient volume on guideline adherence (56, 60). These 
studies had consistent findings in spite of being carried out in different settings within the 
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hospital. Imai-Kamata et al. examined this comparing hospitals with high and low surgical 
volumes (56). Beckmezian et al. compared children managed in EDs who had presented at 
times of low patient volume compared to those presenting at times of high patient volume (60). 
Both studies found that high patient volume was consistent with lower levels of guideline 
compliance.  
 
2.3.8.5 Hospital Environment 
 
There was one study which compared guideline adherence between rural and urban 
hospitals(94). This was a large-scale population study of moderate to high methodological 
quality. The study found that rural hospitals were less likely to comply with nine out of the ten 
guideline recommendations studied. However, this effect was only notable in hospitals of larger 
bed size. There was no difference noted in compliance between rural and urban hospitals of 




This review found in each of the four categories variables associated with guideline 




Consistently across studies of moderate and high methodological quality the age of the patient 
was shown to be a predictor of guideline adherence. Older patients were less likely to be treated 
in accordance with guidelines. This effect was noted in acute presentations such as stroke and 
chronic presentations such as malignancy. This may be due to the fact that elderly patients are 
more likely to have co-morbidities than their younger counterparts. Single condition guidelines 
may not fit with complex comorbid patients. In the guideline section of this review we noted 
that ease of use was a critical factor to the implementation of guidelines. Attempting to treat 
older, often multi-morbid patients may make it difficult to implement guidelines and lead to 
clinicians deviating from guideline recommendations.  Furthermore, the holistic nature of 
geriatric medicine may influence the use of clinical guidelines in elderly patients. Clinical 
guidelines are often targeted at management of a single disease, whereas holistic management 
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involves considering the patient as a whole person. This approach may lead to doctors 
appropriately disregarding guideline recommendations.  
As with elderly patients, patients with co-morbidities were less likely to have guideline 
concordant care. This again is likely due to a comorbidity adding a degree of complexity to the 
decision making process. Following guidelines based around a single condition in multi-morbid 
patients may be challenging due to concerns regarding polypharmacy, patient’s compliance and 
adverse drug events. Sales et al. found that when a co-morbidity was concordant with the acute 
presentation (i.e. with overlapping treatment) then patients were more likely to have guideline 
adherent care(66). This concordance eliminated any difficulty in managing an acute 
presentation and a co-morbidity simultaneously as the treatment overlapped. As the level of 
concordance fell so did levels of compliance with the guideline. Another potential concern in 
treating patients with co-morbidities is that patients with co-morbidities are often excluded 
from trials which form the building blocks of clinical guidelines. This may lead to concerns by 
clinicians of a lack of evidence supporting the use of guidelines in this patient population(75).  
The effect of the severity of the illness depended on the acuity of the condition. Patients with a 
severe, acute presentation were more likely to have guideline adherent care than patients with a 
mild acute presentation. This can be attributed first of all to the highly protocolised nature of 
medical emergencies. Furthermore, the action of following a guideline in this scenario could be 
associated with greater perceived utility and benefit to patient outcomes than in a non-acute 
scenario.  In the non-acute setting, this situation was reversed with patients with severe chronic 
illnesses having a lower likelihood of guideline adherent care. This non-compliance with 
guidelines in the non-acute setting may be appropriate as both studies included were examining 
patients with malignancy. As before, adopting a holistic approach for more severe malignancies 
may be more appropriate than following guideline mandated treatments plans.  
The evidence in regards to the effect of the gender of the patient is mixed. Both male and 
female gender was found to be associated with guideline compliance in some studies and in 
others was shown to have no effect at all. 
The race of the patient was shown to have an effect on guideline adherence in two studies. 
Both of these studies, published in America, found black and Hispanic minorities were less 
likely to receive guideline adherent care. Again, the results of these studies may reflect the 
idiosyncratic racial biases existing in America and may lack external validity. Indeed, ethnicity 








Studies which examined the effect of the gender of the clinician consistently showed that 
female doctors were more likely to follow guidelines than their male peers. The cause of this 
observed effect has not been examined in any qualitative studies. There have been no studies 
which examined how male clinicians may interact with guidelines differently. However, female 
clinicians have been shown to communicate more effectively with patients than their male 
colleagues (95). The two studies included in this review examined guideline adherent care for 
long term conditions: osteoporosis and congestive cardiac failure. More effective 
communication may lead to more appropriate assessment of these patients which would 
increase likelihood of guideline adherence.  
Younger doctors were shown to be more likely to follow guidelines than their older colleagues. 
This may be due to the fact that younger doctors will have all come of age in a time when use 
of clinical guidance was commonplace. However, the fact that the years of training or seniority 
of grade had no effect is somewhat contradictory.  
There was a noted association between being treated by the specialty in the acute presentation 
and the patients receiving guideline adherent care for the acute presentation. Clinicians who are 
specialists in the topic are more likely to be up to date on current guidelines in their field. This 
finding is in keeping with studies of guideline attributes. Guidelines which do not require new 
knowledge or skill for the clinician to apply are more likely to be applied. Specialists may be 
more likely to have the knowledge or skills to apply guideline recommendations than their 




The ease of use and compatibility of a guideline with a doctor’s values, skills and routines are 
the critical factors which influence the successful implementation of a guideline. This finding is 
in keeping with innovation research which has noted that compatibility is the key to the 
adoption of any new method, idea or product (96).  Innovations that require a low degree of 
behavioural change are more likely to succeed. Ease of use leads to increasing frequency of use 
which leads to habit forming behaviour.  
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Compatibility also comes in to play when considering the development process of a guideline. 
Guidelines which were developed by the target user group had higher levels of compliance. If 
the author of the guideline understands the working pattern of the user group the guideline will 
be more likely to be followed. Additionally, an important aspect of this was the concept of 
social networks. Social networks are groups of individuals connected by interpersonal 
relationships. Ideas and innovations spread through social networks(97). If the guideline is 
developed by clinicians within a group, it will spread more efficiently through the group than if 
developed by an author outside the social network.  
 
2.4.4 Environment  
 
This review examined a number of multi and single faceted implementation strategies. The 
common factor of multi-faceted implementation strategies shown to improve compliance was 
“localisation”. The localisation of a guideline ensures that recommendations can be 
implemented in a given setting with the resources available. As a result this will increase the 
ease of use and compatibility with practice of a clinical guideline. Of note, there were no 
studies found that examined the effect of localisation as a single-faceted implementation 
strategy.  
On analysing the single faceted implementation strategies, both feedback and having 
specialised teams for guideline implementation were shown to improve compliance with 
guideline recommendations.  
Hospital size and volume were found to be associated with guideline adherence. In qualitative 
studies, lack of time is often cited as a barrier to following guidelines (7). Larger, busier 
hospitals may mean that clinicians have less time per patient and may lead to clinicians not 




There were several limitations to the search process. The search strategy may have missed 
publications where compliance with guidelines was not the primary outcome. Additionally, all 
study selection, data collection and quality assessment were carried out by one researcher. As a 
result, there may be a potential for this one researcher’s selection bias to influence results. A 
further limitation of this study is that a large body of qualitative research was not included. 
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Whilst this meant that the review remained appropriately focused, it excluded publications 
which held an insight in to doctors reported facilitators and barriers to guideline compliance.  
A key limitation of this review is that there were multiple study designs included. Due to the 
subject matter, there are limited randomised control trials relating to this subject matter 
therefore study designs which rank lower in the hierarchical ranks of evidence based medicine 
were included.  
Additionally, there was noted heterogeneity between the outcome statistics of the studies 
making meta-analysis of the results not possible.  
A quality limitation that was present in all included studies in which included an intervention 
was a lack of blinding of participants. This introduced a performance bias to these studies 
which may have affected the results.  
This review was based upon four categories of factors which influence clinical guideline 
compliance: patient, doctor, guideline and environment. These categories were chosen to mirror 
previous behavioural studies (7, 8). This study could have been improved by the addition of a 
fifth category – disease related factors. This could include factors such as the prevalence of the 
disease, the symptoms displayed and the bodily system which the disease affects.  
Another potential limitation of adopting this categorisation is that it limits the examination of 
the interplay between factors in different categories, for example the patient’s gender and the 
physicians gender. Indeed, there was only one study included in this review which examined 
the interplay between different categories (54).  
A second limitation in the literature is that a number of studies, particularly those focusing on 
physician related factors, opted to not study ‘non-modifiable’ factors, such as physician’s 
gender or physician’s age. Whilst these factors are indeed non-modifiable, understanding which 
of these factors have a significant effect on guideline compliance can allow guideline 
developers to improve the design of their guidelines by targeting specific patient or physician 
groups or environments where low compliance has been identified.  
A final limitation of the review is that of the primary outcome: guideline compliance. 
Guideline compliance is only a worthwhile endeavour if it has a positive effect on clinical 






2.5 Conclusion  
 
This literature review demonstrates that guideline compliance is complex and affected by a 
wide range of factors. Compliance with guideline recommendations is affected by the patient 
on whom the guideline is being use, the doctor using the guideline, the environment in which 
the doctor is working and the guideline itself.  
This review found a number of studies which assessed guideline compliance over four 
different categories: patient, doctor, environment and guideline. However, there were few 
studies which assessed how these factors from different categories interact with one another. Of 
importance there were no studies which examined how guideline related factors interacted with 
doctor related factors. Understanding how different demographics of doctors interact differently 
with clinical guidelines could have important implications in the field of guideline 
development.  
There were no included studies which examined the effect of the design or development 
process of guidelines. This means that this project will be the first comprehensive evaluation of 
the effects of these variables on guideline compliance. Additionally, this project will be the first 






3 Chapter 3 – Methods 
 
3.1  Overview 
 
The overall aim of this study was to further understand factors involved in clinician use of and 
compliance with clinical guidance.  The independent variables analysed were categorised as 
patient, doctor, environmental, and guideline related factors.  
This mixed methods study examined and compared guideline use and compliance between two 
different designs of clinical guidance, the Management Guidelines for Common Medical 
Conditions (known locally as the ‘Blue Book’), and its successor Hospital HealthPathways. The 
study compared practice between 2015 and 2016. Between these two years for the most part the 
clinical content of the guidance did not change, however, the design and format of the guidance 
did. Therefore, this allowed the examination of how the way in which a guideline is developed 
and presented affects compliance with recommendations within that guideline.  
Three clinical conditions, and their corresponding guidance pages in the Blue Book and 
Hospital HealthPathways, were selected for analysis: 
- Community Acquired Pneumonia 
- Acute Pancreatitis 
- Intracranial Haemorrhage on Warfarin  
For each condition two equivalent time periods were selected. Patients in this first time period 
were managed by clinicians using the Blue Book, and patients in the second were managed by 
using Hospital HealthPathways.  
For each time period all adult patients managed in Christchurch Public Hospital were 
identified.  
Information was collected on the demographic characteristics of each patient, as well as 
information on their clinical features, such as co-morbidities and severity of their acute 
presentation. Data relating to the demographic characteristics of the clinician assessing each 
patient were also collected. Finally, the environment within the hospital in which each patient 
was assessed and managed was also noted. This allowed examination of the effect on 
compliance of the other three categories of variables, patient, doctor and environmental factors, 




The independent variables examined in this study are summarised in Table 3-1.  
 
Independent Variables Included in Compliance Data Analysis 
Guideline 
Development process 












Location within the hospital 
Table 3-1 Independent Variables Included in Compliance Data Analysis 
The use of clinical guidance pages was explored using Google Analytics software. Data were 
collected on the date and time doctors accessed the clinical guidance pages of the three selected 
conditions. The date and time of website use was compared to the date and time of hospital 
admissions of included patients with the three selected conditions.   
For each of the three selected conditions, specific recommendations within the clinical 
guideline were identified, and an audit of compliance with each recommendation was 
undertaken.  A comparison was made between compliance with guideline recommendations 
when the guidance was presented in the Blue Book and when the guidance was presented in 
Hospital HealthPathways. Sub-group analysis of patient, doctor and environmental variables of 
each case was carried out to determine the effect these variables had on guideline compliance 
with the Blue Book and with Hospital HealthPathways.  
A survey of resident medical officers and senior medical officers was carried out to better 
understand guideline use and compliance. A questionnaire was sent to clinicians with questions 
asking them to determine their patterns of and reasons for use of the Hospital HealthPathways 
website. This enriched the results of the study of Google Analytics data as this software does 
not provide information of the demographic characteristics of those using the website. The 
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questionnaire also asked resident medical officers to identify any obstacles or barriers to 
following specific guideline recommendations, to help understand the reasons for non-
compliance.  
As part of the audit of Community Acquired Pneumonia patients, any reasons for non-
compliance with guideline recommendations were noted. The reasons for non-compliance were 
then examined for emerging themes and categorised into groups. The proportion of patients 
with a documented reason for non-compliance, i.e. patients for whom non-compliance was 
‘appropriate’, was quantified. 
The methods by which each objective of the study was achieved is summarised below: 
A. To examine the effect of a change in the development process and design of a clinical 
guideline on use of that guideline  
Retrospective audit of guidance website use with data from Google Analytics 
Survey of RMOs and SMOs on guideline use 
B. To examine the effect of a change in the development process and design of a clinical 
guideline on compliance with guideline recommendations  
Retrospective audit of clinical records 
C. To determine how patient, clinician and environmental variables effect compliance 
with local clinical guidance 
Retrospective audit of clinical records 
D. To determine how a change in the development process and design of a clinical 
guideline interacts with the effects of patient, clinician and environmental variables on 
compliance.  
Retrospective audit of clinical records 
E. To describe doctors’ attitudes towards facilitators and barriers of implementation of 
local clinical guidance in their practice.  
Survey of RMOs and SMOs on facilitators of and barriers to compliance with local 
clinical guidance 
F. To describe and quantify reasons for ‘appropriate’ non-compliance with guideline 
recommendations. 






3.2 Selected Conditions 
 
There were three clinical conditions selected for analysis: 
- Community Acquired Pneumonia 
- Acute Pancreatitis 
- Intracranial Haemorrhage on Warfarin  
These conditions were selected to allow a broad scope of clinical practice to be analysed. One 
reason was their varying prevalence. Community acquired pneumonia is the most prevalent of 
the three, followed by acute pancreatitis and then intracranial haemorrhage on warfarin with 
approximately 600, 200 and 20 admissions per year respectively (98-100).   It was hypothesised 
that clinicians would be more likely to use a guideline for less prevalent conditions as they 
would be less familiar with how to assess and manage these patients.  
The conditions were selected to include a number of different medical specialties. Patients with 
community acquired pneumonia are assessed and managed by emergency, general and 
respiratory physicians whilst in hospital. Acute pancreatitis is managed by emergency 
physicians, general surgeons and, if required, intensivists. Intracranial haemorrhage on warfarin 
is often managed concurrently by a number of physicians from different teams including 
emergency physicians, neurosurgeons, intensivists, and general medicine physicians. It was 
hypothesised that compliance with guideline recommendations may differ depending on the 
specialty of the clinician.  
Finally, the selection decision was based on the perceived controversy of individual guideline 
recommendations. Guideline recommendations which are perceived to be controversial have 
been shown to have reduced rates of compliance  (6, 76). Selected recommendations within the 
intracranial haemorrhage on warfarin guideline are controversial. Specifically, the use of fresh 
frozen plasma as a reversal agent in cases of intracranial haemorrhage has a questionable 
evidence base (101). It was hypothesised that if controversial guideline recommendations do 
have a lower level of compliance, clinicians may be less likely to follow guideline 






3.3 Selected Time Periods 
 
For each selected condition, two distinct equivalent time periods were selected for analysis. 
Patients in the first time period were managed by clinicians using the Blue Book, and patients 
in the second were managed using Hospital HealthPathways. All patients admitted and assessed 
in CPH diagnosed with each of the three conditions within each selected time period were 
identified. 
The Hospital HealthPathways website was developed in a gradual page-by-page process. As a 
result pathways for individual conditions went live on different dates. A deliberate gap was left 
between the launch of the Hospital HealthPathways guidance page for the condition and the 
studied time period to ensure adequate bed-in of the new clinical guidance platform.  
The length of the time period was different for each condition, reflecting the relative 
prevalence of each. A longer time period for less prevalent conditions allowed for an adequate 
sample size. 
The two time periods for each of the three clinical conditions, and the launch date of the 
corresponding Hospital HealthPathways guidance page, is summarised in Table 3-2. 
 




Hospital Health Pathways Time Period 






01/09/2015 01/12/2015 3 17/08/2016 01/09/2016 01/12/2016 3 
Acute 
Pancreatitis 01/08/2015 01/02/2016 6 
28/07/




05/05/2014 24/11/2015 18 24/11/2015 30/11/2015 05/05/2017 18 
Table 3-2 Start and End Date, Duration of Blue Book Study Time Period , HHP Launch Date of Each Guidance 
Page, Start and End Date, Duration of Hospital HealthPathways Study Time Period for Community Acquired 
Pneumonia, Acute Pancreatitis and ICH on Warfarin Groups 
 
3.4 Patient Identification Process 
 
Clinical definition and exclusion criteria were developed for each selected condition. The 
exclusion criteria applied identified patients who would be expected to be managed out with the 
selected guideline.  
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All in-patients for each of the three selected conditions were identified by International 
Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10-CM) 
codes assigned to the patients on discharge. ICD-10-CM codes are diagnostic classification 
codes developed by the World Health Organisation, and are the international standard for 
classifying diseases and health conditions. All patients discharged from hospital in the CDHB 
are assigned an ICD-10 code classifying the disease or health condition which led to their 
admission.  
There was a cohort of community acquired pneumonia patients who could not be identified 
using ICD-10-CM codes. These patients were discharged directly from the emergency 
department, and thus not formally admitted, who were not assigned ICD-10-CM codes. This 
cohort of patients was identified using Health Care Analytics Solution (HCAS) technology. 
 
3.4.1 HCAS  
 
HCAS is a data analysis programme developed by the CDHB in partnership with Hewlett 
Packard Enterprise. It was launched in March 2017.  
HCAS allows the analysis of structured and unstructured clinical data. Structured data includes 
traditional database data such as clinical coding or laboratory results. Unstructured data 
includes bodies of clinical text such as electronic clinical records, discharge summaries, and 
radiology reports.  
HCAS works by the input of data from two sources. The first source is clinical data from the 
CDHB Data Warehouse, including observations, laboratory results, radiology reports, and all 
electronic clinical records, information that would traditionally be found in a patient’s clinical 
records. The second data source is groups of data known as ‘knowledge sources’. These include 
coding databases, clinical ontologies, and lists of medication. HCAS enriches that data from the 
first source by tagging and mapping it to data such as codes, ontologies and classifications from 
the latter source. The architecture of HCAS and this data enrichment process is illustrated in 
Figure 3-1 (pg.50).  
Hypothesis testing on HCAS is carried out by applying filters to this large data set. Filters can 
be combined using Boolean operators. If the query required analysis of unstructured data 
HCAS allows the user to analyse this data by a process called ‘Concept + searching’. Concept + 
searching allows the searching of all words or language linked to a concept within a specific 




Figure 3-1 Health Care Analytics Solution Architecture. Images provided courtesy of Dr Alan Stein, HPE Big Data 
 
3.5 Patient Identification  
 
3.5.1 Community Acquired Pneumonia 
 
All adult patients admitted to hospital with community acquired pneumonia between the 1st of 
August 2015 and 1st of December 2015, and between the 1st of August 2016 and 1st of 
December 2016 were identified. 
Pneumonia was defined as “an acute illness with radiographic pulmonary shadowing which 
was at least segmental or present in one lobe, and was neither pre-existing nor of other known 
cause.”(98) Community acquired pneumonia was defined as a pneumonia which was not 
contracted in a hospital or a long term care facility.  
All patients with the ICD-10-CM codes J12 to 18 were identified, which includes patients 
coded as having pneumonia.  
HCAS was utilised to identify the patients directly discharged from the emergency department. 
This cohort was identified by applying filters to the radiology reports of all chest x-rays carried 
out in the CPH ED during the time period. The reports were searched for words linked to the 
concept of pneumonia and its radiographic findings in the SNOWMED CT ontology, such as 
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consolidation, infiltration, effusion, and abscess. This identified all patients with radiographic 
features of pneumonia assessed in the ED during the time period.  
The lists of patients identified via ICD-10-CM codes and via HCAS were combined and 
duplicates removed. The assessment documentation and radiology reports of all patients were 
then manually reviewed to ensure patients had both clinical and radiographic features of 
pneumonia.  
Patients were excluded from analysis if they had bronchiectasis, hospital acquired pneumonia, 
known or suspected tuberculosis, aspiration pneumonia, immunosuppression, or if the 
presentation was an expected terminal event, as patients with these conditions would be 
expected to be managed   out with the guideline. 
 
3.5.2 Acute Pancreatitis 
 
All adult patients admitted to hospital with acute pancreatitis between the 1st of August 2015 
and the 1st of February 2016, and between the 1st of August 2016 and the 1st of February 2017 
were identified. 
Acute Pancreatitis is defined as an acute inflammation of the pancreas which generally 
presents with severe abdominal pain. It is diagnosed if the patient fulfils two out of three 
criteria: abdominal pain, serum amylase greater than 159 units/L or lipase greater than 210 
units/L, and radiographic evidence of pancreatitis on imaging (102).  
Patients were identified using ICD-10-CM codes K85.0 to K85.9 which includes all diagnostic 
codes for acute and subacute pancreatitis. The electronic health records of these patients were 
individually reviewed to ensure they met the diagnostic criteria for acute pancreatitis.  
Patients were excluded if they had chronic pancreatitis or known pancreatic malignancy.  
 
3.5.3 Intracranial Haemorrhage on Warfarin 
 
All adult patients admitted to hospital with an intracranial haemorrhage on warfarin between 
the 5th of May 2014 and the 24th of November 2015, and between the 30th of November 2015 
and the 5th of May 2017 were identified. 
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Intracranial Haemorrhage on Warfarin is defined as an intracranial bleed which occurs whilst 
the patient is taking the anticoagulant medication warfarin. It is diagnosed if there was a 
radiographically confirmed intracranial bleed and the patient was taking warfarin at the time of 
the bleed (100).  
Patients were identified using ICD-10-CM codes I60 to I62, which include non-traumatic 
subarachnoid haemorrhage, intracerebral haemorrhage, and unspecified intracranial 
haemorrhage, and codes S06.5 to 6.6 which includes traumatic subdural and sub-arachnoid 
haemorrhages. The radiology reports and electronic health records of these patients were 
individually reviewed to confirm radiographic evidence of an acute intracranial bleed, and that 
the patient was taking the medication warfarin at the point of admission.  
Patients were excluded from the analysis if the presentation was an expected terminal event 
that was managed with palliative intent.    
 
3.6 Data Collection  
 
Independent and outcome variables to be included in the analysis were defined prior to data 
collection. These independent and outcome variables are described in detail below.  
 
3.7 Guideline Use 
 
3.7.1 Google Analytics 
 
The use of The Blue Book and Hospital HealthPathways websites as a whole and use of 
individual guideline pages within those websites were assessed using data on website traffic 
and activity obtained from Google Analytics software.  
Google Analytics is a system which generates statistics about activity on a website for the site 
owner.  The system works by attaching tracking codes to the base of a website page. Each time 
a website page is accessed the tracking code loads and generates a ‘hit’ which is sent to Google 
Analytics. Google Analytics uses hits to generate reports which tell the website owner who the 
user is and how they interact with their website (103).  
The metric utilised in this study was a unique page view. A unique page view is an aggregate 
concept of user session and page views. A user session is a single visit to a website including 
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all pages viewed. A page view is a single viewing of a webpage. A unique page view is an 
alternative to basic page views, which eliminates the factor of multiple views of the same page 
within a single session. If a user views the same page more than once in a session, this will only 
count as a single unique page view.  
The first outcome was the total and average number of unique page views per month of the 
website as a whole and for each of the three selected conditions.  
The second outcome of interest was the total number of unique page views per day on the 
individual guidance pages of each of the three selected conditions in the selected time frame.  
 
3.7.2 Guidelines Use Independent Variables 
 
The effects of guideline and environmental factors on guideline use were analysed in this 
section. Google Analytics does not have the capacity to directly link use of a website to a 
specific doctor or patient.  
The effect of a change in the development process and design of a clinical guideline use was 
examined by comparing the volume and trends of use of The Blue Book website with those of 
the Hospital HealthPathways website. 
The effect of the total volume of patients with a given condition each day on guideline use was 
also examined. Patient volume was considered as number of admissions per day, number of 
discharges per day and overall volume (admissions plus discharges).  
 
3.7.3 Guideline Use Outcomes Variables 
 
The first outcome was the total and average number of unique page views per month of the 
website as a whole and for each of the three selected conditions.  
The second outcome of interest was the total number of unique page views per day on the 
individual guidance pages of each of the three selected conditions in the selected time frame.  
The proportion of patients in each sample for whom there was a unique page view on the 
corresponding guidance page in their mean assessment time (the mean time between arrival of 
the patient to hospital and admission to ward or discharge) was also considered as an outcome. 
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3.8 Compliance Independent Variables 
 
For each of the three conditions, data were collected on the same patient, clinician and 
environmental variables to determine their influence on guideline compliance.  
The age, gender and ethnicity of each patient were collected. This information was obtained 
from the patient’s electronic health record. 
Information relating to the clinician managing each case was collected. The managing clinician 
was defined as the most senior clinician documented in the notes as assessing the patient at the 
time the diagnosis was made. The seniority and specialty of the clinician was collected from 
electronic and paper assessment records. The seniority of the clinician was categorised as house 
officer, registrar or SMO. The gender of the clinician was obtained from the name documented 
on each assessment record. If the name documented was illegible, or a unisex name, 
clarification was sought from the CDHB Resident Doctor Support Team who are responsible 
for employing all RMOs. 
The hospital environment in which the assessment was carried out was established using the 
time at which the patient arrived in the emergency department and the time the patient was 
admitted to the ward. If the electronic health record was completed by an emergency physician 
or completed by a specialty doctor prior to the patient being admitted to the ward, then that case 
was counted as being managed in the emergency department. If the patient’s electronic health 
record showed that they had been referred directly to a ward, or if the assessment record was 
completed after the time of admission to a ward, then this was counted as a ward assessment.  
For each of the three selected conditions, information was collected on the clinical features and 
co-morbidities of each case relating specifically to that condition. 
 
3.8.1 Community Acquired Pneumonia 
 
The severity of the illness for each CAP patient was assessed using the CURB-65 score. 
CURB-65 is an acronym for each of the risk factors covered by the scoring system, namely 
presence of confusion, a serum urea level greater than 7mmol/L, a respiratory rate greater than 
or equal to 30 breaths per minute, a blood pressure less than or equal to 90 mmHg systolic or 60 
mmHg diastolic, and patient age greater than or equal to 65 years. Each risk factor is accorded 
one point to a maximum score of five (104, 105). If a CURB-65 score was documented in the 
assessment record then that was noted. If it was not documented by the assessing clinician then 
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the CURB-65 score was calculated. Confusion was defined as any documented acute 
disorientation to time, place or person by nursing or medical staff at the point of admission, or a 
diagnostic score in a delirium screening tool such as the Abbreviated Mental Test Score 
(AMTS)(106) or a 4AT score(107).Urea results were obtained from admission blood tests. 
Respiratory rate and blood pressure was noted from the admission observations. The most 
severe recorded observation prior to the administration of antibiotics was used to calculate the 
CURB-65 score, i.e. the highest respiratory rate or lowest blood pressure. Patients with a 
CURB-65 score of 0 or 1 are classified as having a mild pneumonia, patients with a CURB-65 
score of 2 are classified as having a moderate pneumonia and patients with a CURB-65 score of 
3-5 were classified as having a severe pneumonia.  
If chronic obstructive pulmonary disease (COPD) was recorded in the assessment 
documentation, clinical letters, or general practitioner notes, this was also noted.   
 
3.8.2 Acute Pancreatitis 
 
The predicted severity score was calculated for each included acute pancreatitis patient. The 
predicted severity was calculated using the scoring system that was presented in each guidance 
platform. 
For The Blue Book group, the Ranson prognostic criteria was used to predict severity of acute 
pancreatitis (108). A case was predicted to be severe if the patient met three or more of any of 
the following five criteria: age >55 years, white blood cell count level greater than 16 x 109/L, 
glucose level greater than 11.1 mmol/L, lactate dehydrogenase level greater than 350 units/L, 
aspartate aminotransferase level greater than 250 units/L. 
For the Hospital HealthPathways group, predicted severity on admission was calculated using 
either Systemic Inflammatory Response Syndrome (SIRS) criteria or C-reactive protein (CRP) 
levels. Pancreatitis is classified as predicted severe if the patient meets the SIRS criteria or has 
a CRP level greater than 150mg/L. The SIRS criteria are positive if two or more of the 
following features are present: temperature above 38 or less than 36 degrees Celsius, heart rate 
greater than 90 beats per minute, respiratory rate greater than 20 breaths per minute or a PaCO2 
less than 32mmHg, and a white blood cell count greater than 12 x 109/L, less than 4 x 109/L, or 
greater than 10% bands. If a patient does not meet the SIRS criteria or does not have a CRP 




3.8.3 Intracranial Haemorrhage on Warfarin  
 
For each case of intracranial haemorrhage on warfarin the mechanism of the intracranial bleed 
was noted as either traumatic or atraumatic. This information was found in the clinical history 
documented in the assessment record.  
The indication for treatment with warfarin was also documented. This was found in the past 
medical history or drug history in the assessment documentation, in the electronic clinical 
record, or the general practitioner notes.  
 
3.9 Compliance Outcomes Variables 
 
The outcome of interest was compliance with guideline recommendations. For each selected 
disease, individual guideline recommendations were selected as parameters of compliance. 
Each case was marked as being compliant or not compliant with the selected recommendation. 
Compliance was assessed against individual recommendations, but also in combination and 
overall. A case was marked as being compliant overall with recommendations if every one of 
the selected guideline recommendations was followed.  
These examined recommendations were chosen to represent different aspects of the patient’s 
care, including assessment, management, and discharge planning. Furthermore, the selected 
recommendations were chosen to represent clinical decisions that could be made by all grades 
of clinicians. For example, the acute pancreatitis guideline recommends that on discharge 
patients should be listed for a laparoscopic cholecystectomy. This recommendation was not 
selected to be a compliance parameter as junior doctors on the team would not be making the 
decision to list a patient for an elective procedure. 
The compliance parameter for each of the three selected conditions are as follows: 
 
3.9.1 Community Acquired Pneumonia 
 
There were four recommendations selected as compliance parameters for the community 
acquired pneumonia guideline: 
- Assess the severity of disease by calculating a CURB-65 score.  
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Clinicians were assessed as having complied with the guideline recommendation if a 
CURB-65 score was documented in the initial assessment document, or on a post-take 
ward round depending on when the diagnosis was made.  
- The selected route of antibiotic administration should be based on the CURB-65 score.  
Patients with a mild CAP (CURB-65 score 0 or 1) can be treated with oral antibiotics. 
Patients with moderate or severe CAP (CURB-65 score of 2-3 and 4-5 respectively) 
should be treated with dual intravenous therapy. If the route of antibiotic administration 
was appropriate for the documented or calculated CURB-65 score (calculated as 
described above) then the management was marked as being compliant with guideline 
recommendation. The route of antibiotic administration was found by reviewing patient 
drug charts. The antibiotic of interest was defined as the first antibiotic prescribed after 
the diagnosis was made.  
- The choice of antibiotics should be based upon the CURB-65 score.  
Mild CAP can be treated with a single oral agent, moderate CAP is treated with dual 
antibiotic therapy, and antibiotics for severe CAPs have a wider spectrum of cover. The 
individual agents advised by the guideline are summarised in Table 3-3 (pg.57-58).  If 
the choice of antibiotic was appropriate for the documented or calculated CURB-65 
score then the management was marked as being compliant with the guideline 
recommendation. The antibiotic prescribed was found by reviewing the patient drug 
chart. The antibiotic of interest was defined as the first antibiotic prescribed after the 
diagnosis was made. 
 
Severity of CAP Guideline Recommended 
Antibiotic Agent 
Guideline Recommended 
Antibiotic Agent if penicillin 
allergic 
Mild (CURB-65 score 0 or 1) Amoxicillin 500mg po 3 times 
a day for 7 days 
Doxycycline 200mg po on the 
first day and then 100mg once a 
day for 7 days 
Moderate (CURB-65 score 2-
3) 
Amoxicillin 1g IV 8 hourly 
then 500mg po 3 times a day 
for 7 days 
And either 
Azithromycin 500mg once a 
day for 3 days 
or 
Doxycycline 200mg on the first 
day and then 100mg for 7 days 
If mild allergy: 
Cefuroxime 1.5 g IV every 
eight hours then 500 mg po 
twice a day 
And  
Azithromycin 500mg once a 
day for 3 days 
If severe allergy:  
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Vancomycin See dosing 
guidelines (consult Infectious 
Diseases for oral step-down 
therapy) 
And 
Azithromycin 500 mg po once 
a day for 3 days 
Severe (CURB-65 score 4) Amoxicillin + clavulanic acid 
IV 1 g + 200 mg every 8 hours, 
and either: 
Azithromycin orally 500 mg 
once daily, 
 Or 
Clarithromycin IV 500 mg 
every 12 hours for 1 or 2 doses, 
then change to azithromycin 
orally 500 mg once a day 
If mild allergy: 
Cefuroxime 1.5 g IV every 
eight hours then 500 mg po 
twice a day  
And either: 
Azithromycin 500 mg po once 
a day  
or 
Clarithromycin 500 mg iv 
every twelve hours (for 1 or 2 
doses then change to 
azithromycin 500 mg po once a 
day) 
If severe penicillin allergy: 
Consult infectious disease 
Very severe (CURB-65 score 
5) 
Amoxicillin + clavulanic acid 
IV 1 g + 200 mg every 8 hours, 
then orally 500 mg + 125 mg 
three times a day 
and 
Gentamicin IV 5 mg/kg ideal 
body weight initial  
and 
Clarithromycin IV 500 m 
g IV every 12 hours: 
Consult infectious disease 




- Patients should have a follow-up chest X-ray 6 weeks after discharge if one of the 
following is present: ongoing symptoms, suspicious radiological features on initial 
imaging, a significant smoking history, asbestos exposure, or if recommended by a 
radiologist.  
Compliance was assessed by a review of discharge summaries in the patient’s 
electronic health record. If a follow-up chest x-ray had been arranged (or not arranged) 
appropriately then this was marked as compliant.  
 
Compliance with the CURB-65 score, and route and choice of antibiotic recommendations 
were looked at in combination to assess the overall compliance of the admitting clinician. 
Compliance with route and choice of antibiotics were looked at in combination to assess if the 
management aspect of patient care was compliant with guideline recommendations.  
 
3.9.2 Acute Pancreatitis 
 
There were two recommendations selected for examination within the acute pancreatitis 
guideline.  
- Assess predicted severity of acute pancreatitis for each patient.  
Each case was marked as compliant if there was a documented severity score in the 
assessment record at the point of diagnosis.  
- Avoid using serial measurements of amylase to assess severity and monitor progress.  
Amylase is used to diagnose pancreatitis only, and serial measurements should be 
avoided. This was done by documenting the number of serum amylase levels taken 
after the diagnosis of pancreatitis was made. Cases were classified as compliant if there 
were no further amylase levels measured.  
 
A case was judged as being overall compliant if management was compliant with both the 
amylase and severity compliance parameters.  
 
3.9.3 Intracranial Haemorrhage on Warfarin  
 
The following compliance parameters were selected: 
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- Complete the Blood Components Form (QMR022B). Clearly write "Life threatening 
bleed in patient on warfarin". The guidance advises to rapidly obtain prothrombin 
complex concentrate (Prothrombinex VF) and fresh frozen plasma ‘Life Threatening 
Bleed in Patient on Warfarin’ should be written on the blood component request form. 
Cases were marked as compliant if this was documented on the form. 
- Give Prothrombinex VF 50 units/kg, FFP 1 unit and phytomenadione (vitamin K) 5 mg 
immediately. The guidelines advise the immediate administration of these three reversal 
agents once an intracranial bleed has been confirmed. Cases were marked as compliant 
if all three reversal agents were prescribed. This information was obtained from the 
patient's drug and IV fluid prescription chart.  
- Minimum monitoring must include a coagulation screen 15 minutes after administering 
Prothrombinex-VF and FFP then at 4 to 6 hours. 
Cases were marked as compliant if a coagulation screen was performed 15 minutes 




A questionnaire was distributed to all trainee interns, and resident and senior medical officers 
working in the Canterbury District Health Board. The survey was designed, formatted and 
distributed using the online development software Survey Monkey.  
The survey was named ‘An Evaluation of Hospital HealthPathways’. It was carried out 
between the 7th of August 2017 and the 4th of September 2017. A copy of the survey 
questionnaire is in Appendix D. Reminders were sent by email at two and three weeks after 
initial distribution. The survey was not anonymous as participants were offered an incentive to 
participate in the form of a prize draw for a voucher for a local restaurant.  
The survey was designed such that respondents were not required to answer a question before 
advancing on to the next questions. As a result, the total number of respondents varied per 
question. 
The survey consisted of a mixture of 19 open and closed questions.  
There were five questions relating to the demographics of the respondent, one question 
regarding frequency of HHP use, and five questions regarding the usability of the website itself  
 The questionnaire also contained two graded questions regarding obstacles to following two 
guideline recommendations within the Community Acquired Pneumonia pathway: choice of 
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antibiotics and the arrangement of a follow-up chest x-ray on discharge. The Community 
Acquired Pneumonia pathway was selected for inclusion in the survey as it is the most 
prevalent of the three conditions. Due to the high prevalence of community acquired 
pneumonia it was hypothesised that it would be managed by a wide cross section of different 
clinicians. As a result, it was thought that the majority of respondents to the survey would have 
had experience of managing patients with this condition. Furthermore, the survey was 
developed after the initial audit of compliance with community acquired pneumonia was 
completed and thus provisional results from the analysis were available. The graded questions 
were developed using the ‘Barriers and facilitators assessment instrument’ developed by the 
Centre for Quality of Care Research at the Radbound University Nijmegen Medical Centre 
(109). For each recommendation, suggested barriers to following the guidance were listed. 
Respondents were asked to what extent they agreed that these listed barriers were obstacles to 
following the specific guideline recommendation. The strength of their agreement or 
disagreement was expressed using a Likert scale.  
There was one graded question where respondents were asked about general barriers to 
following guidance on the Hospital HealthPathways website. Respondents were also asked two 
open questions regarding barriers to use of the guidance on the Hospital HealthPathways 
website, and on suggestions for improvement.  
 
3.11 Appropriate Non-Compliance 
 
The concept of ‘appropriate non-compliance’ was explored with two guideline 
recommendations within the Community Acquired Pneumonia pathway. Data for this sub-
analysis was collected as part of the audit of the clinical records.  
Two specific guideline recommendations in the CAP guidance were assessed: choice of 
antibiotic, and decision to admit. For each guideline recommendation management was 
categorised as compliant, non-compliant but with a documented reason, or non-compliant with 
no documented reason.  
The reasons for non-compliance with the selected guideline recommendation were noted.  
Three researchers analysed the documented reasons for non-compliance in each case, and 
identified emerging themes.  The reasons for non-compliance were categorised using these 
themes. Defining clinical appropriateness of documented reasons for non-compliance on a case-
by-case basis was considered to be beyond the limits of a retrospective study. However, each 
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thematic category of reasons for non-compliance was assessed individually and all were found 
to be clinically appropriate reasons for deviation from clinical guideline recommendations. 
Therefore, each non-compliant case with a documented reason for non-compliance was 
categorised as having received ‘appropriate’ non-compliant management.  
The proportion of patients who received appropriate non-compliant management was 
quantified.   
 
3.12 Data Analysis 
 
The data collected from Google Analytics, the data warehouse, the retrospective note review 
and the survey were entered in to Excel spreadsheets. All statistical analyses were performed 
using R 64 x 3.3.2 software.  
 
3.12.1 Study Sample  
 
χ2 and Fisher tests were used to determine if there were any significant differences in the 
characteristics of included cases from The Blue Book time period and the Hospital 




The total number of unique page views was calculated for each month for each website over a 
two year period. This period was December 2013 to December 2015 for The Blue Book and 
December 2015 to December 2017 for Hospital HealthPathways. Monthly totals were also 
calculated for each of the three selected conditions.  
For both The Blue Book and Hospital HealthPathways, the mean number of unique page views 
per month was calculated for the website as a whole for the same two-year time periods.   
The mean number of unique page views per month was calculated for each of the three 
selected conditions over a one year time period. Differences between the two means were 
calculated using a Student’s T-test.  
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The ‘assessment time’ for each of the three selected conditions was determined by calculating 
the mean time in minutes between arrival of the patients and admission to ward or discharge 
from department. The time calculated was rounded to the nearest hour. If a there was a unique 
page view on the corresponding guideline page within the mean assessment time then that case 
was assigned a score of ‘1’ and was termed ‘Hit Positive’; if there was not a unique page view 
within the calculated mean length of stay to the emergency department then this was assigned a 
score of ‘0’ and was termed ‘Hit Negative’. The number and percentage of ‘Hit Positive’ 
patients in each time period was presented. Pearson χ2 testing was carried out to determine if 
there was a significant difference between the proportions of Hit Positive patients in the Blue 
Book time periods and Hospital HealthPathways time periods. P values of .05 or less were 
considered to be statistically significant.  
The total number of unique page views per day on each of the three selected conditions 
guidance within the selected time frame was calculated, as was the total number of patients 
both admitted and discharged with each selected condition on each day in the selected time 
period. A negative binomial regression analysis was carried out to determine the relationship 
between counts of patients per day and counts of unique page views per day. Negative binomial 
regression was found to be the most appropriate regression model due to significant ‘clumping’ 
noted in the data, over dispersion, and the presence of minimal zero counts. Outliers were 
analysed and removed if found to be leveraging the model. Results were presented as a 





For each selected guideline recommendation, if a patient received guideline compliant care 
they were assigned a “1”, if they received non-compliant care then they were assigned a “0”. 
The number and percentages of patients receiving guideline compliant care were presented as 
overall results, and by independent variable subgroup.  
Simple logistic regression analysis was used to identify patient, doctor and environmental 
variables significantly associated with guideline compliance. For the purpose of statistical 
analysis, the one numerical independent variable, age of the patient, was converted in to a 
categorical variable. The age of the patient was categorised in to one of four groups: 18-44 
years, 45-64 years, 65-74 year and over 75 years. As observations recorded within the clinician 
and environment variables related to the admitting clinician and location, the effects of these 
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variables were not analysed in compliance outcomes which included recommendations on 
management of the patient which occurred after admission, such as recommendations on 
inpatient care or discharge planning. These outcomes included: correct follow up imaging for 
patients with community acquired pneumonia, correct number of amylase levels for patients 
with acute pancreatitis and overall compliance with all guideline recommendations. The results 
of the univariate analysis were presented as an odds ratio with 95% confidence intervals. P 
values of less than 0.05 were considered to be statistically significant.  
A multivariate logistic regression was built to simultaneously model for the influence of 
patient, clinician, and environmental factors on guideline compliance. The multivariate model 
was built in 2 steps. A multivariate model for each of the 3 categories of variables (patient, 
doctor and environmental) was developed, entering all variables within a category that were 
significant at the P<.05 level in the single logistic regression analysis. All variables significant 
at the P<.05 level from the separate models were entered into a final multivariate regression 
equation. The data was presented as odds ratios (ORs) and 95% confidence intervals as derived 
from multivariate model estimates. Two-sided P values of .05 or less were considered to be 




As respondents were not required to answer each question before advancing through the 
survey, the total number of respondents was reported at the base of each table of survey results 
presented. The frequency of responses to different options on closed questions within the 
survey was presented as number and percentage of total responses. 
The results relating to frequency of use were analysed by different demographic clinician 
variables including seniority, gender and specialty. Responses were presented as the number 
and percentage frequency of each gender, grade and specialty of doctor.  χ2 testing was 
undertaken to determine if there was a significant difference in response to frequency of use by 
different groups.  
The responses to open questions relating to barriers to guideline compliance were analysed for 
emerging themes. These themes were categorised in to doctor, environmental and guideline 




3.12.5 Appropriate Non-Compliance  
 
In this proportion of the analysis, The Blue Book and Hospital HealthPathways groups were 
considered together. 
 For each the selected guideline recommendations each case was categorised as having 
received management that was: compliant, non-compliant with no reason documented for 
deviation from guideline recommended management or non-compliant with a reason 
documented for deviation from guideline recommended management. The number and 
percentages of cases in each category was documented.  
The documented reasons for appropriate non-compliance were analysed for emerging themes 
by three clinicians. The number of cases with a documented reason for appropriate non-
compliance within each theme was reported. 
The percentage of total patients in each group who received appropriate non-compliant 
management was calculated. This percentage was subtracted from 100% to obtained suggested 
target levels for compliance with guideline recommendations. 
 
3.13 Ethical Approval 
 
Ethical approval for this project was sought from the Health Disability and Ethics Committee 
(HDEC). The project proposal was assessed by the secretariat of HDEC against Standard 
Operating Procedures. HDEC concluded that this study was out with the scope of HDEC 
review as described in section three of the Standard Operating Procedures and therefore did not 
require further HDEC review or approval.  
 
3.14 Support and Expert Assistance Received  
 
The identification of patients, data collection for community acquired pneumonia, utilisation 
data collection, survey development and distribution, and all statistical analysis were carried out 
personally.  
The collection of compliance data for acute pancreatitis patients was carried out by Dr Oliver 
Thomas. The collection of compliance data for Intracranial Haemorrhage on Warfarin patients 
was carried out by Dr Claire Salter and Dr Lyn Pugh.  
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The knowledge on statistical modelling was gained from attending: Statistics Workshops for 
Postgraduates and Staff: Statistical Modelling 1. This was a three day course provided by 
Austina Clark and Ting Wang, Department of Mathematics and Statistics, University of Otago. 
The course covered exploratory data analysis, model formulation, parameter estimation, model 
checking and result interpretation. The final methodology of the statistical analysis was devised 
with the support of Dr John Pearson, Biostatistical Consultant, University of Otago.  
Filter application and concept searching of HCAS was carried out following a training course 
(spanning five half-day training sessions) on advanced usage of the system, organised by 
Michael O’dea, Planning and Funding Team, CDHB. The final search strategy was developed 
with the expert advice of Dr Alan Stein, Hewlett-Packard Enterprises and John Quayle, 
Decision Support, CDHB.   
Feedback on survey questions was obtained from both technical writers at Streamliners Ltd 
and clinical editors from the Hospital HealthPathways team.  
The documented reasons for appropriate non-compliance were analysed for emerging themes 
by myself with expert input from Prof Mike Ardagh, Professor of Emergency Medicine and 
Jeanelle Beltran, Technical Writer, Streamliners Ltd. 
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4 Chapter Four - Results  
 
4.1 Chapter Overview  
 
In each section of this chapter, the results relating to the three examined conditions will be 
listed in turn.  
For each condition, analysis was undertaken for two groups of patients: those managed in the 
time period when the clinical guidance was provided by The Blue Book and those managed in 
the time period when the clinical guidance was provided by Hospital HealthPathways. These 
groups will hereafter be referred to as The Blue Book group and the Hospital HealthPathways 
group or abbreviated as BB or HHP respectively.  
The first section begins with details of the results of the study sample identification process. 
The demographic characteristics of patients, their clinicians and the location in the hospital in 
which they were diagnosed will be listed. The characteristics of the patients in The Blue Book 
and in the Hospital HealthPathways groups for each of the three selected conditions will be 
compared. 
The next section examines the overall observed use of guidance website pages, and how the 
frequency and volume of use is affected by guideline, environmental and clinician related 
variables.  This section begins by detailing the trends for website use as a whole, and then for 
the individual CAP, acute pancreatitis and ICH on warfarin guideline pages. This section goes 
on to examine the effect of guideline-related factors by comparing guideline use between 
different topics and different designs of the guidance website. The volume of guideline use as 
an outcome is examined as the proportion of patients in a group with a unique page view on the 
guidance website within their mean assessment time.  The effect of patient volume, an 
environmental factor, is then examined by showing the results of regression analysis on the 
relationship between the volume of patients with a given condition presenting each day and the 
volume of traffic on the corresponding guidance page. The final part of this section examines 
the association between gender, specialty and seniority of clinician, and reported frequency of 
website use. 
The chapter goes on to detail the results of an audit of compliance with guideline 
recommendations for each of the three selected conditions in turn. The proportion of patients 
receiving compliant care as a whole will be listed, as will the percentages for subgroups of 
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patients. This section presents the results of single and multiple regression analyses of the effect 
independent variables have on compliance with guideline recommendations.  
The chapter then continues by exploring the concept of guideline compliance in greater depth 
by showing the results of the questionnaire sent to physicians. The perceived barriers to 
compliance with individual guideline recommendations, and with clinical guidance as a whole, 
will be discussed. 
The final section of the chapter explores the concept of appropriate non-compliance. For two 
individual recommendations within the CAP pathway the documented reasons for non-
compliance will be described, categorised and quantified.  
 
4.2 Study Sample 
 
4.2.1 Community Acquired Pneumonia 
 
4.2.1.1 Study Sample Identification 
 
Patients were identified using data from ICD-10-CM codes and the results of an HCAS search 
of chest x-ray reports. Lists of patients from these two search processes were combined and 
duplicates removed leaving 856 patients in The Blue Book time period and 840 patients in the 
Hospital HealthPathways time period. The radiology reports and electronic health records of 
these patients were reviewed to ensure that patients met both clinical and radiological inclusion 
criteria. Any patients with any identified exclusion criteria were disqualified from the study. 





The Blue Book Hospital HealthPathways 
856  840  
 Did not meet radiological inclusion criteria:  32 
 Did not meet radiological 
inclusion criteria:  21 
 Did not meet clinical inclusion 
criteria: 48  
Did not meet clinical inclusion 
criteria: 45 
776  774  
 
Excluded: 




- Expected terminal event: 
17 
- Aspiration pneumonia: 
32 
- Hospital acquired 
pneumonia: 5 
- Bronchiectasis: 19 
- Aged under 18years: 37 
 Excluded: 




- Expected terminal 
events: 2 
- Aspiration pneumonia: 
26 
- Hospital acquired 
pneumonia: 6 
- Bronchiectasis: 7 
- Aged under 18 years:  
48 
343  388  
  Inadequate documentation, or 
clinical records not available: 48 
 Inadequate documentation, or 
clinical records not available: 32 
295  356  
Figure 4-1  Community Acquired Pneumonia: Study Sample Selection Process 
  
Clinician gender was the only variable for which there were cases with missing data. Data 
were not available for the gender of the clinician in 80 cases: 48 (14%) in The Blue Book group 
and 32 (8.3%) in the Hospital HealthPathways group. This was due to challenges in the data 
collection process such as the clinician’s handwriting being illegible in assessment documents 
or the clinician having a unisex name. The data were diagnosed as being ‘missing at random’. 
This is when missing observations (in this case the gender of the clinician) are not related to the 
value of the observation (in this case male or female) but rather of another observed variable (in 
this case specialty of clinician). Comparative analysis found that there was a significant 
difference in the proportions of missing and observed data for clinicians working in different 
specialties. Clinicians working in general medicine were overrepresented in cases with missing 
gender data. This is due to the fact that general medicine assessments are handwritten, which 
differs to other specialties whose assessments are completed electronically. The use of 
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handwritten assessments meant that the clinician’s name was not always legible and thus their 
gender was unknown. Electronic assessments are tagged automatically with the clinician’s 
name at the bottom.  
Comparative analysis demonstrated no significant difference in any other independent variable 
or any outcome variables between cases with missing clinician gender data and cases with 
observed clinician gender data. Furthermore, there was no significant difference between the 
Blue Book and Hospital HealthPathways groups with missing data. The cases with missing 
observations and the comparative analysis are presented in Appendix E. 
Following consultation with a biostatiscian, in light of the randomness of missing data and the 
small proportion of cases with missing data these cases were omitted from the single and 
multiple regression analysis by list wise deletion. 
Therefore, in the final study sample there were 651 community acquired pneumonia patients 
included, of which 295 were in the Blue Book time period and 356 were in the Hospital 
HealthPathways time period. 
 
4.2.1.2 Demographic Characteristics 
 
The patient demographic characteristics on included cases are displayed in Table F-1, 
Appendix F. There was no statistically significant difference between the demographic 
characteristics of the patients managed in The Blue Book and Hospital HealthPathways time 
periods.  
There was approximately equal proportions of males and female in both the Blue Book and 
Hospital HealthPathways groups. The mean age of the included patients in both groups was 69 
years, ranging from 18 to 98 years old in The Blue Book group and 20-98 years in the Hospital 
HealthPathways group. The majority of patients in both groups were aged over 75 years. In 
both groups the majority of patients in the sample self-identified as being of NZ European 
ethnicity. Māori was the largest minority ethnic group, followed by Pacific Islanders.  
In regards to the clinical features, of the included patients, approximately 30% had been 
diagnosed with chronic obstructive pulmonary disease (COPD). The majority of cases of 
pneumonia were mild or moderate and only a small minority of patients were admitted with 
severe disease 
The demographic characteristics of the clinicians managing each case are listed in Table F-2, 
Appendix F. There was approximately equal representation of male and female clinicians 
managing patients with CAP. The majority of patients were assessed by registrars. The majority 
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of patients with CAP were assessed by clinicians working in the general medicine department, 
followed closely by clinicians working in emergency medicine. When comparing The Blue 
Book and Hospital HealthPathways groups, there was no significant difference between the 
proportion of clinicians of different genders and different seniorities. There was a significant 
difference in the proportions of clinicians working within different specialties. There was a 
higher proportion of emergency medics (HHP 46% vs BB 42%) and a lower proportion of 
general medics (HHP 48% vs BB 54%) in the Hospital HealthPathways group in comparison to 
The Blue Book group.  
The location in which the patients were managed within the hospital is listed in Table F-3, 
Appendix F. The majority of patients were managed in the emergency department and the 
remaining patients were diagnosed in an acute ward. There was not a significant difference 
between The Blue Book and Hospital HealthPathways groups in regards to the environment 
within the hospital in which the patients were managed.  
 
4.2.2 Acute Pancreatitis 
 
4.2.2.1 Study Sample Identification 
 
All patients who received the ICD-10-CM codes K85-89 on discharge in the selected time 
periods were identified. In total, there were 417 cases identified. This equated to 182 cases in The 
Blue Book group and 235 cases in the Hospital HealthPathways group. The electronic clinical 
records of all of the identified encounters were reviewed, and inclusion and exclusion criteria 












The Blue Book Hospital HealthPathways 
182  235  
 Did not meet diagnostic 
inclusion criteria: 8 
 Did not meet diagnostic 
inclusion criteria: 5 
174  230  
 Excluded: 
- Chronic pancreatitis 
- 70 
- Diagnosis made 
outwith CDHB or by 
GP 2 
 Excluded: 
- Chronic pancreatitis 
93 
- Diagnosis made 
outwith CDHB or by 
GP 10 
102  127  
 Inadequate documentation, or 
clinical records not available 
-1 
 Inadequate documentation, or 
clinical records not available 
- 1 
101  126  
Figure 4-2 Acute Pancreatitis: Study Sample Selection Process 
There were three cases with missing data relating to the gender of the clinician. This again was 
due to handwriting of the clinician being ineligible. As with community acquired pneumonia 
these cases were omitted from analysis by listwise deletion.  
Therefore, in the final study sample there were 224 acute pancreatitis patients included, of which 
99 were in the Blue Book time period and 125 were in the Hospital HealthPathways time period. 
 
4.2.2.2 Demographic Characteristics 
 
The demographic characteristics of included patients with acute pancreatitis are listed in Table 
G-1, Appendix G. 
There were higher proportions of male patients (BB: 56.6%, HHP: 59.2%) than female patients 
(BB: 43.4%, HHP: 40.8%) in both groups. The mean age of patients for both groups was 53 
years, ranging from 18-92yrs in The Blue Book group and 20-96 years in the Hospital 
HealthPathways group. The majority of included patients were NZ European in ethnicity. The 
majority of patients had mild pancreatitis (BB: 84.8%, HHP: 83.2%). On comparison there was 
no significant difference in the patient characteristics of the two groups.  
The demographic characteristics of the clinicians managing patients with acute pancreatitis are 
listed in Table G-2, Appendix G. The majority of patients were managed by male clinicians 
(BB: 59.6%, HHP: 60.8%). 60% of patients in both groups were initially diagnosed and 
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managed by a registrar. Comparison between The Blue Book and Hospital HealthPathways 
groups showed that there was a significant difference in the proportions of patients managed by 
different specialties between the two time periods.  In the Blue Book group 55.6% of patients 
were managed by general surgeons and 41.4% of patients were managed by emergency medics. 
In the Hospital HealthPathways group however, only 37.6% of patients were managed by 
general surgeons and 51.2% of patients were managed by emergency medics.   
In Table G-3, Appendix G the locations within the hospital in which patients with acute 
pancreatitis were diagnosed and managed is listed. Overall, the diagnosis was made for the 
majority of patients in the emergency department (BB: 70.5%, HHP: 69.6%). For the remaining 
patients the diagnosis was made in an acute ward. There was no significant different between 
The Blue Book and Hospital HealthPathways groups of patients in regards to where the diagnosis 
was made.  
 
4.2.3 Intracranial Haemorrhage on Warfarin 
 
4.2.3.1 Study Sample Identification 
 
All patients who received the ICD-10-CM codes I60-I62 and S06.5 and S06.6 on discharge in 
the selected time periods were identified. The electronic health records and radiological report 
records were reviewed to determine which patients met the inclusion criteria. Patients with any 
exclusion criteria present were excluded from the analysis. The study sample identification 
process is shown in Figure 4-3.  
 
The Blue Book Hospital HealthPathways 
511  518  
 Did not meet diagnostic 
inclusion criteria:  
- Not taking warfarin 
457 
 Did not meet diagnostic    
inclusion criteria:  
- Not taking warfarin 
462 
54  56  
 Excluded: 
- Palliated 20 
 Excluded: 
- Palliated 25 
34  31  




The data collection process for these patients proved challenging as the presentations were 
often medical emergencies. In practical terms this meant that a number of clinicians from 
different teams were often involved in the management of the patient during their initial 
assessment. As a result there was a large proportion of cases where it was not possible to 
identify the gender, specialty or seniority of the clinician managing the patient. The study 
sample identification process identified all patients from the launch date of the Hospital 
HealthPathways page to the time of this study. However, in spite of a comprehensive 
identification process, the study sample size was small and inadequately powered to complete 
subgroup analysis due to low prevalence of this condition. As a result the decision was taken 
not to delete cases with missing data but rather simply present overall compliance rates, 
including those cases with unknown values. Additionally, due to the small sample size and the 
propensity of unknown values, univariate and multivariate analysis was not carried on the data 
in this condition.  
 
4.2.3.2 Demographic Characteristics  
 
The demographic characteristics of the patients included in the study sample are listed in Table 
H-1, Appendix H.  
There were approximately equal proportions of male and female patients presenting with ICH 
on warfarin in both groups. The average age was 74 (range: 38-92) years and 76 (range: 49-93) 
years in the Blue Book and Hospital HealthPathways groups respectively. The majority of 
patients were aged over 75 years. The majority of patients were of NZ European ethnicity, and 
the largest minority group was Māori patients. The indication for taking warfarin in the 
majority of patients in both groups was atrial fibrillation (AF). Overall, of the included patients 
67.8% and 41.9% of Blue Book and Hospital HealthPathways patients respectively had a 
traumatic intracranial haemorrhage. There was no significant difference in the characteristics of 
patients in The Blue Book group and the Hospital HealthPathways group.  
The demographic characteristics of the clinicians managing the patients with ICH on warfarin 
are listed in Table H-2, Appendix H. There was a notable proportion of cases with missing data 
for each variable. The missing data was higher in The Blue Book group, this is likely due to 
greater numbers of assessments being documented on paper as opposed to on computer in this 
time period making it more challenging to identify the clinicians involved. There were 
significant differences between the proportions of doctors of different genders and seniorities 
between the two groups but this is likely due to higher proportions of cases of unknown 
variables in the Blue Book group.  
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The locations within the hospital in which patients in the ICH on Warfarin were diagnosed are 
listed in Table H-3, Appendix H. The majority of patients were managed in the emergency 
department (BB: 90%, HHP 74%). There was no significant difference in the location within 
the hospital in which patients were diagnosed between The Blue Book and the Hospital 
HealthPathways groups.  
 
4.3 Use of the Clinical Guidance Websites 
 
4.3.1 Observed Frequency of Use  
 
The Hospital HealthPathways website has a high volume of use and this volume has increased 
over time. In the two years since the launch of the website the average number of unique page 
views per month on the Hospital HealthPathways site was 17,124. Examination of the trends 
over time shows that the number of unique page views on the Hospital HealthPathways site was 
steadily rising in a linear fashion (Figure 1). This observed rise is due in part to the increase in 
the number of pathways on the website over time. The pages of the three selected did not show 
the same clear linear trend (Appendix I). The CAP page did show a trend indicating a rise in the 
number of monthly unique page views, however this trend was less apparent on examination of 
the acute pancreatitis and ICH on warfarin pages (Appendix I).  
 
 
Figure 4-4 Total Monthly Unique Page Views on The Blue Book Website December 2013 - December 2015 and on 





























In comparison, in the two years prior to its expiration the average number of unique page 
views on The Blue Book website as a whole was 10,990. Between 2013 and 2015, trends 
showed that the number of unique page views per month was relatively steady for the site as a 
whole and for the CAP, acute pancreatitis and ICH on warfarin pages individually (Appendix 
I).   
The development process and design of clinical guideline both affect the volume of use. The 
volume of use of guidance pages for comparable conditions was higher for Hospital 
HealthPathways than The Blue Book.  The mean number of unique page views per month was 
significantly higher on the Hospital HealthPathways guidance pages than The Blue Book page 
(Table 4.1).  
 
  
The volume of use did differ between different topics of clinical guidance. The mean number 
of unique page views differed between the different topics of guidance. The CAP page had the 
highest mean number of unique page views, followed by acute pancreatitis and then ICH on 
warfarin. This order of volume of use matches the order of prevalence of the three conditions.  
A change in the guidance platform led to a change in the proportion of patients in which the 
corresponding guidance page was accessed within four hours of their arrival. For CAP, acute 
pancreatitis and ICH on Warfarin the mean assessment time was four hours. The number and 
proportion of ‘Hit Positive’ patients (patients for whom there was a unique page view on the 
corresponding guidance page within four hours of their arrival to hospital) is listed in Table 4-2 
(pg.77). 
  
 Average Number of Monthly Page Views p value* 
Guidance Page BB HHP  
Community Acquired Pneumonia 174 237 <0.01 
Acute Pancreatitis 37 60 <0.0001 
ICH on Warfarin 23 38 <0.01 
*Statistical significance of difference in means calculated using Students T-test 
 
 
Table 4-1 Mean Number of Monthly Page Views on The Blue Book and Hospital HealthPathways Websites for 
Three Selected Conditions  
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 Guidance Pages Unique Page View 
within 4hrs of 
admission  
N (%) 
No Unique Page 




CAP   <0.001 
BB 95 (27.7) 248 (72.3)  
HHP 249 (64.2) 139 (35.8)  
Acute Pancreatitis   < 0.001 
BB 11 (10.9) 90 (89.1)  
HHP 41 (32.5) 85 (67.5)  
ICH on Warfarin    
BB 19 (61.3) 12 (38.7) 0.42 
HHP 23 (74.2) 8 (25.8)  
*Pearson χ2 testing was carried out to determine if there was a significant difference between the proportions of 
Hit Positive patients in the Blue Book time periods and Hospital HealthPathways time periods 
 
Table 4-2 Number and Percentages of Patients with Unique Page View On Corresponding Guidance Page in Mean 
Assessment Time 
 
There were higher proportions of Hit Positive patients in the Hospital HealthPathways group 
for both community acquired pneumonia and acute pancreatitis than The Blue Book group. 
There was found to be statistically significant for these two conditions. Whilst the proportion of 
Hit Positive ICH patients was higher in the Hospital HealthPathways group, the difference 
between the two groups did not reach statistical significance on analysis.  
Negative binomial regression analysis showed a modest, significantly positive relationship 
between the volume of patients being admitted and the volume of unique page views on the 





Community Acquired Pneumonia 
 BB  HHP  
Patient Volume RR* (95% CI) P Value** RR (95% CI) P Value 
Admission 1.07 (1.01-1.13) 0.03 1.07 (1.03-1.12) <0.001 
Discharge 1.05 (0.98-1.12) 0.20 1.05 (1.01-1.09) 0.02 
Overall 1.06 (1.02-1.11) <0.01 1.04 (1.01-1.05) <0.01 
Acute Pancreatitis 
 BB  HHP  
Patient Volume RR (95% CI) P Value RR (95% CI) P Value 
Admission 1.11 (0.99-1.26) 0.08 1.13 (0.98-1.30) 0.09 
Discharge 1.19 (0.87-1.61) 0.27 1.08 (0.93-1.24) 0.31 
Overall 1.13 (1.02-1.25) 0.02 1.12 (1.02-1.24) 0.02 
Intracranial Haemorrhage on Warfarin 
 BB  HHP  
Patient Volume RR (95% CI) P Value RR (95% CI) P Value 
Admission 1.30 (1.08-1.57) <0.01 1.18 (0.99-1.42) 0.07 
Discharge 1.35 (1.08-1.69 0.07 1.17 (0.96-1.42) 0.12 
Overall 1.18 (1.05-1.33) <0.01 1.16 (1.03-1.30) 0.01 
*Rate Ratio **P value represents significance of relationship between predictor variable (patient volume) on 
outcome variable (volume of page views on clinical guidance pages). Calculated using negative binomial 
regression analysis.  
 
Table 4-3 Results Negative Binomial Regression Analysis 
The strength of the relationship between patient volume and website use did not differ between 
each of the three selected conditions. Equally, there was no difference between analyses of 
volumes of patients at different points of their hospital journey (i.e. admission vs discharge). 
Finally, there was no notable difference in this relationship between The Blue Book and 
Hospital HealthPathways.  
 
4.3.2 Reported Frequency of Use 
 
Data from Google Analytics provided information on site use, but the program does not 
identify the specific user of the website. As a result, this analysis was unable to show how use 
of the site was affected by the demographics of the clinician. In the absence of observed data on 
website use by subgroup of clinician, the results of the survey of hospital SMOs and RMOs 
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supplemented this data with information on reported frequency of use of Hospital 
HealthPathways site. 
The results of the survey found a wide spread in the reported frequencies of use of the Hospital 
HealthPathways site, ranging from never to over five times per day (Table 4-4).  
 


























Overall 24 (10) 75 (30) 31 (12) 61 (24) 51 (20) 8(3)  
Gender       0.02 
Male 15 (12) 47 (37) 11 (9) 28 (22) 20 (16) 6 (5)  
Female 8 (7) 28 (23) 20 (17) 32 (27) 31 (26) 2 (2)  
Seniority       <0.001 
TI/HO 1 (2) 2 (3) 3 (4) 29 (43) 28 (41) 5 (7)  
Registrar 3 (5) 16 (24) 10 (14) 19 (28) 17 (25) 2 (3)  
SMO 20 (17) 57 (50) 18 (16) 13 (11) 6 (5) 1 (1)  
Specialty       0.10 
Emergency 
Medicine 1 (4) 2 (8) 1 (4) 5 (20) 12 (48) 4 (16)  
General 
Medicine 3 (6) 13 (25) 4 (8) 18 (35) 12 (23) 2 (4)  
General 
Surgery 0 (0) 7 (37) 2 (11) 6 (2) 3 (16) 1 (5)  
*P value calculated by χ2 testing to determine if there was a significant difference in response to frequency of 
use by different groups.  
Total number of respondents to this question: n= 250 
 
Table 4-4 Reported Frequency of Use of Hospital HealthPathways Website  
 
Sub-group analysis of reported frequency of use found that there was a significant difference in 
responses between different genders and seniorities of clinicians when asked on their frequency 
of use of the Hospital HealthPathways website. Conversely, there was no significant difference 
in frequency of use between different specialties.  
 
4.3.3 Use of Clinical Guidelines: Summary  
 
The first key finding of this analysis is that the Hospital HealthPathways website has seen a 
steady increase in its use over time. In the two year period since its launch (2015-2017), the 
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average number of monthly unique page views is higher on the Hospital HealthPathways site 
than the average number of unique page views on The Blue Book in the two years prior to its 
expiration (2013-2015).  
The second key finding is in regards to the temporal relationship between patient arrival and 
guideline use: there was a significantly higher proportion of ‘Hit Positive’ patients in the 
Hospital HealthPathways group than The Blue Book group. This finding shows that the website 
page was accessed in a higher proportion of patients in the Hospital HealthPathways group at 
the point of their admission. However, it should be noted that a unique page view cannot be 
directly linked to an individual health professional or patient.  
Finally, the reported frequency of use of the Hospital HealthPathways site differs between 
different sub-groups of clinicians. There is a significant difference in reported frequency of use 
between clinicians of different gender and seniority.  
In practical terms what these findings suggest is that volume of use of a guidance page is 
related to the design and format of the website, and to the topic of the guidance page.  
Equally, the demographics of the clinician appear to play a part in guideline use. There exists a 
variation in local clinical guideline use between clinicians. The results of the survey show that 
female clinicians and more junior clinicians report they use Hospital HealthPathways more 
frequently.  This variation in behaviour may lead to a variation in compliance with guideline 
recommendations.  
 
4.4 Compliance with Clinical Guideline Recommendations  
 
4.4.1 Community Acquired Pneumonia 
 
4.4.1.1 Overall Compliance 
 
In three out of four of the selected individual guideline recommendations, and in all three of 
the combined measures compliance was higher in the Hospital HealthPathways group of 




Guidance The Blue Book Hospital HealthPathways  












documented 96 (33) 199 (68) 119 (33) 237 (67) 0.78 
Correct route of 
antibiotics 187 (63) 108 (37) 239 (67) 117 (33) 0.31 
Correct choice of 








64 (22) 231 (78) 115 (32.) 241 (68) 0.01 
Correct follow up in 
regards to arranging 
imaging ‡ 




26 (9) 269 (91) 36 (10) 320 (90) 0.52 
* P value calculated using Pearson χ2 testing to test difference in proportions of compliant and non-compliant 
patients in Blue Book and HHP groups 
** There were 15 cases in the BB group and 20 cases in the HHP group who died on admission therefore not 
included in this analysis for this outcome. 
† CURB-65 score documented and correct route and choice of antibiotics prescribed. 
‡Correct route and choice of antibiotics prescribed 
∞CURB-65 score documented, correct route and choice of antibiotics prescribed and correct follow 
up imaging arranged. 
**  
Table 4-5 Overall Compliance with Community Acquired Pneumonia Clinical Guideline Recommendations  
 
This difference was found to be statistically significant in one selected guideline measure: the 
choice of antibiotics. A higher proportion of patients received the correct choice of antibiotics 
in the Hospital HealthPathways group than The Blue Book group (35.4% vs 25.1%). There was 
also a significant difference in the proportion of patients with compliant care in one compliance 
parameter: the management the patient received on admission. Of the included patients, 32.3% 
received management compliant with guidelines in the Hospital HealthPathways group, 
whereas in The Blue Book group only 21.7% of patients received guideline compliant care.   
The number and percentage of patients receiving compliant care for each guideline 




4.4.1.2 Single Logistic Regression 
 
4.4.1.2.1 Patient Variables 
 
The severity of the patient’s pneumonia, the presence or absence of a co-morbidity, and the age 
of the patient were all found to have a significant effect on the likelihood of a patient receiving 
guideline compliant care (Appendix K).   
Patients with moderate and severe pneumonias were significantly more likely to receive 
guideline compliant care than patients with mild pneumonia. Other than the guideline 
recommendation relating to follow up imaging, this finding was consistent across all individual 
guideline recommendations. Furthermore, severity was also a significant predictor of 
compliance across all combined compliance outcomes including admission, management and 
overall. This finding was consistent in both the Blue Book, and Hospital HealthPathways 
groups. In considering combined outcomes, increasing severity of pneumonia was shown to 
have a significant effect on management and admission. Patients with both moderate (OR 5.67 
(3.19-10.06), <0.001) and severe (OR 11.08 (5.30-23.17), <0.001) pneumonias have an 
increased likelihood of receiving overall guideline compliant care.  
The co-morbidity COPD was associated with a lower probability of receiving the correct 
follow-up in regards to imaging. In both the Blue Book (OR 5.88, CI 3.52 - 9.82, <0.001) and 
Hospital HealthPathways (5.67 CI 3.52- 9.15, <0.0001) groups patients without COPD were 
significantly more likely to have the correct follow-up arranged on discharge groups than 
patients with COPD.  
Increasing age of the patient was associated with increased likelihood of receiving guideline 
compliant care in regards to the route of antibiotics. In The Blue Book group, patients aged 65-
74 years (OR 5.04 (2.11- 12.04) and over 75 years (OR 6.61 (2.93- 14.92) were significantly 
more likely to receive guideline compliant care than patients in the younger age group. In the 
Hospital HealthPathways group this finding was only evident for over the age of 75 years (OR 
3.15 CI 1.50-6.62, p<0.01). 
In single logistic regression, the gender and ethnicity of the patient was not significantly 





4.4.1.2.2 Clinician Variables 
 
The gender, grade and specialty of the clinician were all found to have significant effect on 
receiving guideline compliant care across a number of recommendations.  
In the Blue Book group, patients treated by male clinicians were less likely to have a 
documented CURB-65 score (OR 0.49 (0.30- 0.80), p <0.001) and antibiotics prescribed by the 
correct route (OR 0.48 (0.30 -0.78), <0.01) than female clinicians. Regression analysis of the 
Hospital HealthPathways group found that clinician gender was not a significant predictor of 
guideline compliance, and that there was no significant variation in compliance between male 
and female clinicians.  
In the Blue Book group, the grade of clinician had a significant effect on compliance with one 
selected guideline recommendation: documentation of CURB-65 score. Trainee Interns and 
House Officers were significantly more likely to document a CURB-65 score than registrars 
(OR 2.76 (1.60- 4.77), p<0.001)). This finding was not noted in the Hospital HealthPathways 
group.  
The specialty of the clinician was also a significant factor in The Blue Book group: clinicians 
working in sub-specialties (specialties other than emergency medicine, general medicine or 
respiratory medicine) were significantly less likely to prescribe the correct route of antibiotics 
(OR 0.09 (0.01-0.74, 0.03). The specialty of the clinician did not affect the likelihood of 
guideline compliance in the Hospital HealthPathways group.  
 
4.4.1.2.3 Environmental Variables 
 
In both The Blue Book and Hospital HealthPathways group, the location within the hospital 





4.4.1.3 Multiple Logistic Regression  
 
The results of the multiple logistic regression analysis are listed in Table 4-6.  
 
The Blue Book  
Compliance 
Outcome 
Variable  OR (95% CI)* P value** 
CURB-Score 
Documented 
Grade  TI/HO 2.92(1.67-5.12) <0.001 
 Severity  Severe  6.07 (1.41-26.07) 0.02 
Correct Route of 
Antibiotics 




Doctor Gender Male 0.37 (0.15-0.89) 0.03 
 Severity Moderate 7.52 (2.19-25.86) <0.01 




Severity Moderate 5.47 (2.55-11.71) <0.001 
  Severe 21.52 (4.58-101.14) <0.001 
Hospital HealthPathways   
CURB-Score 
Documented 
Co-morbidity No COPD 1.99 (1.18-3.36) <0.01 
 Severity Moderate 1.87 (1.20-2.95) <0.01 
Correct route of 
Antibiotics 
Severity Moderate 38.50 (17.27-85.86) <0.001 
  Severe 23.13 (2.84-188.57) <0.01 
*OR (95% CI) = Odds ratio (95% Confidence Interval) **P value calculated using multiple logistic regression 
model  
 
Table 4-6 Multiple Logistic Regression Analysis: Predictors of Compliance with Community Acquired Pneumonia 
Clinical Guideline Recommendations 
 
4.4.1.3.1 Patient Variables 
 
In multivariate analysis, severity of the pneumonia remained a significant predictor of 
guideline compliance across all selected individual and combined guideline recommendations. 
Patients with moderate and severe pneumonias were significantly more likely to have received 
guideline compliant care than patients with mild pneumonia. This finding was evident in both 
Hospital HealthPathways and the Blue Book groups across a number of recommendations.  
In multi-variate analysis the absence of a co-morbidity remained a significant predictor of 
guideline compliance in assessment documentation in the Hospital HealthPathways group. 
Patients without COPD were significantly more likely to have a CURB-65 score documented 
than patients with COPD (OR 1.99 (1.18-3.36), <0.01).  
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4.4.1.3.2 Clinician Variables 
 
In considering the groups individually, in the Hospital HealthPathways the gender, grade and 
specialty of the clinician did not significantly affect compliance in multivariate analysis. This is 
in contrast to The Blue Book where gender and grade of clinician had a significant effect on the 
likelihood of receiving guideline compliant care.  
 
4.4.2 Acute Pancreatitis  
 
4.4.2.1 Overall Compliance 
 















of amylase levels 
ordered on 
admission 
63 (64) 36 (36) 82 (66) 43 (34) 0.78 
Predicted severity 
score calculated 




6 (6) 93 (94) 12 (10) 113 (90) 0.46 
* P value calculated using Pearson χ2 testing to test difference in proportions of compliant and non-compliant 
patients in Blue Book and HHP groups 
 
Table 4-7 Overall Compliance with Acute Pancreatitis Clinical Guideline Recommendations 
 
Table 4-7 shows the overall compliance with acute pancreatitis guideline recommendations. 
Approximately equal percentages of patients in the Blue Book and Hospital HealthPathways 
groups had the correct amylase levels ordered on admission (63 vs 66%).  A smaller proportion 
of patients in Hospital HealthPathways group (10%) was compliant with the recommendation 
to document a predicted severity score than the Blue Book group (16%). The rate of overall 
compliance (amylase plus severity) was low (BB 6%, HHP 10%).  
There was no statistically significant different in compliance between The Blue Book and 
Hospital HealthPathways groups.  
The number and percentage of patients receiving compliant care for each guideline 
recommendation by each individual subgroup is presented in Appendix L.  
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4.4.2.2 Single Logistic Regression 
 
4.4.2.2.1 Patient Variables 
 
There was no significant difference in likelihood of receiving guideline compliant care 
between different subgroups of patients in all three selected guideline recommendations 
(Appendix M). This result was consistent across both The Blue Book and Hospital 
HealthPathways groups.  
 
4.4.2.2.2 Clinician Variables 
 
In both the Blue Book (22.78 (6.83-101.0), <0.01) and Hospital HealthPathways groups (OR 
11.51 (2.46-53.99), <0.01), patients treated by general surgeons were significantly more likely 
to have a predicted severity calculated than patients treated by emergency medics. This was 
also the case when comparing doctors working in sub-specialties other than general surgery 
with emergency medics.  
There was no significant difference in providing guideline compliant care between different 
grades or genders of clinicians.  
 
4.4.2.2.3 Environmental Variables 
 
Patients managed in the emergency department were significantly less likely to have a 
predicted severity score calculated than patients managed on an acute ward (CI 0.43 (0.22-
0.93), 0.03) in the Hospital HealthPathways group (OR 0.37 (0.14-0.94), 0.04). This effect of 
environment within the hospital was not evident in The Blue Book group.  
 
4.4.2.3 Multiple Logistic Regression  
 
In multiple regression models specialty remained a significant predictor for having a predicted 
severity score calculated, with general surgeons and other subspecialties being significantly 
more likely to calculate a predicted severity score than emergency medics (Table 4-8, pg.87).  
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The Blue Book 
Compliance 
Outcome 





17.71 (3.42-92.45) <0.0001 
  Other 64.07 (8.25-
497.88) 
<0.0001 





18.73 (4.33-81.00) <0.0001 
  Other 46.78 (8.43-
248.72) 
<0.0001 
Table 4-8 Multiple Logistic Regression Analysis: Predictors of Compliance with Acute Pancreatitis Clinical 
Guideline Recommendations 
 
4.4.3 Intracranial Haemorrhage on Warfarin 
 
4.4.3.1 Overall Compliance 
 
 The Blue Book Hospital HealthPathways  











Correct choice of reversal 
agents 14 (45) 17 (55) 13 (42) 18 (58) 1 
Correct follow up coagulation 
screen 11 (35) 20 (65) 15 (48) 16 (52) 0.44 
Correct documentation on 
blood component request form 8 (26) 23 (74) 16 (52) 15 (48) 0.07 
Compliance with all guideline 
recommendations 3 (10) 28 (90) 7 (23) 24 (77) 0.30 
* P value calculated using Pearson χ2 testing to test difference in proportions of compliant and non-compliant 
patients in Blue Book and HHP groups 
 
Table 4-9 Overall Compliance with ICH on Warfarin Guideline Clinical Guideline Recommendations 
 
The compliance with each of the selected recommendations and overall is presented in Table 
4-9. Compliance improved in two out of the three selected guideline recommendations, 
documentation on the blood components form and follow-up coagulation screen, between The 
Blue Book and HHP. Conversely, a higher proportion of Blue Book patients received the 
correct choice of reversal agent (45 vs 42%).  
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There was no significant between the Hospital HealthPathways group and The Blue book 
group, though this may be due to the small sample size.  
The number and percentage of patients receiving compliant care for each guideline 
recommendation by each individual subgroup is presented in Appendix N.  
 
4.4.4 Guideline Compliance: Summary  
 
In the majority of the selected recommendations change from The Blue Book to Hospital 
HealthPathways led to an overall improvement in compliance.  
In CAP, co-morbidity and severity of illness were predictors of guideline compliant care. The 
gender, grade and specialty of the clinician had a significant effect on guideline compliance in 
the Blue Book group. However, in patients managed in the Hospital HealthPathways group 
there was no evident variation between different subgroups of clinicians. In acute pancreatitis, 
none of the patient- related factors had a significant effect on the likelihood of patients 
receiving guideline compliant care.  However, in both Blue Book and HHP groups, general 
surgeons and clinicians working in other sub-specialties were significantly more likely to 
document a predicted severity than emergency medics in multi-variate regression analysis.  
In practical terms this means that a change in the design and format of the guidance meant a 
reduction in variation of practice between different sub-groups of clinicians. However, this 
change in design did not reduce variations between patients with different clinical features. 
Patients with more severe disease and patients without co-morbidities were still significantly 
more likely to receive care in accordance with guideline recommendations.  
4.5 Reported Barriers to Compliance with Clinical Guideline 
Recommendations 
 
In the survey sent to RMOs and SMOs were two questions in relation to identified barriers to 
compliance with two guideline recommendations within the community acquired pneumonia 
pathway: choice of antibiotics and ordering a follow-up chest x-ray on discharge for patients 






Responses to Survey Question 
A recent audit has found that only 35% of patients with community acquired pneumonia (CAP) are 
given the correct antibiotic. The CAP Hospital HealthPathways page provides recommendations on 
which antibiotics to prescribe based on a CURB-65 score. To what extent do you agree that the 
following are reasons you might not follow this part of the pathway: 







I am unfamiliar with these pathway recommendations 124 (60.2) 35 (16.9) 47 (22.8) 
These pathway recommendations are not evidence 
based. 152(74.5) 47 (23.1) 5 (2.5) 
These pathway recommendations do not apply to all 
patients. 35 (17.2) 52 (25.5) 117 (57.4) 
I do not believe that these pathway recommendations 




These pathway recommendations are unclear. 156 (76.5) 35 (17.2) 13 (6.4) 
These pathway recommendations are too complex to 
follow. 159 (78.0) 38 (18.6) 6 (2.9) 
I do not trust the authors of this pathway. 176 (86.3) 25 (12.3) 3 (1.5) 
I prefer to follow a routine I’m familiar with. 114 (55.9) 58 (28.4) 32 (15.7) 
I have a general resistance to working according to 
clinical pathways. 173 (84.8) 23 (11.3) 8 (3.9) 
I do not have time to access this pathway. 139 (68.1) 38 (18.6) 27 (13.2) 
Other doctors on my team do not cooperate in 
applying these pathway recommendations. 99 (48.5) 56 (27.5) 49 (24.0) 
I’ve looked and I can’t find this guidance on Hospital 
HealthPathways 151 (74.0) 33 (16.2) 21 (10.3) 
Total number of respondents to question: n=207 
Table 4-10 HHP Survey Responses - Question Fourteen 
 
The survey responses for barriers to compliance with guideline recommendations regarding 
antibiotic choice are listed in Table 4-10. 57.4% of clinicians agreed with the statement that 
‘This pathway recommendation does not apply to all patients’. This was the only barrier that a 
majority of clinicians agreed was an obstacle to compliance. This correlates with the findings 
from the compliance section earlier in this chapter that patient related variables, such as co-
morbidity and severity of illness, significantly affect the likelihood of receiving guideline 








A recent audit has found that follow up chest x-rays were correctly ordered for 70% of CAP 
patients. The CAP Hospital HealthPathways page gives criteria for which patients should 
have a follow up chest x-ray. To what extent do you agree that the following are reasons you 
might not follow this part of the pathway? 







I am unfamiliar with these pathway 
recommendations 71 (37.6) 27 (14.3) 91 (48.1) 
These pathway recommendations are not 
evidence based. 125 (67.2) 57 (30.7) 4 (2.2) 
These pathway recommendations do not 
apply to all patients. 63(34.1) 59 (31.9) 63 (34.1) 
I do not believe that these pathway 
recommendations will make any difference to 
the outcome of my patient. 
132 (71.0) 49 (26.3) 5 (2.7) 
These pathway recommendations are unclear. 120 (65.2) 57 (31.0) 7 (3.8) 
These pathway recommendations are too 
complex to follow. 135 (73.0) 48 (26.0) 2 (1.1) 
I do not trust the authors of this pathway. 159 (85.5) 24 (12.9) 3 (1.6) 
I prefer to follow a routine I’m familiar with. 109 (58.6) 47 (25.3) 30 (16.13) 
I have a general resistance to working 
according to clinical pathways. 156 (84.3) 24 (13.0) 5 (2.7) 
I do not have time to access this pathway. 127 (68.3) 37 (19.90) 22 (11.8) 
Other doctors on my team do not cooperate in 
applying these pathway recommendations. 89 (48.4) 53 (28.8) 42 (22.8) 
I’ve looked and I can’t find this guidance on 
Hospital HealthPathways 134 44 (23.9) 6 (3.3) 
Total number of respondents to question: n= 189 
Table 4-11 HHP Survey Responses - Question Fifteen 
 
The survey responses for barriers to compliance with ordering a follow-up chest x-ray on 
discharge are presented in Table 4-11.  The barrier which had the highest proportion (48.1%) of 
clinicians agree with the statement was “I am unfamiliar with these pathway 
recommendations”. The data on use found that there was no significant relationship between 
volume of patients being discharged and volumes of website use. This suggests that doctors are 
not accessing the clinical guideline website when discharging patients. This may lead to them 
being unfamiliar with guideline recommendations relating to discharge and follow up of 
patients. In response to this question, 34.1% of clinicians agree that the recommendations not 
applying to all patients was an obstacle to compliance. Again, this is concordant with the results 
of the compliance section that patients with co-morbidity (COPD) were less likely to receive 
care that was compliant with this guideline recommendation.   
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Clinicians were asked in an open question if there were any barriers to following the guidance 
in Hospital HealthPathways in general. The responses were analysed for common themes 
which were categorised in to clinician, environment and guidance related factors (Table 4-12).  
 
Can you think of any other barriers to following the guidance in Hospital 
HealthPathways? 
Clinician 
Lack of awareness 
Reluctance to change 
Feel they know what to do without looking up guideline 
General resistance to guidelines/ pathways 
Embarrassment of looking up 
Don't know what you don't know 
Won't improve things for patient 
Environment 
Lack of access to computers 
Lack of time 
Lack of equipment /resources 
Slow Wi-Fi 
Lack of support/ agreement from seniors 
Pathway 
Lack of references 
Lack of mobile friendly 
Lack of ability to customise/ personalise 
Too simplistic 
Too much information 
Search function 
Guidelines not comprehensive 
Table 4-12 Identified and Categorised Themes from Answers to  HHP Survey - Question Seventeen  
 
In general, the majority of clinician responses sited attitudinal barriers to following clinical 
guidance. Examples included feeling reluctant to change, feeling like they already know what 
to do, and feeling embarrassed to be seen to be looking things up. A commonly reported 
obstacle to following guidelines was outcome expectancy: the perception that following a 
guideline recommendation will not improve the outcome for a given patient. The most 
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commonly reported environmental barrier was lack of time in the working day to consult 
guideline recommendations. Clinicians reported a number of barriers to following guidelines 
relating to the design of the Hospital HealthPathways website. The most commonly reported 
barrier was the poor standard of the search function and that there was not a mobile phone 
friendly version.  
 
What improvements could be made to Hospital HealthPathways? 





Ensure that team environment is supportive 
Training 
Table 4-13 HHP Survey Responses- Question Eighteen 
 
Clinicians when asked how Hospital HealthPathways could be improved (Table 4-13). 
Clinicians overwhelmingly responded that they want the website to be available in a mobile 
friendly format, in particular an app format that they could customise and save preferences on.  
 
4.5.1 Barriers to Compliance: Summary 
 
The majority of clinicians agreed that a barrier to following guideline recommendations in 
prescribing the correct choice of antibiotics was that that the recommendation did not apply to 
all patients. Barriers reported to ordering follow-up imaging were different, with the largest 
cohort of clinicians agreeing that lack of familiarity with guideline recommendations was a 
barrier to compliance. Clinicians reported a number of attitudinal barriers to following 
guidelines. The felt that the lack of a mobile friendly version of the site was a barrier to 
compliance. They reported that creating a mobile-phone-friendly version of the guidance 




4.6 Appropriate Non-Compliance with Clinical Guideline Recommendations 
 
The concept of ‘appropriate non-compliance’ was explored by assessing two specific guideline 
recommendations in the CAP guidance: choice of antibiotic and decision to admit the patient to 
hospital. 
For each of these recommendations, documented reasons for appropriate non-compliance were 
identified and quantified.  
 
 Guideline Recommendations 
 Choice of antibiotics N 
Decision to Admit 
N 
Compliant 222 359 
Non-compliant and reason 
documented 89 198 
Non-compliant and no reason 
documented 420 125 
N/A* - 49 
*N/A – patients discharged from the emergency department.  
 
Table 4-14  Number of Patients with Guideline Compliant and Non-Compliant Care with Community Acquired 
Pneumonia Clinical Guideline Recommendations 
 
Table 4-14 illustrates the numbers of patients who received compliant care, non-compliant care 
with no reason documented and non-compliant care with reason documented.  
There were 289 individual appropriate reasons given for not complying with guideline 
recommendations. These reasons were grouped into 17 different categories. These categories 
are defined in Appendix O.  
An appropriate reason for non-compliance with antibiotic choice recommendations was 
documented in 89 (17.5%) patients who received non-compliant care. The reasons documented 
are presented in Table O-1, Appendix O.  Reasons documented for non-compliant were pre-
dominantly patient related. The most commonly documented reasons were sepsis (n=12), the 
patient being objectively unwell (n=11), and concurrent infection from a different source 
(n=10). 
A reason for non-compliance with admission guidance was documented in 198 (61.3%) of 
non-compliant cases. The reasons documented are presented in Table O-2, Appendix O. Again, 
reasons documented for non-compliant were pre-dominantly patient related. The most 
frequently documented reason was a concurrent acute process requiring admission (n=95), 
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followed by admission being required for further investigation (n=32), the patient being 
objectively unwell (n= 24), and sepsis (n=14). 
When considering the total sample, i.e. combining patients who received compliant and non-
compliant care, there was an appropriate documented reason for non-compliance with antibiotic 
guideline recommendations for 12.2% of patients. There was an appropriate documented reason 
for non-compliance with admission guideline recommendations for 27.1% of patients. These 
figures represent the rates of appropriate non-compliance with the guideline recommendations. 
By subtracting these figures from 100%, these figures can be used to calculate more appropriate 
targets for compliance with guideline recommendations, in these cases 87.8% and 72.9% 
respectively.  
 
4.6.1 Appropriate Non-Compliance Summary 
 
In the sample of patients, there were documented appropriate reasons for non-compliance for 
12.2% and 27.1% of patients with regard to antibiotic and admission guideline 
recommendations, respectively. Calculating proportions such as these can be used to adjust 
target levels of compliance with guideline recommendations.  
The reasons commonly documented for non-compliance with both guideline recommendations 
reflected scenarios where the patient was acutely unwell or clinically complex, therefore 
warranting management divergent from clinical guidelines. 
This indicates that expecting 100% compliance with guideline recommendations may not be 
appropriate in real world clinical practice. An understanding of appropriate rates of non-
compliance can be used calculate more suitable targets.  
 
4.7 Chapter Summary  
 
This study shows how changing the format and design of clinical guidance can alter use of and 
compliance with a guideline. 
The change from The Blue Book to Hospital HealthPathways led to an increase in the volume 
of use of the guidance website.  
In considering guideline compliance, the most pertinent finding was that re-design of the 
guidance website was associated with a reduction in variation in behaviour between different 
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clinicians. The grade, specialty and seniority of a clinician had no significant effect on 
compliance with the Community Acquired Pneumonia guideline recommendations in the 
Hospital HealthPathways group. However, there did remain a variation in practice between 
different subgroups of patients. Patients with milder disease and patients with COPD were 
significantly less likely to receive guideline compliant care. This was evident across both 
designs of clinical guidance. This result is in keeping with the findings of the survey which 
found clinicians perceived a barrier to following clinical guidance was that the 
recommendations did not apply to all patients.  
The fact that guidelines do not apply to all patients means that there are scenarios where it is 
rational or appropriate for a clinician not to comply with guideline recommendations. The 
reasons documented for non-compliance were often patient related factors such as a concurrent 
acute problem or comorbidity. Therefore expecting, or even mandating, 100% compliance with 
guideline recommendations may not best for patient care. An understanding of appropriate rates 





5 Chapter Five - Discussion 
 
5.1 Summary of Findings  
 
This study showed that change in the development process and design of clinical guideline was 
associated with an increase in use and an increase in compliance with recommendations within 
those guidelines. 
Clinician related variables, including gender, seniority and specialty of clinicians were found 
to be factors which had a significant effect on guideline compliance in the Blue Book group of 
patients. This variation in practice between clinicians was no longer significant in the Hospital 
HealthPathways group. Age, co-morbidity and severity of illness were all shown to be 
significant variables within the patient category that exerted an effect on guideline compliance. 
The environment within the hospital in which the patient was managed was not a significant 
predictor of guideline compliance. These patient and environmental factors were significant 
predictors of compliance in both The Blue Book and Hospital HealthPathways groups. 
The guideline not being applicable to all patients was the most commonly reported barrier to 
guideline-compliance. This finding was consistent with the compliance results that patients 
with co-morbidities are significantly less likely to receive guideline compliant care.  
Reasons for non-compliance were documented in a number of patients. These reasons for non-
compliance were for the most part patient related factors such as the presence of a concurrent 
acute process or co-morbidity.  
This study explored the contributors to use and compliance with clinical guidelines in the four 
categories of; guideline, patient, doctor and environment. It added significantly to the 
understanding of the contributors in these categories. However, in addition, there are two key 
findings of this study which are novel:  
 
5.1.1 Guideline design can improve compliance and reduce variation in practice 
between different clinicians 
 
This study showed that the change in the platform of clinical guidance, from the Blue Book to 
Hospital HealthPathways, was associated with both an increase in use of and compliance with 
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that guideline by clinicians. In addition, it reduced the variation in practice among different 
types of clinician, seen in the Blue Book period and variably noted in previous literature.  
There are two key differences between the platforms: the development process and the style. 
An edition of The Blue Book was produced once every two years and each chapter was written 
by one doctor: a senior clinician working within the relevant specialty department. The 
technical writing company Streamliners were contracted to make online PDFs of each guideline 
within The Blue Book but did not provide any input in to the style of each guideline or across 
the website as a whole. As a result, there was no uniform structure or style applied across the 
website. Each guideline within Hospital HealthPathways is written by a team of people 
including a clinical editor (a member of the target audience of the website), subject matter 
expert and a technical writer. The technical writers have a larger role in the development of the 
content of Hospital HealthPathways. They edit the language, structure and style of each 
pathway and ensure the pathway is written in accordance with the Style Guide. The technical 
writers ensure a consistency in style across the entire website.  
The examination of the use of the website showed a steady increase in views of the Hospital 
HealthPathways website as whole since its launch. Moreover, for each of the three selected 
conditions the guidance page on the Hospital HealthPathways website had a higher average 
number of unique page views per month. These results show that clinicians are not only 
accessing the website more frequently than its predecessor, but they are accessing it at the point 
of consultation with a patient they are admitting.     
In the Community Acquired Pneumonia groups, the change from The Blue Book to Hospital 
HealthPathways was associated with not only to an increase in use and compliance, but also to 
a reduction in variation in practice between different clinicians. The gender, grade and specialty 
of the clinician were significant predictors of compliance with guideline recommendations in 
The Blue Book group of patients. This variation was not evident in the Hospital 
HealthPathways group. The change from the Blue Book to Hospital HealthPathways led to 
improved compliance in groups such as male clinicians, more senior clinicians, and sub-
specialties of clinicians. This shows that whilst clinician related factors can be a significant 
factor associated with guideline compliance, this association is not constant, and can be altered 
by a re-design of the clinical guidance.  
Clinical guidance are tools which aim to optimise patient care by translating research evidence 
into practice. The results of this study show the importance of enhancing this tool through 
improving the way in which the guideline is presented. 
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5.1.2 Following guideline recommendations may not be appropriate in a given 
clinical scenario  
 
For selected guideline recommendations there was a proportion of patients for whom a reason 
for non-compliance was documented by the clinician in the clinical notes. The fact that a reason 
for non-compliance is documented suggests a calculated deviation from guideline 
recommendation. Reasons commonly documented for non-compliance point to rational, 
clinically sound decision-making from clinicians. Examples of reasons for non-compliance 
with antibiotic and admission-related guideline recommendations include: objective evidence 
of the patient being more unwell than was captured in the scoring system in the guideline, the 
patient having a co-morbidity which was affecting the clinical picture, or the patient having a 
concurrent acute problem. Identifying reasons for non-compliance highlights that clinical 
guidelines, which are often based around a single condition or presentation, are not applicable 
in every clinical scenario.  
In this study we found clinicians documented a reason for non-compliance with clinical 
guideline recommendations in 12-27% of cases. The reasons documented suggest a calculated 
deviation from guideline recommendations based upon the clinical scenario. This shows that 
100% compliance with these guideline recommendations is not an appropriate target and may 
not in the best interests of patient care. While the conclusion that there should not be an 
expectation of 100% compliance might appear an obvious one, it is a conclusion that has not 
been articulated in the literature, and no attempt has been made to quantify it. 
 
5.2 Interpretation of Results within the Context of the Wider Literature 
5.2.1 Factors Affecting Clinical Guideline Compliance 
 
This study found that patient related factors are the dominant, consistent predictors of guideline 
compliance. These factors included: severity of illness and presence of co-morbidity. These 
findings are concurrent the wider literature. Previous studies have noted that patients with a 
more severe illness in an acute setting are more likely to receive guideline compliant care (51, 
60, 67). This is likely due to the fact that acute severe illness are often treated as medical 
emergencies which are driven by protocols, such as the Sepsis Six or the Advanced Life 
Support Treatment Algorithm (68, 69).  
The presence of co-morbidities has also been shown to be associated with a reduced 
compliance with clinical guidelines (8, 51, 53, 61, 64). A review of a number of practice 
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guidelines by Mutasingwa et al noted that fewer than half of the published guidelines assessed 
were adequately able to address issues related to patients with co-morbidities(27). This is due to 
the fact that guidelines are often based upon single conditions and are therefore unable to 
accommodate the complexities introduced by the presence of co-morbidities.  
The study found that a number of clinician related factors were associated with guideline 
compliance in the Blue Book sample. These included seniority, specialty and gender of the 
clinician.  
Trainee Interns and House Officers were significantly more likely to follow clinical guideline 
recommendations than registrars or senior medical officers. This finding differs from that of the 
wider literature. Three studies assessed in the literature review section of this study found that 
seniority did not have a significant effect on compliance with guideline recommendations (70, 
71). In this study setting, trainee interns and house officers would be more likely to have been 
introduced to Hospital HealthPathways as medical students and thus their use be more 
ingrained in their medical practice. It would be useful to re-examine these findings in the future 
to determine if this observed effect remains following a longer bed in period of Hospital 
HealthPathways.  
On examination of the specialty of the clinician, doctors working in other sub-specialties were 
found to be less likely to provide compliant care. There was no significant difference found 
between doctors working in emergency medicine, respiratory medicine and general medicine. 
The literature suggests that guideline compliance is more likely with specialists relevant to the 
acute presentation(63, 71). As community acquired pneumonia is a prevalent condition, this 
presentation is likely to be managed as regularly by emergency medics and generalists as 
respiratory physicians.  However, other sub-specialities would be less likely to manage it 
acutely therefore the findings of this study are in keeping with the wider literature. 
Finally, this study found male doctors in the Blue Book time period less likely to provide 
guideline compliant care than their female counterparts. This finding is in keeping with the 
wider literature (53, 54). 
The novel approach of this study is that it is the first to examine how patient and clinician 






5.2.2 Appropriate Non-Compliance  
 
This study found that the most commonly documented reasons for non-compliance with clinical 
guideline recommendations were dominantly patient related. The reasons most commonly 
documented included: sepsis, concurrent acute process and the patient being objectively unwell. 
This is concurrent with the findings of Art et al which also noted that the most commonly 
reasons for deviation were patient-related (28). However, their most common reasons for non-
compliance differed. They noted that the most common reasons for deviation from guidelines 
were “contraindications” and “patient decision”. This difference in findings highlights the 
reality that reasons for intentional non-compliance will be specific to individual guideline 
recommendations.  
 
5.3 Strengths of Study  
 
A key strength of this study was in the originality of the research question. The effect on 
compliance of the way clinical guidelines are presented has not been previously assessed. 
Earlier studies of guideline implementation have focussed on the attributes of clinical 
guidelines themselves. These include factors such as the evidence-base of the guideline, the 
compatibility of the guideline with clinician’s values and routines, and if applying the 
recommendation requires new knowledge (6, 76). The results of this previous research point to 
the fact that ease-of-use is an attribute associated with compliance: clinicians will apply clinical 
guideline recommendations in their practice if it is easy to do so. The results of our study are in 
keeping with this finding, as altering the design of a guideline to increase ease-of-use improved 
compliance.  
This project also adopted innovative methods for data collection. The programs used to 
identify patients and collect data in this research project (HCAS and Google Analytics) are 
novel in the field of research relating to clinical guideline implementation.  
Health Care Analytics Solution (HCAS) was launched in 2017 and, aside from pilot projects 
involved in the development of the program, this the first time this program has been used in an 
academic research project in New Zealand. The use of HCAS allows the identification of the 
study sample using structured, semi-structured, and unstructured data. This project has 
demonstrated how this program can be successfully used to identify cohorts which were 
previously not captured by coding data.  
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This project has shown that Google Analytics is a program that can provide objective data on 
the use of a clinical guidance website. A literature search found no published studies in which 
the outcome of guideline use was directly, objectively measured. Data have previously been 
collected on this outcome by two methods: survey or using proxy measures. The use of the 
survey to collect data on use is subject to potential error due to self-report bias. Clinicians have 
been shown to overestimate their own compliance with clinical guidelines, and this may also be 
the case when they are asked to estimate the frequency of their use. Proxy measures, such as 
compliance or patient outcomes, are more objective, though there is the potential for the data to 
be affected by confounders. The use of proxy measures is not justifiable if there is a way of 
directly measuring the data: Google Analytics. The program, whilst widely used in the business 
world, has rarely been used in the world of medicine. A search of the literature reveals that it 
has been used as a process evaluation of public health programs: there have been two studies 
published which used Google Analytics to evaluate the use of public health patient information 
websites(110, 111). However, this research project is the first to date to demonstrate how this 
methodology can be used to evaluate the use of clinical guidelines.  
A final strength of this project was its comprehensive and thorough study sample identification 
process. The use of HCAS plus the detailed review of clinical records prior to inclusion in the 
sample resulted in a comprehensive identification of all patients presenting to hospital with 
each of the three selected conditions. This approach resulted in a sample which is representative 
of patients presenting with these conditions in the Canterbury District Health Board.  
 
5.4 Weakness of Study 
 
A large proportion of this body work was a retrospective audit of clinical records. As a result 
this study is subject to the possible biases involved in the analysis of pre-existing data. The first 
potential limitation of this study was in the presence of missing data. The practicalities of 
extracting data from notes meant that it was not always possible to ascertain information about 
the clinician assessing each patient. In collecting data on the community acquired pneumonia 
patients, there were 11% of patients for whom the gender of the clinician managing them was 
unknown. This was due to handwriting in the clinical notes being illegible and unisex names. 
This missing data was recognised as being missing at random: the data missing was due to 
another variable as opposed to the outcome of that observation. There was a higher proportion 
of clinicians working in general medicine for whom the gender was unknown. These data were 
excluded from analysis by listwise deletion. This means unfortunately that a proportion of 
patients managed by general medics were not included in the analysis. In the ICH on Warfarin 
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group, there was a large amount of missing information. This is due to the nature of the ICH on 
Warfarin as an acute presentation. It is generally treated as a clinical emergency and as a result 
there are a number of clinicians present, concurrently assessing and managing a patient. The 
small sample size of this group meant that univariate and multivariate analysis was not 
possible. In light of this analysis not being carried out, the decision was taken to not delete 
these cases and simply present the numbers and proportions of cases with unknown variables.  
A second potential bias resulting from retrospective analysis was that data collectors were not 
blinded during data collection. Blinding would not have been possible as the data collection 
required searching through clinical notes to find an admission corresponding to a certain date. 
Knowledge of the date of admission is knowledge of whether the patient was in The Blue Book 
or Hospital HealthPathways group. The effects of this bias were somewhat ameliorated by 
having pre-prepared data collection forms.  
Another limitation of this study was related to the information gathered on guideline use from 
Google Analytics. This programme provides precise data on the patterns and trends of use of 
clinical guidance pages. However, this program does not collect data on users and so each page 
view cannot be linked to a specific clinician. This meant that in examining factors associated 
with frequency of use of the website the information had to be obtained from use reported in 
the survey data. As previously stated, reported use of guidelines is potentially unreliable as it is 
subject to self-report bias. This bias was minimised by informing respondents that survey 
responses were to be treated anonymously. Equally, contrary to surveys relating to compliance, 
frequency of guideline use is not subject to feelings of doing the right or wrong thing, so 
clinicians may be more likely to be truthful. 
The analysis of each of the three selected conditions made comparisons between two groups of 
patients managed in equivalent months of two years: 2015 and 2016. Whilst there were no 
significant differences in the demographic characteristics of patients in each group, there was a 
significant difference in the groups in relation to the specialty of managing clinicians. In the 
Hospital HealthPathways group there were higher proportions of emergency medics assessing 
and diagnosing patients than the Blue Book for both acute pancreatitis and community acquired 
pneumonia. This difference needs to be taken in to account when considering the outcome of 
compliance on this study.  
There are several potential explanations for the findings other than the change in design and 
development process of the guideline platform. Firstly, there may have been increased 
awareness of local clinical guidelines due to the promotion associated with the introduction of 
the new platform. The Hospital HealthPathways website was advertised by a large web banner 
across the home page of the CDHB intranet. Additionally, the development process of a 
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Hospital HealhPathways requires engagement with greater numbers of staff than the Blue Book 
did. This may have contributed to increased awareness amongst local staff and thus increased 
use and compliance with guideline recommendations. However, it should be noted that both 
these factors are encompassed within the design and development process of guideline.   
Another potential explanation of these results is that in the 2016 group staff would still have 
had access to The Blue Book online through the hospital intranet. It may be that improved 
compliance does not reflect the change in design of the local clinical guideline platform but in 
fact reflects that two clinical guideline platforms were available. However, it should be noted 
that in the 2016 study period there were only 90 unique page views on the Blue Book 
community acquired pneumonia page, in comparison to the 711 unique page views on the 
equivalent Hospital HealthPathways page in the same time-period.  
A limitation of the analysis of the non-compliance data was that no post-hoc adjustment for 
multiple comparisons, such as Bonferroni correction, was applied. The Bonferroni correction is 
a post-hoc analysis that is applied to reduce the risk of a type one statistical error when multiple 
analyses are applied on a single data set (112). The robustness of the findings was tested by 
applying the Bonferroni correction to a small sample of the results and no difference was found 
in the statistical significance of the results.  This finding, coupled with the small size of the 
significant p values (<0.001), meant that the Bonferonni correction was judged to be 
unnecessary in this analysis and application of this adjustment may introduce this risk of a type 
two statistical error (113).  
 The section of the study relating to appropriate non-compliance is limited by the retrospective 
methodology adopted. The rates of appropriate non-compliance reported in this study are likely 
to be an underestimate of the true rates. Cases of appropriate non-compliance were only 
counted if the clinician had documented their reasoning in the clinical notes. In clinical 
practice, clinicians are not required to document if and why they are not following a guideline. 
Therefore, the rates of appropriate non-compliance reported are likely to be an underestimate as 
in a retrospective study it was not feasible to count cases of appropriate non-compliance where 
reasons were not documented in the clinical notes. The understanding of appropriate non-
compliance could be furthered by prospective observational research, which could explore 
cases of non-compliance which may not be recorded in the clinical notes. A further limitation 
of this study is that whilst all the categories of reasons for non-compliance were considered 
appropriate, this review did not consider decisions to deviate from guideline recommendations 




5.5 Medical Implications of Findings 
 
5.5.1 Guideline Development  
 
Clinical guidelines are tools which aim to optimise patient care by translating research 
evidence in to recommendations for day-to-day clinical practice. The results of this study show 
the importance of optimising this tool.  
This study has demonstrated that whilst guideline compliance is subject to the effects of non-
modifiable patient and clinician related factors, the effect these factors have is not fixed and can 
be modified by changing the design of the guideline. The change in guideline design from The 
Blue Book to Hospital HealthPathways led to a reduction in variation in practice between 
different clinicians. However, there did remain a variation in practice between different 
patients. This has implications for future guideline development to address the persistent 
variation associated with these patient factors.  
The advertising and marketing approach to understanding and changing clinical practice 
focuses on developing the best possible product to communicate an idea (26). This study has 
shown that focus on design of the guideline, or the presentation of the idea, improved 
compliance and reduced variation in practice. The survey results showed that many users of 
Hospital HealthPathways felt that by modifying the design and creating a mobile friendly or 
app version of the guideline compliance could be improved further. This finding has 
implications for the future development of clinical guidelines.  
An important change between The Blue Book and Hospital HealthPathways was a change in 
the development process of each pathway. The change in the team developing each pathway 
resulted not only in the introduction of a technical writer (and the resulting change in style of 
the clinical guideline) to the team but also in the addition of a clinical editor. The clinical 
editors are health professionals of the target audience of the Hospital HealthPathways website. 
Clinical guidance developed by the target audience is associated with increased compliance (8).  
This finding fits with sociological research that shows that ideas and messages that spread 
through social networks are more likely to be adopted or to change behaviour than ideas 
imposed upon people(114). Having the guideline developer being an influential person within a 
social network of clinicians, such as a popular registrar, is likely to lead to the awareness of this 
guideline spreading through the population and increase likelihood of adoption of those 




5.5.2 Quality Standards Assessment 
 
Clinical guidelines are generally a collection of recommendations which focus on the 
assessment and management of a single condition.  However, in real life we are rarely treating 
just one condition. Patients are complex: they each respond to a disease process in an individual 
pattern and come with their own individual set of co-morbidities, ideas, concerns and 
expectations. This complexity means that there are scenarios where not following a guideline 
recommendation is the right thing to do. This concept of correctly disregarding guideline 
recommendations, or ‘appropriate non-compliance’, is not recognised. Indeed, there are places 
where individuals or institutions face penalties for not following clinical guidance (115). By 
identifying and recognising scenarios where non-compliance is appropriate we are recognising 
that at this time guidelines are a tool to optimise patient care can only go so far and dealing 
with complexity remains in the hands of the clinician.  
The results of this study have implications for health professionals who assess quality 
standards in health care institutions. Audits of local clinical practice against guideline 
recommendations often aim for compliance rates of 100%. NICE acknowledges that there are 
clinical scenarios where due to professional judgement or patient preference guideline 
recommendations may not be appropriate in practice, yet still suggests an 100% standard for 
compliance(18). The quantifying of appropriate non-compliance can lead to an adjustment of 
standards for those auditing clinical practice, allowing a clearer picture of the quality of care an 
institution is providing.   
Exploring reasons for non-compliance can also help improve clinical guidelines as a tool.  For 
example, where appropriate non-compliance is found to be very high, the guideline developer 
may conclude that if there are many valid reasons to deviate, then the guidance does not have 
sufficient coverage, and should include advice on that deviation as part of its content. As a 
result, the appropriate non-compliance rate would then fall as the non-compliant actions 
clinicians wished to make are included in, and guided by the clinical guideline. In this way, 
appropriate non-compliance levels could be used as a feedback mechanism for clinical 
guidelines developers. 
 
5.6 Future Research 
 
The results of this research project can be built upon by undertaking research using a 
prospective observational methodology. This methodology would be able to link use to a 
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specific clinician, managing a specific patient. This would provide information on how the 
characteristics of both the clinician and the patient affect guideline use. Furthermore, 
environmental time series factors such as time of day, time of year, and day of the week could 
be included as variables in the analysis as potential factors associated with guideline use.  
This methodology would also help better understand clinicians’ reasons for not complying 
with clinical guidelines. As stated, clinicians are not obliged to document why their 
management differs from that of a guideline recommendation, so this method would capture 
cases where the deviation was not documented. 
The understanding of appropriate non-compliance could also be improved by reviewing 
reasons for non-compliance on a case-by-case basis by an expert panel. This would allow the 
‘correctness’ of the clinical decisions made in deviating from guideline recommendations to be 
explored further. 
The results of this study can also be built upon in the field of guideline development. This 
study showed that re-design of the guidance platform was associated with an improvement in 
compliance. However, in spite of this improvement, in the majority of case patients did not 
receive guideline compliant care. Future research could explore how improving guideline 
design could further improve compliance. The survey of RMOs and SMOs found that a number 
of clinicians wanted the clinical guidance in a mobile friendly format that was customisable to 
their preferences and sent notifications of updates. Future research could examine how re-
design of clinical guidelines in this way effects compliance.  
Additionally, the selected outcome of this study has been clinical guideline compliance. Future 
research could study outcomes including length of stay, in-hospital complications and 
mortality. However, it could prove to be challenging to demonstrate direct association between 




The goal of this study was to understand what factors affect guideline use and compliance and 
to understand how these factors interact. The factors were considered under the headings of; 
guideline, patient, doctor and environment. Patient factors, including co-morbidities and 
severity of illness, were significant factors contributing to non-compliance. However, a 
significant change in the guideline development, format and presentation not only improved use 
and compliance but also reduced the variation associated with the doctor related factors. 
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Previous research has suggested that usability can improve use and compliance, but this study 
is the first to show a significantly modified platform can improve compliance and reduce 
clinician-related variation.   
To aid understanding the influence of patient factors involved in guideline compliance one 
must examine cases with non-compliance, in particular cases with appropriate non-compliance. 
This will provide information on clinical scenarios where the guideline recommendations are 
not appropriate. This has important implications for the assessment of quality standards. 
Furthermore, guideline developers can use this to expand their guidelines to plug gaps in 
compliance. 
This a new area of research and the results of this study can be built upon by prospective 
observational studies examining current formats of local clinical guidance, and by testing the 
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Dyc NG 2011 America 
Controlled 
Before and after 
30 
Dykes PC 2005 America 
Controlled 
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Foy R 2002 United Kingdom Mix-methods 4664 
Franke AL 2008 N/A Meta-analysis N/A 
Goldman LE 2008 America Cross-Sectional 1075 
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Viroga S 2017 Uraguay 
Controlled 
Before and after 
296 
Waldorff FB 2004 Denmark 
Controlled 
Before and after 
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Yancey JB 2012 America Prospective audit 183 
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Baker R Y Y ND Y Y Y Y NA Y Y Y Y Y High 
Doherty 
SR Y N ND ND Y Y Y NA Y Y N Y N 
Moderate 
Forrest 
CB Y Y Y Y N Y Y NA Y Y NA Y N 
Moderate 
Mold JW Y N Y N N N N N N Y ND Y Y Low 
Owen 
RR Y Y Y Y N Y Y NA Y Y N Y Y 
Moderate 
van der 
Berg Y Y N Y Y Y N NA Y Y ND Y Y 
Moderate 
Yealy 






Table B-2 Quality Assessment of Included Systematic Review and Meta-Analysis 
Author Is the 
review 
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Y Y NA Y N N Y NA Y N NA N Y Moderate 
Beckmann 
KR 
Y ND N ND N N NA NA N Y N NA Y Moderate 
Bekmezian 
A 
Y Y Y Y N Y Y Y Y Y N N Y High 
Berg GM Y Y Y Y N N Y Y Y Y N N Y Moderate 
Bryan MA Y N ND Y N NA Y Y N N ND NA Y Moderate 
Burgers JS Y Y Y Y N N Y NA Y Y NA N N Moderate 
Delangle C N Y NA ND N N N Y N N N NA N Low 
Dronkers 
E 
Y Y ND ND N N Y Y Y Y N N Y Moderate 
Erickson 
BK 





Y Y N N/A N N/A Y Y Y Y N Y Y Moderate 
Grol R Y Y Y Y N Y Y NA Y Y ND ND Y Moderate 
Haas C Y Y NA Y N NA ND N Y Y ND NA N Moderate 
Halm EA Y N NA Y N Y N NA N Y NA NA Y Moderate 
ImaiKamata Y Y Y Y N N NA Y Y Y ND NA Y High 
Jami P N Y NA Y N NA NA N N N N NA N Low 
Kane BG N Y NA Y N NA Y ND N Y N NA N Moderate 
Kelly AG Y Y NA Y N NA Y Y Y Y N NA Y High 
Khalid L Y Y NA ND N N Y Y Y N NA NA Y Moderate 
Lantner R  N Y NA Y N NA NA NA N N Y NA N Moderate 
Ma K Y Y Y Y N Y Y Y Y Y N NA Y High 
Nagpal J Y Y Y Y Y N Y Y Y N N NA N Moderate 
Ohlsson H Y Y Y N N N Y Y Y Y ND N Y Moderate 
Sales AE Y Y Y Y N N Y Y Y Y N N Y Moderate 
Sandhu KS Y Y Y Y N N Y NA Y Y N N N Moderate 
Satman I Y Y NA Y N NA NA Y Y Y N NA Y Moderate 
Scales JR  Y Y Y Y N NA N Y Y Y N NA Y Moderate 
Schiffman 
J 





Y Y N/A N/A N N Y Y Y Y N/A N Y Moderate 
Thomas 
BS  
Y Y NA Y N N NA NA Y Y N NA Y Moderate 
Valle CW Y Y Y Y N N/A Y N Y N N N/A N Moderate 
Yancey JB N N Y Y N N N Y N Y ND Y N Moderate 










































Dyc NG Y N ND N Y Y N N Y N N Low 
Dykes 
PC 
Y N Y Y Y Y ND N Y N N Moderate 
Hogli JU N Y Y N Y Y ND N Y N Y Moderate 
Holyroyd 
BR 
Y Y Y Y Y Y ND N Y N N Moderate 
Lingarad 
L 





Y Y Y Y Y Y N N Y Y Y High 
Mol PG Y Y Y ND Y Y ND N Y Y Y High 
Viroga S Y N Y ND Y Y ND N Y N N Moderate 
Waldorff 
FB 
Y Y Y Y Y Y ND Y Y N N Moderate 







C. Appendix C - Literature Review - Data Collection of Included Studies 
 
Table C-1 Literature Review Results of Individual Studies 
Author Population Intervention Comparison Outcome Follow up  Key Results 
Baker R General practices 
Tailor made 
implementation strategies - 
i.e. identifying barriers to 
implementation and then 
focussing strategies on said 
barriers 
Baseline pre intervention 
Adherence to guidelines for 
management of patients with 
depression in general practice. 
12 months 
Intervention significantly 
improved levels of suicide 
assessment (OR 5.6 2.8-11.3) 
and BDI score < 11 at 16 weeks 
(2.5 (1.2-5.2). It did not affect 
the adherence with other 
guideline recommendations. 
Baumhäkel M Patients with heart failure N/A 
Gender of patients, gender of 
physicians 
Guideline recommended drug 
use and target dose 
6 months 
Female patients were less 
likely to have guideline 
recommended choice or dose of 
drug. Patients treated by female 
clinicians are more likely to 
have guideline recommended 
choice or dose of drug. There 
was no difference in the 
treatment of male or female 
patients by female clinicians 
whereas male clinicians 
prescribed less medication at 
lower doses for female patients. 
Beckmann KR 
Adolescents seen in US 
EDs with STIs 
N/A 
Ethnicity, payer status, gender 
and geographic region 
The US Centres for Disease 
Control and Prevention (CDC) 
recommendations for sexually 
4 years 
Males were significantly more 
likely to receive antibiotic 
treatment compliant with 
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transmitted infection treatment 
are used as a benchmark for the 
appropriate management of 
sexually transmitted infections 
guidelines OR 6.3 1.0–38.7. 
p<0.07. Ethnicity, insurance 
type and geographic region did 
not have a significant effect on 
adherence. 
Bekmezian A 
Paediatric ED asthma 
visits 
N/A 
Patient variables were 
demographics, triage acuity, 
mode of arrival, past history of 
asthma, fever (>38.0°C), 
tachyponea, hypoxia (oxygen 
saturation < 93%), and 
secondary diagnosis of 
pneumonia.  
Guideline non-adherence - 
e.g. delayed or omitted 
corticosteroids for children 
with asthma 
5 years 
Age significantly affected odds 
of receiving corticosteroids:  
<24 months 2.59 1.29, 5.23, 
and 2–5 years 2.25 1.19, 4.24, 
and 6–12 years 1.32 0.68, 2.55.  
Berg G Septic patients Sepsis response team Baseline 
Adherence to sepsis 6 
guidelines 
1 year 
Patients managed by sepsis 
response team were more likely 
to be treated in accordance to 
guideline recommendations. 
Bryan MA 
Patients diagnosed with 
bronchiolitis < 24 months 
old from 2009 to 2012 
N/A 
Age, medical complexity, ED 
triage acuity, admission season 
Adherence to bronchiolitis 
clinical pathway 
N/A 
Children in the highest 
adherence tertile had a 
significantly younger mean age 
compared with those in the 
lowest tertile.  No significant 
difference by sex, race, medical 
complexity, triage acuity, 
seasonality and mean age 
compared with those in the 
lowest tertile.   
Burgers JS General practitioners N/A 
Attributes of clinical 
guidelines 
High guideline compliance / 
low guideline compliance 
ND 
Recommendations with high 
compliance rates were to a 
lesser extent those requiring 
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new skills (7% compared with 
22% in recommendations with 
low compliance rates), were 
less often part of a complex 
decision tree (12% versus 
25%), were more compatible 
with existing norms and values 
in practice (87% versus 76%), 
and more often supported with 
evidence (47% versus 31%).  
Delangle C 
Patients admitted with 
acute bacterial meningitis 
N/A 
Patient factors: age, presence 
of neck stiffness. Management 
factors: presence of referral 
letter, documented suspicion 
of meningitis in admission 
letter. 
Adherence with 17th 
consensus conference (SPILF 
2008) for managing bacterial 
meningitis 
2 years 
Neck stiffness and suspicion of 
meningitis documented in 
admission letter led to 
significantly quicker antibiotics 
/ lumbar puncture. Age of 
patient, having an admission 
letter and admission via the 
emergency department did not 
affect overall outcome. 
Doherty SR Rural hospitals 
Multifaceted: reminder, 
audit and feedback, 
education session, guideline 
development, 
implementation team, 
identifying barriers to 
implementation, identifying 
knowledge gap. 
Baseline data plus control 
group 
Adherence to asthma 
guidelines 
6 months 
No improvement in adherence 
noted in control group. 
Significant improvement noted 
in assessment and spirometry 
but not in other guideline 
recommendations. 
Dronkers E 
Patients with newly 
diagnosed HNSCC without 
distant metastasis 
N/A 
Patient factors: age ,gender, 
comorbidities, tumour stage, 
marital status 
Non-compliance with head & 
neck cancer treatment 
1 year 
In multiple logistic regression 
associated with non-adherent 
care: high comorbidity score 
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3.40 2.0–5.7, advanced tumour 
stage 3.40* 1.4–8.5, [prior head 
and neck cancer not yet treated 
2.56* (1.1–5.7). When stratified 
for gender age >65yrs:  7.22* 
(2.4–22.1), female gender 
2.66*(1.5–4.8). Elderliness, 
single marital status, female 
gender, high tumour stage and 
severe comorbidity are 
predictive factors. 
Dyc NG Residents working in ED 
Educational programme 
including : lecture, 
distribution of pocket cards 
and a peer-administered 
weekly review of 
institutional UC guidelines 
and a 12-question multiple-
choice test 
Normal practice 
Knowledge of urinary catheter 
guidelines and proportion of 
urinary catheters correctly 
placed 
ND 








automated pathway in 
electronic medical record 
(order sets, interdisciplinary 
plan of care, self-
management plan), access 
to evidence for clinicians 
and patients, HF self-
management education 
tools, and ongoing 
Normal practice pre 
intervention. Also compared 
guideline adherence in a 
separate group of stroke 
patients with no intervention 
Guideline adherence ND 
There were no significant 
differences in adherence with 






Women diagnosed with 




between guideline adherence 
and non-adherence care. 
National Comprehensive 
Cancer Network guideline 
adherent care 
5 years 
Patients who received non-
adherent care were significantly 
older (69 vs 61.9 p <0.001), 
they had higher proportions of 
advanced stage cancer (III/IV) 
(77.2% vs 64.2%, 11.4% vs 
8.7% respectively, p<0.04), 
higher proportions of sub-
optimal surgical cryoreduction 
(45.6% vs 22%, p<0.001) and 
lower proportions of private 
insurance (42.7 - 25.3%, 
p=0.001). Ethnicity, histology 
type and BMI did not have a 
significant effect. 
Forrest CB 
Children aged 2 months to 
12 years visiting ED with 
otitis media 
Clinician decision support 
+ physician feedback 
Usual care Guideline adherence 24 months 
CDS led to significant increase 
in guideline adherence across 
some domains e.g. 4.4% 
increase in comprehensive 
guideline adherence for otitis 
media. However, this was not 
consistent across all guideline 
recommendations. However, in 
second time period there was 
not a difference in adherence. 
Feedback only significantly 
improved guideline adherence 
across all recommendations. 
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There was not an additive 
effect.  
Foy R 
Cases attending a 
gynaecological hospital 
Audit and feedback Guideline attributes 
Compliance and change in 
clinical practice 
18 months 
Guidelines that were 
compatible with clinician 
values had higher compliance 
both pre and post intervention. 
Post intervention: 4.26 (2.44, 
6.08), p< 0.001. Guidelines that 
required change in routine was 
associated with lower 
compliance: 1.77 (3.19, 0.35). 
Franke AL Systematic reviews N/A  
Patient, clinician, pathway, 
environment and 
implementation strategies 
Guideline adherence  N/A  
Pathway: complexity, evidence 
base, written by the target 
group (found to be + in one 
review and - in another). 
Implementation strategies: 1 
review did not favour multi-
faceted over single, 2 did. No 
clear evidence to support 1 
implementation strategy. 
Professionals: Young 
professionals more likely to 
follow guidelines. Plus: 
awareness of guideline favours 
implementation. Patients: co-
morbidity reduces likelihood of 
following guidelines. 
Environment: limited time and 




Goldman LE Rural and urban hospital N/A Rural vs urban hospitals 
Performance measures for 10 
guideline recommendations: 5 
for AMI, 2 for HF and 3 for 
CAP. 
1 year 
Rural hospitals demonstrated 
lower adherence to the 
management of AMI/HF but 
higher adherence for the 
management of CAP. 
Adherence was more marked in 
rural hospitals with large bed 
size. 
Grilli R Trials N/A  
Guideline: specialty area, type 
of procedure (diagnostic, 
surgical, etc.) and complexity, 
trialability and observability. 
Guideline compliance N/A  
Specialty areas of cardiology 
and oncology showing the 
highest compliance (mean 
63.6% and 62.2%, 
respectively). 
Recommendations concerning 
procedures with high 
complexity had lower 
compliance rates than those low 
on complexity (41.9% vs. 
55.9%; P = 0.05), and those 
judged to be high on trialability 
had higher compliance rates 
than those low on trialability 
(55.6% vs 36.8%; P = 0.03).  
Grol R General practitioners N/A Attributes of guideline: 
Compliance with 47 
recommendations in 10 
national clinical guidelines 
3 months 
Recommendations were 
followed in, on average, 61% 
(7915/12 880) of the decisions. 
Controversial recommendations 
were followed in 35% 




recommendations in 68% 
(7029/10 383) of decisions. 
Vague and non-specific 
recommendations were 
followed in 36% (826/2280) of 
decisions and clear 
recommendations in 67% 
(7089/10 600) of decisions. 
Recommendations that 
demanded a change in existing 
practice routines were followed 
in 44% (1278/2912) of 
decisions and those that did not 
in 67% (6637/9968) of 
decisions. Evidence based 
recommendations were used 
more than recommendations for 
practice that were not based on 
research evidence (71% 
(2745/3841) v 57% 
(5170/9039)). 
Haas C 
Patients admitted with 
STEMIs in Switzerland 
N/A  Age 
Adherence to American 
College of Cardiology/ AHA 
2008 guidelines 
1 year 
Global adherence to guideline 
measures was significantly 
higher among younger patients 
(45.9% - 31.4% p <0.0075) 
Halm EA 
Patients seen in ED with 
pneumonia between 1996 
and 1997 
N/A 
Patient: age, ethnicity, gender, 
insurance status, employment 
status, severity, comorbidity. 
Clinician: attitudes about care. 
Guideline developed by study 
team for treating patients with 
mild pneumonia 
11 months 
In multiple regression model 
increased odds of guideline 
non-adherence: age > 65 2.7 
(1.2-6.2), male sex 2.3 (1-5.2), 
multi-lobar disease 3.5 (1-12.2), 
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Environment: arrived at night 
or at the weekend. 
primary care physician involved 
in triage decision 3.0 (1.2-7.1). 
Hogli JU 
Patients admitted to 
hospital with CAP or 
AECOPD who were treated 
with antibiotics 
Audit and feedback and 
distribution of paper copy 
of guideline 
Normal practice 
Proportion of guideline 
adherence antibiotic 
prescription in regards to dose 
and choice 
3 & 6 months.  
Overall mean prescribing of 
appropriate empirical 
antibiotics increased from 61.7 
to 83.8 % (P < 0.001), overall 
mean total treatment duration 
decreased from 11.2 to 10.4 
days (P = 0.015). With ITS we 
found that six months post-
intervention, the effect on 
appropriate empirical antibiotic 
prescribing had increased and 
sustained, while the effect on 
treatment duration was at pre-
intervention level. 
Holyroyd BR 
Patients with ankle/ foot 
presentations presenting to 
4 EDs (2 intervention, two 
control) 
Educational session by 
local opinion leader plus 
audit and feedback 
Passive dissemination of 
guideline 
Proportion of patients 
receiving ankle radiographs 
2 years 




Patients who had 
undergone inguinal hernia 




Patient demographics: age, 
sex, operation, complications 
and risk of SSI. Hospital 




prescription: choice and 
duration 
1 year 
Larger size of hospital with 
increasing surgical volume was 
associated with non-adherent 
guideline care. Number of beds 
> 700: (0.78 (0.66–0.91) 
0.002*). Number of procedures 
> 62: 0.30 (0.26–0.36) <0.001. 
Patient age and gender did not 




Patient receiving medical 
OP care in a tertiary 
teaching hospital 
N/A Co-morbidities 
Compliance with the Joint 
National Committee (JNC) 
hypertension guidelines 
2 months 
Patients with diabetes, CKD 
and stroke were less likely to 
receive guideline adherence 
choice of drugs for 
hypertension.  
Kane BG 
ED visits to an urban 
teaching hospital 
N/A Gender of patients 
Compliance with the Centre’s 
for Disease Control and 
Prevention recommendations 
for the diagnosis and treatment 
of sexually transmitted 
diseases 
1 year 
Men were significantly more 
likely to receive safe sex 
instructions (p<0.001) but 
otherwise no significant 
difference between men and 
women in guideline adherence. 
Kelly AG 
Patients admitted to US 
hospitals between 2003 and 
2009 with acute stroke 
eligible for thrombolysis 
N/A Patient factors 
Adherence with stroke 
guidelines. Predictors of door 
to thrombolysis time for 
ischaemic stroke 
6 years 
 In the multivariable model, 
the following variables were 
associated with less likelihood 
of imaging being completed 
within 25 minutes: age >70 
years; female gender; non-white 
race; history of diabetes, 
peripheral vascular disease, or 
prosthetic heart valve; 
transportation other than 
ambulance; arrival >60 minutes 
after symptom onset; and 
hospital location in the 
Northeast. Patients with 
National Institutes of Health 
Stroke Scale scores of 16 to 25 
(compared with other strata) 
were most likely to have 
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Patients seen in primary 
care prescribed long term 
opioid treatment for chronic 
non-cancer pain 
N/A 
Resident vs attending 
physicians 
Adherence to opioid 
prescribing guidelines 
1 year 
No significant difference in 
adherence to opioid guidelines 




65yrs bearing asthma 
related ICD-9 codes for 
fiscal year in 2002 in the 
community hospitals 
N/A 
Age, ICU admission, seen by 
asthma specialist, insurance 
To evaluate current IP asthma 
management as per 1997 
National Asthma Education 
and Prevention Program 
(NAEPP) 
1 year 
Patients were more likely to 
receive guideline concordant 
medication if: ICU admission, 
had been reviewed by an 
asthma specialty. Less likely if: 
Medicare/ Medicaid funded 
patient. 
Lingarad L Operation team briefings N/A Baseline data 
Pre-operative antibiotic 
administration as per 
guidelines 
1 year 
Antibiotic prophylaxis was on 
time for 77.6% of cases in the 
pre-intervention phase of the 
study, and for 87.6% of cases in 




diagnosed with colorectal 
cancer seen in one hospital 




Compliance with National 
Comprehensive Cancer 
Network (NCCN) suggestion 
of CT chest for patients 
diagnosed with colorectal 
cancer 
5 years 
Endoscopic tumour features 
obstructing 3.34 (1.82-6.13, 
p<0.001), setting - academic 
3.76 (1.85-7.61) p <0.001, 
medical specialty - 
gastroenterologists 0.40 (0.21-
0.77) < .001 had a significant 
effect on odds of receiving 
guideline adherent care. 
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Matthews JC Patients with heart failure 
Patient specific heart 
failure quality of care report 
card delivered to patients 
Control 
Quality score - sum of 
adherence to 4 medication 
related guideline 
recommendations 
3 months, 6 months 
There was a significant 
improvement in quality score at 
3 months (p<0.023) but not at 6 
months 
Mol PG 
Patients receiving a 
prescription of an 
antimicrobial 
Guideline dissemination 




antimicrobial guidelines on 
drug choice 
2 years 
The first stage of the 
intervention noted a significant 
improvement in compliance: 
+15.5% (95% CI: 8%; 23%). 
Academic detailing did not 
significantly improve 
compliance in second phase. 
Mold JW 
Adults with asthma seen 
by family practitioners 
Local learning 
collaborative and practice 
facilitation 
Usual care plus additive effect 
of interventions compared to 
individual effects 
Adherence to National Heart, 
Lung and Blood's institute 
asthma guidelines 
Blood Institute’s Asthma 
Guidelines. 
18 months 
The addition of practice 
facilitation to performance 
feedback had a significant 
effect on guideline adherence. 
LLC and academic detailing did 
not have a significant effect. 
Nagpal J 
Women living in Delhi, 
India who delivered a live 
viable birth 
N/A 
Public vs private vs NH vs 
home 
Guideline adherent care for 
births 
2 years 
Private hospitals had higher 
rates of guideline adherent care 
than public hospitals or home 
setting. There exists a large 
variability in the care offered. 
Ohlsson H 
All patients in the Skane 
region of Sweden who 
received a statin 
prescription between July 
and December 2005 
N/A 
Gender of patient, 
socioeconomic class of patient, 
private vs publicly funded 
hospitals 
Adherence with statin 
prescription guidelines 
6 months 
Proportion of patients with 
guideline concordance care was 
lower in private health boards 
than public health boards. 
Overall - no difference in the 
gender of the patient and 
guideline adherence care. Men 
aged 70-79 had higher levels of 
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guideline concordant care 
compared to younger men, 
women aged 70-79 had lower 
level of guideline concordant 
care. Among men, low income 
and cohabitation was associated 
with higher levels of guideline 
concordant care. 
Owen RR 
Patients with acute 
exacerbation of 
schizophrenia 
Enhanced strategy with a 




Adherence in anti-psychotic 
medication management for 
schizophrenia 
6 months 
No change in guideline 
adherence 
Sales AE Post MI patients N/A 
Co-morbidities vs no- 
comorbidities plus concordant 
vs non-concordant 
comorbidities. 
Guideline adherence post 
myocardial infarction 
5 years 
Both concordance and 
symptomatic scores were 
positively associated with 
guideline compliance, with 
correlations of 0.32 and 0.14, 
respectively (p<0.001 for each).  
Sandhu KS 
Patients admitted with 
acute exacerbation of 
COPD 
N/A Specialties 
Guideline adherent care for 
patients with acute 
exacerbations of COPD. 
1 year 
Across the majority of 
guideline recommendations 
guideline adherence was higher 
when care was provided by 
respiratory team than compared 
to general internists and 
hospitalists. 
Satman I 
Patients with type 2 
diabetes 
N/A 
Age, gender, diabetes 
duration, history and number 
of chronic complications and 
body mass index (BMI) of 
patients, physicians’ specialty 
and type of healthcare 
Proportion adherence to 
SEMT guidelines 
1 year 
When different age groups 
were compared, 60–69 and ≥70 
years age groups had 
significantly better adherence 
scores for laboratory evaluation 
compared to 40–49 years age 
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institution were tested as 
possible factors affecting 
guideline adherence 
group (Tukey's test for post hoc 
comparison, p = 0.033 and p = 
0.026, respectively). Adherence 
scores for laboratory 
evaluations were also affected 
by gender, with higher scores 
seen in male patients (Tukey's 
test, 6.8 ± 2.7 vs. 6.5 ± 2.8, p = 
0.021. Diabetes duration 
affected all aspects of guideline 
adherence - shorter duration of 
diabetes equates to poorer 
adherence.  
Scales JR 
ED attendances with 
suspected kidney stones 
N/A 
Patient: age, sex, ethnicity, 
payment type, socioeconomic 
class, arrival by ambulance. 
Environment: computer based 
system, geographic region, and 
academic status. 
Adherence to guideline in 
managing kidney stones: 
laboratory assessment, imaging 
and prescription of an alpha/ 
calcium channel blocker 
3 years 
Use of medical expulsion 
therapy was significantly lower 
in female patients: OR, 0.47; P 
<.001. Age, ethnicity, 
education, income and postcode 
did not have a significant effect. 
Gender did not have a 
significant effect on other 
outcomes. 
Schiffman J 
Patients who underwent an 
ORP or RRP 
N/A 
Age, PSA, biopsy Gleason 
score, number of positive 
biopsy cores, percentage of 
positive biopsy cores, clinical 
tumour stage, nodal stage (Nx 
vs. pN0 vs. pN1), number of 
yielded lymph nodes and 
surgical approach (ORP vs. 
Probability of guideline 
adherence: pelvic lymph node 
dissection. Guideline: 
European Association of 
Urology (EAU) 
3 years 
Within these analyses six 
variables achieved independent 
predictor status: biopsy Gleason 
score, PSA, number of positive 
biopsy cores, clinical tumour 




RARP) were tabulated for 
each patient. 
Solomon DH 
Patients at risk of 
osteoporosis in one 
academic medical across 10 
primary care sites 
N/A 
Patient variables: age, gender, 
comorbidity. Doctor variables: 
gender, age, training status. 
Practice characteristics: 
number of physicians, number 
of patients, hospital based, 
bone densitometry on site. 
Screening for osteoporosis 1 month 
Patient variables that 
significantly lowered the 
probability of guideline 
adherence included age 74 
years (odds ratio [OR] 0.49; 
95% confidence interval [CI]: 
0.43 to 0.55), age 55 years (OR 
0.34; 95% CI: 0.28 to 0.42), 
male sex (OR 0.17; 95% CI: 
0.12 to 0.23), black race (OR 
0.40; 95% CI: 0.34 to 0.47) and 
having more than one comorbid 
condition (OR 0.79; 95% CI: 
0.69 to 0.89). Patients seen by 
male physicians were less likely 
to have care that was adherent 
with guidelines (OR 0.70; 95% 
CI: 0.55 to 0.89). 
Thomas BS 
All patients in airborne 
isolation for suspected 
pulmonary TB from June 
through December 2011. 
N/A 
Demographic comparisons, 
clinical features and incidents 
across hospital stay (e.g. 
timing of tests, consultations 
of specialties). 
Compliance with Centre’s for 
Disease Control and 
Prevention (CDC) guidelines. 
Compliance with guidelines 
should result in timely (within 
48 hours) discontinuation of 




No significant differences in 
demographic characteristics and 
clinical characteristics were 
identified between groups.  
Adjusting for potential 
confounders, pulmonary 
consultation OR 0.14 [0.03–
0.58]), alternate diagnosis for 
discontinuation of isolation (OR 
[95% CI], 4.5 [1.3–15.8]), and 
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early ID consultation (OR [95% 
CI], 4.0 [1.1–14.8]) were 
independently associated with 
timely discontinuation. 
Valle CW 
Children aged 11 who had 
been born in 2001 who 
received a 'well-child' 
health visit 
N/A 
Clinical and demographic 
features of children 
Adherence to the 2011 
National Heart, Lung, and 
Blood Institute lipid screening 
guideline 
1 year 
High risk groups significantly 
more likely to receive screening 
than low risk groups (56-6.4%). 
Overall evaluation of risk 
factors that might have 
prompted screening showed 
that having a history of 
obesity (P < .001) or a family 
history of dyslipidaemia (P 
= .007) was associated with 
lipid screening.  
 
van der Berg General practitioners 
A -dissemination of 
guideline. B- Guideline 
dissemination plus 
educational session. C- 
guideline dissemination, 




Management as per guideline 
plus FEV1 / PEF / number of 
consultations / number of 
symptoms 
1 year 
No significant improvement in 
guideline adherence 
Viroga S 
Women undergoing C 
sections 
Checklist guided pre-
operative team briefing 
Baselines 
Adherence to surgical safety 
guidelines 
1 year 
Following the introduction of 
the checklist the odds of 
undergoing guideline adherence 




Waldorff FB General practitioners 
Multifaceted 
implementation strategy: 
audit and feedback, 
academic detailing, 
education session.  
Baseline data and control 
region 
Guideline adherence - 
monitored by the proportion of 






Women receiving prenatal 
care 
N/A Private vs free clinics 
Adherence with American 
Congress of Obstetricians and 
Gynaecologists (ACOG) 
'Guidelines for Perinatal Care' 
1 month 
Community clinics had a 
significant higher overall 
compliance rate than private 
clinics (42 vs 14%), p<0.001.) 
Yealy Dm 
Patients with a clinical and 
radiographic diagnosis of 
pneumonia. 
Low / moderate / high 
intensity implementation 
programmes 
Differing intensities of 
implementation program 
Proportion of mild 
pneumonias treated in the 
community 
ND 
Moderate and high intensity 
implementation programs led to 






D. Appendix D - Hospital HealthPathways Survey  
 
1. What is your age? 
- 18 to 24 
- 25 to 34 
- 35 to 44 
- 45 to 54 
- 55 to 64 
- 65 to 74 
- 75 or older 
2. What is your gender? 
- Male 
- Female 
- Gender diverse 
- Rather not say 
3. What specialty are you currently working in? 
- General Medicine 
- General Surgery 
- Emergency Medicine 
- Other (please specify) 
4. What is your level of seniority? 
- Trainee Intern 
- House officer (PGY1/2) 
- Senior House Officer (PGY3/4) 
- Registrar 
- Senior Medical Officer 







6. Do you know what Hospital HealthPathways is? 
- Yes 
- No 
7. How did you find out about Hospital HealthPathways? 
- I was given training on it 
- A colleague mentioned it to me 
- I found it via the intranet 
- Other (please specify) 
8. How often do you use Hospital Health Pathways? 
- Never 
- Less than weekly 
- Once a week 
- A few times per week 
- 1-5 times per day 
- Over 5 times a day 
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9. I access Hospital HealthPathways when I am:(Select all that apply) 
- Reviewing patients on admission 
- Managing in-patients 
- Managing patient in an outpatient clinic 
- Have a specific clinical question 
- Discharging patients 
- Other (please specify) 
10. I use Hospital HealthPathways to:(Select all that apply) 
- To know what's expected from the department I’m sending my patient to 
- Access quick reference guidelines (e.g. opioid dosing tables) 
- Do a quick check on my existing knowledge 
- Check if there have been any updates to guidance 
- Access clinical information that I’m not sure about 
- Access information about processes 
- Find contact information 
- Other (please specify) 
11. I access Hospital HealthPathways from:(Select all that apply) 
- Hospital Desktop PC 
- Hospital Laptop 
- My phone 
- My tablet 
- My laptop 
- At home 
12. When I am on the Hospital HealthPathways website I mainly navigate the site 
using: 
- The search functions 
- The table of contents/menu on the left side of the screen 
- Both 
- Other (please specify) 






14. A recent audit has found that only 35% of patients with community acquired 
pneumonia (CAP) are given the correct antibiotic. The CAP Hospital 
HealthPathways page provides recommendations on which antibiotics to prescribe 
based on a CURB-65 score. To what extent do you agree that the following 
are reasons you might not follow this part of the pathway: 
- I am unfamiliar with these pathway recommendations 
- These pathway recommendations are not evidence based. 
- These pathway recommendations do not apply to all patients. 
- I do not believe that these pathway recommendations will make any difference 
to the outcome of my patient. 
- These pathway recommendations are unclear. 
- These pathway recommendations are too complex to follow. 
- I do not trust the authors of this pathway. 
- I prefer to follow a routine I’m familiar with. 
- I have a general resistance to working according to clinical pathways. 
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- I do not have time to access this pathway. 
- Other doctors on my team do not cooperate in applying these pathway 
recommendations. 
- I’ve looked, and I can’t find this guidance on Hospital HealthPathways 
15. A recent audit has found that follow up chest x-rays were correctly ordered for 
70% of CAP patients. The CAP Hospital HealthPathways page gives criteria for 
which patients should have a follow up chest x-ray. To what extent do you agree 
that the following are reasons you might not follow this part of the pathway? 
- I am unfamiliar with these pathway recommendations in Hospital 
HealthPathways 
- These pathway recommendations are not evidence based. 
- These pathway recommendations do not apply to all patients. 
- I do not believe that following these guideline recommendations will make any 
difference to the outcome of my patient. 
- These pathway recommendations are unclear. 
- These pathway recommendations are too complex to follow/ 
- I do not trust the authors of this pathway. 
- I prefer to follow a routine I'm familiar with. 
- I have a general resistance to working according to clinical pathways. 
- I do not have the time to access this pathway 
- Other doctors on my team do not cooperate in applying these pathway 
recommendations. 
- I’ve looked, and I can’t find this guidance on Hospital HealthPathways 
16. To what extent do you agree that the following statements are barriers to you 
using Hospital HealthPathways? 
- I struggle to find access to a computer in my work environment 
- The site is difficult to access on the intranet 
- I am unable to find the information I am looking for on the Hospital 
HealthPathways website 
- The Wi-Fi in the hospital isn’t reliable 
- The site is hard to use on my phone 
17. Can you think of any other barriers to following the guidance in Hospital 
HealthPathways? 
18. What improvements could be made to Hospital HealthPathways to make it easier 








E. Appendix E - Analysis of Missing Data 
Table E-1 Missing Data- Numbers of Patients with Missing Data in each Subgroup & Comparison of Independent 
and Outcome Variables Between Missing and Outcome Variables 
  Blue Book p value* Hospital HealthPathways p value* 
Independent Variables     
Patient Gender Male 17 0.13 7 1 
 Female 31  25  
Patient Age (years) 18-44 4 0.06 1 0.15 
 45-64 10  13  
 65-74 17  6  
 >75 17  12  
Patient Ethnicity NZ Caucasian 42 0.45 29 0.72 
 Other 6  3  
Patient Co-
morbidity COPD 15 1 8 1 
 No COPD 33  24  
Patient Severity Mild 29 0.15 19 0.08 
 Moderate 19  10  
 Severe 0  3  
Doctor Grade TI/HO** 6 0.09 18 0.19 
 Registrar 39  6  
 SMO‡ 3  8  
Doctor Specialty ED† 5 <0.001 3 <0.001 
 GM 30  21  






31 0.82 16 0.6 
 Acute 
Ward 17 
 16  
* P value calculated using Pearson χ2 testing to test difference in proportions of independent variables between 





Compliance Outcomes Blue Book p value* Hospital HealthPathways p value* 
CURB recorded Yes 12 0.38 8 0.43 
 No 36  24  
Correct route of 
antibiotics Yes 25 0.18 16 0.08 
 No 23  16  
Correct choice of 
antibiotics Yes 12 1 8 0.32 
 No 36  24  
Correct follow up in 
regard to arranging 
imaging 
Yes 19 0.14 22 0.43 
 No 28  7  
* P value calculated using Pearson χ2 testing to test difference in proportions of outcome variables between 
cases with missing data and cases without **-Trainee Intern/House Officer †-Senior Medical Officer ‡-





Table E-2 Comparison between Missing Data in Blue Book group and Missing Data in HHP group 
Category Variable p value* 
Independent Variables  
Patient Gender 1 
 Age 0.14 
 Ethnicity 0.24 
 Co-morbidity 0.72 
 Severity 0.09 
Doctor Specialty 0.95 
 Seniority 0.58 
Environment Location in the hospital 0.29 
Outcome Variables  
 CURB score Recorded 1 
 Correct route of antibiotics 1 
 Correct choice of antibiotics 1 
 
Correct follow up in regards 
to arranging imaging 
0.12 
*P value calculated using Pearson χ2 testing to test difference in proportions of independent and outcome variables 






F. Appendix F - Demographic Characteristics of Community 
Acquired Pneumonia Group 










Gender    
Male 143 (48.5) 179 (50.3) 0.89 
Female 152 (51.5) 177 (49.7)  
Age (Years)    
18-44 29 (9.8) 35 (9.8) 0.37 
45-64 64 (21.7) 85 (23.9)  
65-74 64 (21.7) 67 (18.8)  
>75 138 (46.8) 169 (47.5)  
Ethnicity    
NZ European 254 (86.1) 315 (88.5) 0.57 
Māori 17 (5.8) 21 (5.9)  
Pacific Islander 11 (3.7) 11(3.1)  
Other 13 (4.4) 9 (2.5)  
Co-morbidity    
COPD 90 (30.5) 105 (29.5) 0.72 
No COPD 205 (69.5) 251 (70.5)  
Severity of illness    
Mild 140 (47.5) 180 (50.6) 0.59 
Moderate 146 (49.5) 165 (46.3)  
Severe 9 (3.1) 11 (3.1)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 















Gender   1 
Male 140 (47.5) 170 (47.8)  
Female 155 (52.5) 186 (52.2)  
Seniority   0.07 
TI/HO** 65 (22.0) 106 (29.8)  
Registrar 193 (65.4) 213 (59.8)  
SMO† 37 (12.5) 37 (10.4)  
Specialty   0.001 
Emergency Medicine 124 (42.0) 164 (46.1)  
General Medicine 160 (54.2) 171 (48.0)  
Respiratory 3 (1.0) 19 (5.3)  
Other 8 (2.7) 2 (0.6)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 
characteristics of included cases in The Blue Book group and the Hospital HealthPathways group **Trainee 
Intern/House Officers †Senior Medical Officer 
 











ED 199 (67.5) 248 (69.7) 0.32 
Acute Ward 96 (32.5) 108 (30.3)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 
characteristics of included cases in The Blue Book group and the Hospital HealthPathways group 
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G. Appendix G - Demographic Characteristics of Acute 
Pancreatitis Group 










Gender    
Male 43 (43.4) 74 (59.2) 0.83 
Female 56 (56.6) 51 (40.8)  
Age    
18-44 29 (29.3) 43 (34.4) 0.56 
45-64 39 (39.4) 43 (34.4)  
65-74 18 (18.2) 17 (13.6)  
>75 13 (13.1) 22 (17.6)  
Ethnicity   0.66 
NZ European 87 (87.9) 107 (85.6)  
Māori 6 (6.1) 6 (4.8)  
Pacific Islanders 1 (1.0) 4 (3.2)  
Other 5 (5.1) 8 (6.4)  
Calculated Severity    
Mild 84 (84.8) 104 (83.2) 0.88 
Severe 15 (15.1) 21 (16.8)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 














Gender    
Male 59 (59.6) 76 (60.8) 0.96 
Female 40 (40.4) 49 (39.2)  
Seniority    
TI/HO** 20 (20.2) 36 (28.8) 0.09 
Registrar 60 (60.6) 76 (60.8)  
SMO† 19 (19.2) 13 (10.4)  
Specialty    
Emergency Medicine 41 (41.4) 64 (51.2) 0.01 
General Surgery 55 (55.6) 47 (37.6)  
Other Subspecialties‡ 3 (3.0) 14 (11.2)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 
characteristics of included cases in The Blue Book group and the Hospital HealthPathways group **Trainee 
Intern//House Officer †Senior Medical Officer  †Including: Rural Medicine, General Medicine 
 









Emergency Department 71 (71.7) 87 (69.6) 0.17 
Acute Ward 28 (27.7) 38 (30.4)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 






H. Appendix H - Demographic Characteristics of ICH on 
Warfarin Group 
Table H-1 Patient Demographic Characteristics of ICH on Warfarin Groups  
Demographic 
Characteristics 






Gender   1 
Male 15 (48.6) 16 (51.6)  
Female 16 (51.6) 15 (48.4)  
Age (years)   0.70 
18-44 1 (3.2) 0 (0.0)  
45-64 6 (19.4) 5 (16.1)  
65-74 8 (25.8) 7 (22.6)  
>75 16 (51.6) 19 (61.3)  
Ethnicity   0.20 
NZ European 23 (74.2) 28 (90.3)  
Māori 4 (12.9) 3 (9.7)  
Pacific Islanders 3 (9.7) 0 (0.0)  
Unknown 1 (3.2) 0 (0.0)  
Reason for 
Warfarinisation   0.68 
Atrial Fibrillation 18 (58.1) 15 (48.4)  
Pulmonary Embolism/ 
Deep Vein Thrombosis 5 (16.1) 9 (29.0)  
Atrial/ Mitral Valve 
Replacement 6 (19.4) 5 (16.1)  
Other 2 (6.5) 2 (6.5)  
Mode of bleed    
Traumatic 21 (67.8) 13 (41.9) 0.07 
Spontaneous 10 (32.2) 18 (58.1)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 





Table H-2 Clinician Demographic Characteristics ICH on Warfarin Groups  
Demographic 
Characteristics The Blue Book 
Hospital 
HealthPathways p value* 
Gender   0.03 
Male 8 (8) 14 (45)  
Female 6 (19) 10 (32)  
Unknown 17 (55) 7 (23)  
Seniority   0.02 
Registrar 13 (42) 9 (29)  
SMO** 13 (42) 22 (71)  
Unknown 5 (16) 0 (0)  
Specialty   0.62 
Emergency Medicine 15 (48) 20 (65)  
General Medicine 4 (13) 4 (13)  
Neurosurgery 7 (23) 3 (10)  
Other† 3 (10) 3 (10)  
Unknown 2 (7) 1 (3)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 
characteristics of included cases in The Blue Book group and the Hospital HealthPathways group **Senior 
Medical Officer †Including ICU and cardiothoracics 
 









Emergency Department 28 (90) 24 (77) 0.30 
Acute Ward 3 (10) 7 (22)  
*P value calculated using χ2 and Fisher tests as appropriate to determine significant differences in the 




I. Appendix I - Guideline Use  
 
 
Figure I-1 Number of Unique Page Views/Month on Community Acquired Pneumonia Page 
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J. Appendix J - Community Acquired Pneumonia: Subgroup 
Compliance  
Table J-1 Documented CURB-65 Score: Number (percentage) of Patients with Guideline Compliant Care  









Patient     
Gender     
Male 48 (34) 95 (66) 57 (32) 122 (68) 
Female 60 (39) 92 (61) 70 (40) 107 (60) 
Age (years)     
18-44 8 (28) 21 (72) 11 (31) 24 (69) 
45-64 21 (33) 43 (67) 31 (36) 54 (64) 
65-74 26 (41) 38 (59) 24 (36) 43 (64) 
>75 52 (38) 86 (62) 61 (36) 108 (64) 
Ethnicity     
NZ European 93 (37) 161 (63) 114 (36) 201 (64) 
Māori 5 (29) 12 (71) 9 (43) 12 (57) 
Pacific Islands 4 (36) 7 (64) 4 (36) 7 (64) 
Other 6 (46) 7 (54) 0 (0) 9 (100) 
Co-morbidity     
COPD 32 (36) 58 (64) 28 (27) 77 (73) 
No COPD 76 (37) 129 (63) 99 (39) 152 (61) 
Severity     
Mild  45 (32) 95 (68) 54 (30) 126 (70) 
Moderate  57 (39) 89 (61) 68 (41) 97 (59) 
Severe  6 (67) 3 (33) 5 (45) 6 (55) 
Doctor     
Gender     
Male 39 (28) 101 (72) 22 (13) 148 (87) 
Female 57 (37) 98 (63) 32 (17) 154 (83_ 
Seniority BB  HHP  
Trainee Intern/House Officer 36 (55) 29 (45) 20 (19) 86 (81) 
Registrar 63 (33) 130 (67) 30 (14) 183 (86) 
Senior Medical Officer 9 (24) 28 (76) 4 (11) 33 (89) 
Specialty BB  HHP  
Emergency Medicine 43 (35) 81 (65) 31 (19) 133 (81) 
General Medicine 61 (38) 99 (62) 21 (12) 150 (88) 
Respiratory 3 (38) 5 (63) 3 (16) 16 (84) 
Other sub-specialty 1 (33) 2 (67) 0 (0) 2 (100) 
Environment     
Emergency Department 71 (36) 128 (64) 87 (35) 161(65) 
Acute Ward 25 (26) 71 (74) 32 (30) 76 (70) 
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Table J-2 Correct Route of Antibiotics: Number (percentage) of Patients with Guideline Compliant Care 
 Blue Book 









Patient     
Gender     
Male 105 (73) 38 (27) 113 (63) 66 (37) 
Female 107 (70) 45 (30) 126 (71) 51 (29) 
Age (years)     
18-44 11 (38) 18 (62) 18 (51) 17 (49) 
45-64 24 (38) 40 (62) 45 (53) 40 (47) 
65-74 58 (91) 6 (9) 44 (66) 23 (34) 
>75 119 (86) 19 (14) 132 (78) 37 (22) 
Ethnicity     
NZ European 187 (74) 67 (26) 213 (68) 102 (32) 
Māori 10 (59) 7 (41) 15 (71) 6 (29) 
Pacific Islands 6 (55) 5 (45) 8 (73) 3 (27) 
Other 9 (69) 4 (31) 3 (33) 6 (67) 
Co-morbidity     
COPD 72 (80) 18 (20) 74 (70) 31 (30) 
No COPD 140 (68) 65 (32) 165 (66) 86 (34) 
Severity     
Mild 40 (29) 100 (71) 71 (39) 109 (61) 
Moderate 138 (95) 8 (5) 158 (96) 7 (4) 
Severe 9 (100) 0 (0) 10 (91) 1 (9) 
Doctor     
Gender     
Male 86 (61) 54 (39 113 (66) 57 (34) 
Female 101 (65) 54 (35) 126 (68) 60 (32) 
Seniority     
Trainee Intern/House 
Officer 42 (65) 23 (35) 73 (69) 33 (31) 
Registrar 145 (75) 48 (25) 146 (69) 67 (31) 
Senior Medical Officer 25 (68) 12 (32) 20 (54) 17 (46) 
Specialty     
Emergency Medicine 85 (69) 39 (31) 121 (74) 43 (26) 
General Medicine 115 (72) 45 (28) 116 (68) 55 (32) 
Respiratory 6 (75) 2 (25) 17 (89) 2 (11) 
Other sub-specialty 1 (33) 2 (67) 1 (50) 1 (50) 
Environment     
Emergency Department 132 (66) 67 (34) 172 (69) 76 
Acute Ward 55 (57) 41 (43 67 (62) 41 
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Table J-3 Correct Choice of antibiotics: Number (percentage) of Patients with Guideline Compliant Care  











Patient     
Gender     
Male 43 (30) 100 (70) 67 (37) 112 (63) 
Female 43 (28) 109 (72) 59 (33) 118 (67) 
Age (years)     
18-44 7 (24) 22 (76) 10 (29) 25 (71) 
45-64 10 (16) 54 (84) 19 (22) 66 (78) 
65-74 20 (31) 44 (69) 23(34) 44 (66) 
>75 49 (36) 89 (64) 74 (44) 95 (56) 
Ethnicity     
NZ European 71 (28) 183 (72) 109 (35) 206 (65) 
Māori 5 (29) 12 (71) 9 (43) 12 (57) 
Pacific Islands 4 (36) 7 (64) 5 (45) 6 (55) 
Other 6 (46) 7 (54) 3 (33) 6 (67) 
Co-morbidity     
COPD 22 (24) 68 (76) 29 (28) 76 (72) 
No COPD 64 (31) 141 (69) 97 (39) 154 (61) 
Severity     
Mild  23 (16) 117 (84) 39 (22) 141(78) 
Moderate  57 (39) 89 (61) 80 (48) 85 (52) 
Severe  6 (67) 3 (33) 7 (64) 4 (36) 
Doctor     
Gender     
Male 32 (23) 108 (77) 55 (32) 115 (68) 
Female 42 (27) 113 (73) 71 (38) 115 (62) 
Seniority     
Trainee Intern/ House Officer 17 (26) 48 (74) 36 (34) 70 (66) 
Registrar 56 (29) 137 (71) 74 (35) 139 (65) 
Senior Medical Officer 13 (35) 24 (65) 13 (35) 24 (65) 
Specialty     
Emergency Medicine 37 (30) 87 (70) 63 (38) 101 (62) 
General Medicine 44 (28) 116 (73) 57 (33) 114 (67) 
Respiratory 5 (63) 3 (38) 6 (32) 13 (68) 
Other sub-specialty 0 (0) 3 (100) 0 (0) 2 (100) 
Environment     
Emergency Department 51 (26) 148 (74) 91 (37) 157 (63) 
Acute Ward 23 (24) 73 (76) 35 (32) 73 (68) 
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Table J-4 Correct Overall Management on Admission: Number (percentage) of Patients with Guideline Compliant 
Care  
 The Blue Book  Hospital HealthPathways 







Patient     
Gender     
Male 19 (13) 124 (87) 26 (15) 153 (85) 
Female 16 (11) 136 (89) 29 (16) 148 (84) 
Age (years)     
18-44 2 (7) 27 (93) 2 (6) 33 (94) 
45-64 3 (5) 61 (95) 8 (9) 77 (91) 
65-74 6 (9) 58 (91) 11 (16) 56 (84) 
>75 24 (17) 114 (83) 34 (20) 135 (80) 
Ethnicity     
NZ European 29 (11) 225 (89) 48 (15) 267 (85) 
Māori 1 (6) 16 (94) 4 (19) 17 (81) 
Pacific Islands 2 (18) 9 (82) 3 (27) 8 (73) 
Other 3 (23) 10 (77) 0 (0) 9 (100) 
Co-morbidity     
COPD 6 (7) 84 (93) 17 (16) 88 (84) 
No COPD 29 (14) 176 (86) 38 (15) 213 (85) 
Severity     
Mild  5 (4) 135 (96) 8 (4) 172 (96) 
Moderate  26 (18) 120 (82) 42 (25) 123 (75) 
Severe  4 (44) 5 (56) 5 (45) 6 (55) 
Doctor     
Gender     
Male 8 (6) 132 (94) 22 (13) 148 (87) 
Female 22 (14) 133 (86) 32 (17) 154 (83) 
Seniority BB  HHP  
Trainee Intern/House Officer 9 (14) 56 (86) 20 (19) 86 (81) 
Registrar 24 (12) 169 (88) 30 (14) 183 (86) 
Senior Medical Officer 2 (5) 35 (98) 4 (11) 33 (89) 
Specialty     
Emergency Medicine 17 (14) 107 (86) 31 (19) 133 (81) 
General Medicine 17 (11) 143 (89) 20 (12) 151(88) 
Respiratory 1 (12) 7 (88) 3 (16) 16 (84) 
Other sub-specialty 0 (0) 3 (100) 0 (0) 2 (100) 
Environment     
Emergency Department 25 (13) 174 (87) 42 (17) 206 (83) 




Table J-5 Correct Overall Management: Number (percentage) of Patients with Guideline Compliant Care  









Patient     
Gender     
Male 37 (26) 106 (74) 61 (34) 118 (66) 
Female 39 (26) 113 (74) 54 (31) 123 (69) 
Age (years)     
18-44 4 (14) 25 (86) 10 (29) 25 (71) 
45-64 6 (9) 58 (91) 16 (19) 69 (81) 
65-74 18 (28) 46 (72) 20 (30) 47 (70) 
>75 48 (35) 90 (65) 69 (41) 100 (59) 
Ethnicity     
NZ European 65 (26) 189 (74) 100 (32) 215 (68) 
Māori 4 (24) 13 (76) 8 (38) 13 (62) 
Pacific Islands 2 (18) 9 (82) 4 (36) 7 (64) 
Other 3 (23) 10 (77) 3 (33) 6 (67) 
Co-morbidity     
COPD 21 (23) 69 (77) 29 (28) 76 (72) 
No COPD 55 (27) 150 (73) 86 (34) 165 (66) 
Severity     
Mild 13 (9) 127 (91) 28 (16) 152 (84) 
Moderate 57 (39) 89 (61) 80 (48) 85 (52) 
Severe 6 (67) 3 (33) 7 (64) 4 (36) 
Doctor     
Gender     
Male 26 (19) 114 (81) 53 (31) 117 (69) 
Female 38 (25) 117 (75) 62 (33) 124 (67) 
Seniority     
Trainee Intern/House Officer 13 (20) 52 (80) 33 (31) 73 (69) 
Registrar 43 (22) 150 (78) 68 (32) 145 (68) 
Senior Medical Officer 8 (22) 29 (78) 14 (38) 23 (62) 
Specialty  0  0 
Emergency Medicine 32 (26) 92 (74) 59 (36) 105 (64) 
General Medicine 30 (19) 130 (81) 50 (29) 121 (71) 
Respiratory 2 (25) 6 (75) 6 (32) 13 (68) 
Other sub-specialty 0 (0) 3 (100) 0 (0) 2 (100) 
Environment     
Emergency Department 46 (23) 153(77) 86 (35) 162 (65) 





Table J-6 Compliance with All Guideline Recommendations:  Number (percentage) of Patients with Guideline 
Compliant Care  









Patient     
Gender     
Male 16 (11) 127 (89) 14 (8) 165 (92) 
Female 14 (9) 138 (91) 22 (12) 155 (88) 
Age (years)     
18-44 1(3) 28 (97) 1 (3) 34 (97) 
45-64 3 (5) 61 (95) 6 (7) 79 (93) 
65-74 4 (6) 60 (94) 7 (10) 60 (90) 
>75 20 (14) 118 (86) 22 (13) 147 (87) 
Ethnicity     
NZ European 23 (9) 231 (91) 33 (10) 282 (90) 
Māori 1 (6) 16 (94) 3 (14) 18 (86) 
Pacific Islands 2 (18) 9 (82) 1 (9) 10 (91) 
Other 2 (15) 11 (85) 0 (0) 9 (100) 
Co-morbidity     
COPD 4 (4) 86 (96) 6 (6) 99 (94) 
No COPD 24 (12) 181 (88) 36 (14) 215 (86) 
Severity     
Mild  4 (3) 136 (97) 7 (4) 173 (96) 
Moderate  21 (14) 125 (86) 27 (16) 138 (84) 
Severe  3 (33) 6 (67) 2 (18) 9 (82) 
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K. Appendix K - Community Acquired Pneumonia Single 
Logistic Regression  
Outcome Variable  BB  HHP  
   OR (95% CI)* p 
value** 





Gender Femalea - - - - 
 Male 0.88 (0.56 -1.39) 0.58 0.86 (0.56-1.32) 0.49 
 Age 
(years) 
18-44a - - - - 
  45-64 1.24 (0.48- 3.17) 0.66 1.05 (0.46-2.40) 
 
0.91 
  65-74 1.48 (0.59- 3.72) 0.41 1.11 (0.47-2.63) 0.81 
  75+ 1.62 (0.69-3.85) 
 
0.27 1.16 (0.53- 2.50) 0.71 
 Ethnicity White  0.98 (0.50- 1.89) 0.95 1.18 (0.60 - 2.35) 0.63 
  Non-
white a 





1.07 (0.65- 1.76) 0.79 1.71 (1.04- 2.80) 0.03 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 1.45 (0.91- 2.32) 0.12 1.71 (1.10- 2.64) 0.02 
  Severe 5.51 (1.32- 
22.97) 
0.02 1.49 (0.48-4.65) 0.49 
Route of 
antibiotics 
Gender Female a - - - - 





18-44 a - - - - 
  45-64 0.96 (0.40 -2.30) 
 
0.93 0.89 (0.42- 1.92) 
 
0.78 
  65-74 5.04 (2.11- 
12.04) 
 
<0.001 1.52 (0.68- 3.42) 
 
0.30 
  >75 6.61 (2.93- 
14.92) 
 
<0.001 3.15 (1.50- 6.62) 
 
<0.01 
 Ethnicity NZ 
Caucasian 
1.51 (0.81- 2.81) 
 
0.19 1.11 (0.58- 2.13) 
 
0.76 





0.65 (0.40- 1.06) 
 
0.08 0.77 (0.48- 1.23) 
 
0.26 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 4.45 (3.46-5.47) <0.001 3.48 (2.75-4.35) <0.001 
  Severe 4.23 (2.09-9.11) <0.001 2.37 (0.89-4.61) 0.07 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression 
model   a Reference 
 
  
Table K-1 Single Logistic Regression Analysis: Patient Factors for Individual Guideline Recommendations for CAP 
Guideline Recommendations (pt. 1) 
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Table K-2 Single Logistic Regression Analysis: Patient Factors for Individual Guideline Recommendations for CAP 
Guideline Recommendations (pt. 2) 
Choice of 
antibiotics 
Gender Female a - - - - 
 Male 1.20 (0.73 -1.95) 
 





18-44 a - - - - 
  45-64 0.58 (0.20- 1.69) 
 
0.32 0.75 (0.32- 1.80) 
 
0.52 
  65-74 1.22 (0.46- 3.23) 
 
0.69 1.27 (0.53- 3.06) 
 
0.59 
  75+ 1.72(0.70- 4.23) 
 
0.23 1.97 (0.90- 4.32) 
 
0.09 
 Ethnicity White  0.67 (0.34 - 1.31) 
 





- - - - 
 Co-
morbidity 
No COPD 1.39 (0.80- 2.41) 0.24 1.49 (0.93- 2.40) 
 
0.09 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 3.35 (1.94 -  5.77) 
 
<0.001 3.45 (2.20-  5.42) 
 
<0.001 
  Severe 12.70 (2.97 - 
54.34) 
 





Chest X-ray  
Gender Female a - - - - 
 Male 0.81 (0.50- 1.29) 
 





18-44 a - - - - 
  45-64 1.88 (0.79- 4.50) 
 
0.16 0.94 (0.36 -2.46) 
 
0.90 
  65-74 1.23 (0.53 - 2.84) 
 
0.62 0.39 (0.15- 1.00) 
 
0.05 
  75+ 2.07 (0.94 - 4.57) 
 
0.07 0.45 (0.19 - 1.09) 
 
0.08 
 Ethnicity White  0.75 (0.36 - 1.53) 
 





- - - - 
 Co-
morbidity 
No COPD 5.88 (3.52 - 9.82) 
 
<0.001 5.67 (3.52 - 9.15) 
 
<0.001 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 1.09 (0.68 - 1.75) 
 
0.73 0.92 (0.59 - 1.43) 
 
0.71 
  Severe 0.82 (0.20 - 3.40) 
 
0.78 1.05 (0.32- 3.49) 
 
0.93 
*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression 





Table K-3 Table K 3 Single Logistic Regression Analysis: Clinician Factors for Individual CAP Guideline 
Recommendations 
 
Outcome Variable  BB  HHP  
   OR (95% CI)* P 
value** 





Gender Male 0.49 (0.30- 0.80) <0.001 0.91 (0.59- 1.42) 
 
0.68 
 Female a - - - - 
 Grade Trainee 
Intern/House 
Officer 
2.76 (1.60- 4.77) 
 
<0.001 1.47 (0.92- 2.35) 
 
0.12 
  Registrar a - - - - 
  Senior 
Medical 
Officer 
0.78 (0.35 -1.73) 
 
0.53 0.77 (0.37- 1.62) 
 
0.50 
 Specialty General 
Medicine 
0.95 (0.59- 1.52) 
 
0.82 0.87 (0.55-1.30) 0.53 
  Emergency 
Medicinea 
- - - - 
  Respiratory 0.43 (0.12-  1.57) 
 
0.20 0.47 (0.15-1.50) 
 
0.20 
  Other 0.33 (0.04- 2.86) 
 
0.32 0.98 (0.06-1.26) 0.29 
Route of 
antibiotics 
Gender Male 0.48 (0.30 -0.78) <0.01 0.94 (0.61- 1.47) 
 
0.80 
 Female a - - - - 





0.61 1.10 (0.68-1.78) 
 
0.69 
  Registrar a - - - - 
  Senior 
Medical 
Officer 
1.00 (0.50- 2.00) 
 
1 0.64 (0.33- 1.25) 
 
0.19 
 Specialty Emergency 
Medicine a 
- - - - 




0.33 0.58 (0.36-1.01) 0.05 
  Respiratory 0.95 (0.33- 2.74) 
 
0.92 0.49 (0.18-1.30) 0.15 
  Other 0.09 (0.01- 0.74) 
 
0.03 0.36 (0.02-5.81) 0.47 
Choice of 
antibiotics 
Gender Male 0.61 (0.36- 1.03) 
 
0.06 0.77 (0.50 - 1.20) 
 
0.25 
 Female a - - - - 
 Grade Trainee 
Intern/House 
Officer 
0.99 (0.53 - 1.84) 
 
0.97 0.91 (0.56 - 1.46) 
 
0.67 
  Registrar a - - - - 
  Senior 
Medical 
Officer 
1.51 (0.73 -  3.13) 
 
0.26 1.23 (0.63 - 2.41) 
 
0.54 
 Specialty Emergency 
Medicine a 
- - - - 
  General 
Medicine 
0.91 (0.47-1.73) 0.77 0.80 (0.51-1.25) 
 
0.33 
  Respiratory 1.23 (0.21-5.47) 0.79 0.77 
 (0.27-2.00) 
0.60 
  Other 0.54 (0.003-6.95) 0.68 0.32 (0.002-3.97) 0.41 




Table K-4 Single Logistic Regression Analysis: Environmental Factors for Individual CAP Guideline 
Recommendations 
Outcome Variable  BB  HHP  
   OR (95% CI) P 
value 









































- - - - 






Table K-5 Single Logistic Regression Analysis: Patient Factors for Combined CAP Guideline Recommendations: 
(pt1) 
Outcome Variable  BB  HHP  
   OR (95% CI) P value OR (95% CI) P value 
Admission Gender Male 0.96 (0.48- 1.93) 
 
0.91 0.99 (0.56- 1.76) 
 
0.98 
 Female a - - - - 
 Age 
(years) 
18-44 a - - - - 
  45-64 0.65 (0.10 -  
4.12) 
 
0.65 1.51 (0.31-  7.48) 0.61 
  65-74 1.24 (0.24 -  
6.48) 
 




  75+ 2.84 (0.64 - 
12.66) 
 




 Ethnicity NZ 
Caucasian 
0.74 (0.29 - 1.90) 
 
0.53 0.86 (0.36 - 2.03) 
 
0.73 





2.29 (0.92-  5.69) 
 
0.07 0.91 (0.49- 1.68) 
 
0.75 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 6.14 (2.29 -
16.40)  
 




  Severe 26.24 (5.36 - 
128.36) 
 




Management Gender Male 1.11 (0.67 - 1.85) 
 
0.69 1.38 (0.89 - 2.12) 
 
0.15 
 Female a - - - - 
 Age 
(years) 
18-44 a -    
  45-64 0.64 (0.17- 2.44) 
 
0.51 0.51 (0.21 - 1.25 0.14 
  65-74 2.07 (0.64 - 6.67) 
 
0.22 0.98 (0.40 - 2.40) 
 
0.97 
  >75 3.25 (1.08- 9.77) 
 
0.03 1.76 (0.80 - 3.86) 
 
0.916 
 Ethnicity NZ 
Caucasian 
0.92 (0.44 - 1.91) 
 
0.82 0.67 (0.35 - 1.28) 
 
0.22 





1.20 (0.68-  2.12) 
 
0.52 1.24 (0.77 - 2.02) 
 
0.38 
  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 6.33 (3.30-  
12.14) 




  Severe 24.00 (5.37- 
107.23) 
 




*Odds Ratio (95% Confidence Interval) **p value calculated using single generalised logistic regression 
model   a Reference 
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Overall Gender Female a - - - - 
 Male 1.16 (0.53 - 
2.51) 
 






18-44 a - - - - 
  45-64 1.35 (0.14- 
13.50) 
 




  65-74 1.66 (0.18- 
15.46) 
 




  >75 4.74 (0.61- 
36.64) 
 


















2.14 (0.79 - 
5.79) 




  COPD a - - - - 
 Severity Mild a - - - - 
  Moderate 6.02 (2.02 - 
17.93) 
 




  Severe 20.62  (3.75 -
113.38) 
 








Table K-7 Single Logistic Regression Analysis: Clinician Factors for Combined CAP Guideline Recommendations 
 
  
Outcome Variable  BB  HHP  
   OR (95% CI)* P 
value** 
OR (95% CI) P 
value 
Admission Gender Male 0.29 (0.13 - 
0.68) 
 




 Female a - - - - 
 Grade Trainee 
Intern/House 
Officer 
1.26 (0.56 - 
2.85) 
 




  Registrar a - - - - 






0.30 0.66 (0.22 - 
1.98) 
0.46 





0.63 0.57 (0.31-1.04( 0.67 
  Emergency 
Medicine a 
- -   
  Respiratory 0.39 (0.002-
3.49) 
0.47 0.90 (0.22-2.75) 0.86 





Management Gender Male 0.54 (0.31- 
0.95) 
 




 Female a - - - - 










  Registrar a - - - - 






0.72 1.09 (0.54- 
2.18) 
0.86 
 Specialty Emergency 
Medicine a 
- - - - 








  Respiratory 1.16 (0.38-
5.55) 


















Outcome Variable  BB  HHP  




Location Emergency Department 
1.18 (0.70- 2.00) 
 0.54 
1.62 (0.83- 3.13) 
 0.16 
 Acute Ward a - - - - 
Management 
Location Emergency Department 
1.38 (0.78 - 
2.42) 
 
0.27 1.50 (0.93- 2.42)  0.10 
 Acute Ward a - - - - 




L. Appendix L - Acute Pancreatitis: Subgroup Compliance 
Table L-1 Correct Number of Amylase Levels on Admission: Number (percentage) of Patients with Guideline 
Compliant Care  
 The Blue Book Hospital HealthPathways 







Patient     
Gender     
Female 25 (58) 18 (42) 34 (46) 40 (54) 
Male 37 (66) 19 (34) 47 (92) 4 (8) 
Age (years)     
18-44 17 (59) 12 (41) 32 (74) 11 (26) 
45-64 30 (77) 9 (23) 24 (56) 19 (44) 
65-74 9 (50) 9 (50) 11 (65) 6 (35) 
>75 6 (46) 7 (54) 14 (64) 8 (36) 
Ethnicity     
NZ European 57 (66) 30 (34) 67 (63) 40 (37) 
Māori 2 (33) 4 (67) 5 (83) 1 (17) 
Pacific Islanders 1 (100) 0 (0) 2 (50) 2 (50) 
Other 2 (40) 3 (60) 2 (25) 6 (75) 
Severity     
Mild 53 (63) 31 (37) 67 (64) 37 (36) 





Table L-2 Predicted Severity Score Documented on Admission: Number (percentage) of Patients with Guideline 
Compliant Care  
 The Blue Book Hospital HealthPathways 







Patient     
Gender     
Female 8 (19) 35 (81) 7 (9) 67 (91) 
Male 7 (13) 49 (87) 15 (29) 36 (71) 
Age (years)     
18-44 2 (7) 27 (93) 9 (21) 34 (79) 
45-64 7 (18) 32 (82) 8 (19) 35 (81) 
65-74 3 (17) 15 (83) 1 (6) 16 (94) 
> 75 3 (23) 10 (77) 4 (18) 18 (82) 
Ethnicity     
NZ European 14 (16) 73 (84) 22 (21) 85 (79) 
Māori 1 (17) 5 (83) 0 (0) 6 (100) 
Pacific Islanders 0 (0) 1 (100) 0 (0) 4 (100) 
Other 0 (0) 5 (100) 0 (0) 8 (100) 
Severity     
Mild 12 (14) 72 (86) 16 (15) 88 (85) 
Severe 3 (20) 12 (80) 6 (29) 15 (71) 
Doctor     
Gender     
Female 4 (7) 55 (93) 9 (11) 67 (89) 
Male 11 (28) 29 (72) 13 (27) 36 (73) 
Seniority     
Trainee Intern 4 (20) 16 (80) 5 (14) 31 (86) 
Registrar 9 (15) 51 (85) 14 (18) 62 (82) 
Senior Medical Officer 2 (11) 17 (89) 3 (23) 10 (77) 
Specialty     
General Surgery 14 (34) 27 (66) 13 (20) 51 (80) 
Emergency Medicine 0 (0) 55 (100) 2 (4) 45 (96) 
Other 1 (33) 2 (67) 7 (54) 6 (46) 
Environment     
Emergency Department 9 (13) 62 (87) 11 (13) 76 (87) 





Table L-3 Overall Compliance: Number (percentage) of Patients with Guideline Compliant Care  
 The Blue Book Hospital HealthPathways 







Patient     
Gender     
Female 3 (7) 40 (93) 5 (7) 69 (93) 
Male 3 (5) 53 (95) 7 (14) 44 (86) 
Age (years)     
18-44 0 (0) 29 (100) 8 (19) 35 (81) 
45-64 5 (13) 34 (87) 2 (5) 41 (95) 
65-74 1 (6) 17 (94) 1 (6) 16 (94) 
>75+ 0 (0) 13 (100) 1 (5) 21 (95) 
Ethnicity     
NZ European 6 (7) 81 (93) 12 (11) 95 (89) 
Māori 0 (0) 6 (100) 0 (0) 6 (100) 
Pacific Islanders 0 (0) 1 (100) 0 (0) 4 (100) 
Other 0 (0) 5 (100) 0 (0) 8 (100) 
Severity     
Mild 5 (6) 79 (94) 11 (11) 93 (89) 






M. Appendix M - Acute Pancreatitis Single Logistic 
Regression  
Table M-1 Single Logistic Regression Analysis: Patient Factors for Individual Acute Pancreatitis Guideline 
Recommendations 
Outcome Variable  BB  HHP  
   OR (95% CI)* P 
value** 




Gender Male 1.52 (0.67-3.52) 0.31 0.85 (0.40-1.79) 
 
0.66 
 Female a - - - - 
 Age (years) 18-44 a - - - - 
  45-64 2.41 (0.86-6.75) 0.10 0.42(0.17- 1.05) 
 
0.06 





  75+ 0.62 (0.17- 2.28) 
 
0.47 0.58(0.19- 1.76) 
 
0.33 
 Ethnicity Caucasian     
  Other 0.38(0.11-1.30) 
 
0.12 2.06 (0.63- 6.69) 
 
0.22 
 Severity Mild a - - - - 
  Severe 0.89 (0.29- 2.73) 
 
0.84 0.98 (0.37-2.75) 0.98 
Predicted 
Severity 
Gender Male 1.59 (0.53- 4.78) 
 
0.41 1.28 (0.44-3.79) 
 
0.65 
 Female a - - - - 
 Age (years) 18-44 a - - - - 
  45-64 0.49 (0.12-7 2.08) 
 
0.33 2.17 (0.60-7.82) 
 
0.24 
  65-74 0.54 (0.10-  2.99) 
 
0.48 3.56 (0.41- 30.85) 
 
0.25 
  75+ 0.59 (0.09-5  4.02) 
 
0.59 2.22( 0.43-11.49) 
 
0.34 
 Ethnicity Caucasiana - - - - 
  Other 2.05 (0.25-17.20) 
 
0.50 0.01 (0.00-40.23) 1 
 Severity Mild a     
  Severe 1.40(0.35-5.67) 
 
0.63 2.38 (0.80-7.12) 0.12 
Overall Gender Female a     
 Male 0.76 (0.15- 3.96) 
 
0.74 0.98 (0.29-3.28) 0.98 
 Age (years) 18-44 a -  -  
  45-64 38.7 (0.01-131.1) 1 0.22 (0.04-1.1) 
 
0.07 
  65-74 1.65 (0.81-3.93) 1 0.28(0.03-2.44) 
 
0.25 
  75+ 0.92 (0.45-1.96) 1 0.21(0.02-1.83)) 
 
0.16 
 Ethnicity Caucasian   
a 
    
  Other 2.05(0.25-17.20) 0.55 0.03 (0.00-127.03) 1 
 Severity Mild a - - - - 
  Severe 1.16 (0.13-10.66) 0.55 0.45 (0.06-3.69) 0.45 





Table M-2 Single Logistic Regression Analysis: Clinician Factors for Individual Acute Pancreatitis Guideline 
Recommendations 
Outcome Variable  BB  HHP  













 Female a - - - - 









  Registrar a     
















  Emergency 
Medicine a 
- - - - 












Table M-3 Single Logistic Regression Analysis: Environmental Factors for Individual Acute Pancreatitis Guideline 
Recommendations 
Outcome Variable    HHP  





Location ED 0.40 (0.20-1.89) 0.40 0.37 (0.14-0.94) 0.04 
 Acute Ward a - - - - 





N. Appendix N - Intracranial Haemorrhage on Warfarin Sub 
Group Analysis 
Table N-1 Correct Choice of reversal agent: Number (percentage) of Patients with Guideline Compliant Care 
 The Blue Book Hospital HealthPathways 









Patient     
Gender     
Male 7 (47) 8 (53) 8 (50) 8 (50) 
Female 5 (31) 11 (69) 5 (33) 10 (67) 
Age (years)     
18-44 0 (0) 1 (100) n/a n/a 
45-64 1 (17) 5 (83) 3 (60) 2 (40) 
65-74 2 (25) 6 (75) 3 (43) 4 (57) 
>75 10 (63) 6 (38) 7 (37) 12 (63) 
Ethnicity     
NZ European 12 (52) 11 (48) 11 (39) 17 (61) 
Māori 0 (0) 4 (100) 2 (67) 1 (33) 
Pacific Islands 1 (33) 2 (67) n/a n/a 
Other 0 (0) 1 (100) n/a n/a 
Mode of Bleed     
Traumatic 3 (14) 19 (86) 4 (31) 9 (69) 
Atraumatic 6 (67) 3 (33) 9 (50) 9 (50) 
Reason for Warfarinisation     
PE/DVT 3 (60) 2 (40) 5 (56) 4 (44) 
MVR/AVR 1 (17) 5 (83) 2 (40) 3 (60) 
AF 4 (22) 14 (78) 5 (33) 10 (67) 
Other 1 (50) 1 (50) 1 (50) 1 (50) 
Doctor     
Gender     
Male 3 (38) 5 (63) 5 (36) 9 (64) 
Female 3 (50) 3 (50) 6 (60) 4 (40) 
Unknown 8 (47) 9 (53) 2 (29) 5 (71) 
Seniority     
Registrar 6 (46) 7 (54) 1 (11) 8 (89) 
Senior Medical Officer 7 (54) 6 (46) 12 (55) 10 (45) 
Unknown 1 (20) 4 (80) n/a n/a 
Specialty     
Emergency Medicine 7 (47) 8 (53) 11 (55) 9 (45) 
Neurosurgery 3 (43) 4 (57) 0 (0) 3 (100) 
Unknown 0 (0) 2 (100) 0 (0) 1 (100) 
General Medicine 1 (25) 3 (75) 1 (25) 3 (75) 
Other 0 (0) 3 (100) 1 (33) 2 (67) 
Environment     
Emergency Department 13 (46) 15 (54) 15 (63) 9 (38) 




Table N-2 Correct Documentation on Blood Component Form: Number (percentage) of Patients with Guideline 
Compliant Care 
 The Blue Book Hospital HealthPathways 







Patient     
Gender     
Male 1 (7) 14 (93) 10 (63) 6 (38) 
Female 4 (25) 12 (75) 6 (40) 9 (60) 
Age (years)     
18-44 0 (0) 1 (100) n/a n/a 
45-64 0 (0) 6 (100) 4 (80) 1 (20) 
65-74 0 (0) 8 (100) 3 (43) 4 (57) 
>75 5 (31) 11 (69) 9 (47) 10 (53) 
Ethnicity     
NZ European 4 (17) 19 (83) 13 (46) 15 (54) 
Māori 1 (25) 3 (75) 3 (100) 0 (0) 
Pacific Islands 0 (0) 3 (100) n/a n/a 
Other 0 (0) 1 (100) n/a n/a 
Mode of Bleed     
Traumatic 2 (9) 20 (91) 5 (38) 8 (62) 
Atraumatic 3 (33) 6 (67) 11 (61) 7 (39) 
Reason for warfarinisation     
PE/DVT 0 (0) 5 (100) 4 (44) 5 (56) 
MVR/AVR 0 (0) 6 (100) 4 (80) 1 (20) 
AF 5 (28) 13 (72) 8 (53) 7 (47) 
Other 0 (0) 2 (100) 0 (0) 2 (100) 
Doctor     
Gender     
Male 0 (0) 8 (100) 8 (57) 6 (43) 
Female 2 (33) 4 (67) 5 (50) 5 (50) 
Unknown 4 (24) 13 (76) 3 (43) 4 (57) 
Seniority     
Registrar 1 (8) 12 (92) 4 (44) 5 (56) 
Senior Medical Officer 4 (31) 9 (69) 12 (55) 10 (45) 
Unknown 0 (0) 5 (100) 0 (0) n/a 
Specialty     
Emergency Medicine 4 (27) 11 (73) 13 (65) 7 (35) 
Neurosurgery 1 (14) 6 (86) 1 (33) 2 (67) 
Unknown 0 (0) 2 (100) 0 (0) 1 (100) 
General Medicine 0 (0) 4 (100) 1 (25) 3 (75) 
Other 0 (0) 3 (100) 0 (0) 3 (100) 
Environment     
Emergency Department 8 (29) 20 (71) 15 (63) 9 (38) 
Acute Ward 0 (0) 3 (100) 1 (14) 6 (86) 
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Table N-3 Correct Follow up Monitoring of Warfarin Reversal: Number (percentage) of Patients with Guideline 
Compliant care 
 The Blue Book Hospital HealthPathways 









Patient     
Gender     
Male 5 (33) 10 (67) 6 (38) 10  (62) 
Female 1 (6) 15 (94) 9 (60) 6 (40 
Age (years)     
18-44 0 (0) 1 (100) n/a n/a 
45-64 0 (0) 6 (100) 3 (60) 2 (40) 
65-74 0 (0) 8 (100) 2 (29) 5 (71) 
>75 6 (38) 10 (63) 10 (53) 9 (47) 
Ethnicity     
NZ European 4 (17) 19 (83) 13 (46) 15 (54) 
Māori 1 (25) 3 (75) 2 (67) 1 (33) 
Pacific Islands 1 (33) 2 (67) n/a n/a 
Other 0 (0) 1 (100) n/a n/a 
Mode of Bleed     
Traumatic 1 (5) 21 (95) 5 (38) 8 (62) 
Atraumatic 5 (56) 4 (44) 10 (56) 8 (44) 
Reason for 
Warfarinisation     
PE/DVT 1 (20) 4 (80) 3 (33) 6 (67) 
MVR/AVR 1 (17) 5 (83) 3 (60) 2 (40) 
AF 4 (22) 14 (78) 8 (53) 7 (47) 
Other 0 (0) 2 (100) 1 (50) 1 (50) 
Doctor     
Gender     
Male 1 (13) 7 (88) 5 (36) 9 (64) 
Female 1 (17) 5 (83) 7 (70) 3 (30) 
Unknown 4 (24) 13 (76) 3 (43) 4 (57) 
Seniority     
Registrar 3 (23) 10 (77) 4 (44) 5 (56) 
Senior Medical Officer 3 (23) 10 (77) 11 (50) 11 (50) 
Unknown 0 (0) 5 (100) n/a n/a 
Specialty     
Emergency Medicine 5 (33) 10 (67) 10 (50) 10 (50) 
Neurosurgery 1 (14) 6 (86) 1 (33) 2 (67) 
Unknown 0 (0) 2 (100) 1 (100) 0 (0) 
General Medicine 0 (0) 4 (100) 2 (50) 2 (50) 
Other 0 (0) 3 (100) 1 (33) 2 (67) 
Environment     
Emergency Department 11 (39) 17 (61) 12 (50) 12 (50) 





O. Appendix O - Appropriate Non-Compliance 
Table O-1 Categorised Reasons Documented for Non-compliance with CAP Guideline Recommendations of Choice 
of Antibiotics 
Category Definition Number of patients 
with reason 
documented in this 
category 
Antibiotic choice 
targeted to culture 
sensitivities 
Doctor tailored the choice of 
antibiotics to culture sensitivities. 
6 
Sepsis Patient met criteria for the diagnosis of 
sepsis based on observations and results 
not covered by the CURB-65 score e.g. 
high temperature and tachycardia. 
11 
Objectively unwell Observations or results (not covered by 
CURB-65 score) out of normal range 
e.g. oxygen saturations 
12 
Concurrent infection 
from another source 
Patient presented with a concurrent 





Radiographic features suggested severe 
pneumonia e.g. abscess. 
3 
Drug related (e.g. 
allergy, intolerance) 
Patient was unable to take antibiotic 
based on CURB-65 score due to drug 
allergy or intolerance. 
4 
Continuation of care Doctor continued antibiotic course 
started by an acute member of staff (e.g. 
paramedics, ED doctors). 
5 
Subjectively unwell Doctor documented that patient looked 
“unwell” with no supporting abnormal 
observations or results. 
5 
Failure of oral 
antibiotics 
Patient received one or more courses of 
oral antibiotics in the community with 
no resolution of symptoms. 
9 
Senior Medical Officer 
advice 
Doctor based management on advice of 
senior medical officer. 
3 
Suspicion of an 
atypical infection 
Patient had risk factors for, or clinical 
or radiological findings of an atypical 
infection. 
4 
Co-morbidity Patient had a co-morbidity that affected 
the choice of antibiotics. 
4 
Multiple Reasons More than one of the above reasons 
documented 
8 
Other Includes: “infection resolving”, “broad 
cover”, “smoker”, “young” and 






Table O-2 Categorised Reasons Documented for Non-Compliance with CAP Guideline Recommendation on 
Admission Decision 
Category Definition Number of patients with 
reason documented in 
this category 
Other acute illness Patient suffered from a 
secondary acute process which 
requires admission. 
93 
Sepsis Patient met criteria for the 
diagnosis of sepsis based on 
observations and results not 
covered by the CURB-65 score 
e.g. high temperature and 
tachycardia. 
14 
Objectively unwell Observations or results (not 
covered by CURB-65 score) 
out of normal range e.g. 
oxygen saturations 
25 
For further investigation Patient admitted for further 
investigation e.g. CT chest if 
chest X-ray showed sign of 
malignancy. 
32 
Co-morbidity Patient required inpatient 
management for co-morbidity. 
5 
Poor mobility Patient was unable to 
mobilise, therefore unsafe for 
outpatient management. 
3 
Social input Patient required input from 
multi-disciplinary team 
3 
Failure of oral antibiotics Patient received one or more 
courses of oral antibiotics in 
the community with no 
resolution of symptoms. 
8 
Complications on chest X-ray Radiographic features 
suggested severe pneumonia 
e.g. abscess. 
6 
Symptom management Patient required inpatient 
management of symptoms 
relating to CAP e.g. pleuritic 
chest pain. 
4 
Admission for IV antibiotics 
based on culture sensitivities 
Doctor tailored choice of 
antibiotics to culture 
sensitivities. Patient required 
admission for IV antibiotics. 
2 
For review by another team Admitted for a review by 
another specialty team 
1 
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